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Summary 
Structural and functional studies of integral membrane proteins currently represent a most challenging 
research area. Since many integral membrane proteins are involved in disease, understanding their 
structure/function relationship could greatly improve the efficiency of drug discovery. This requires the 
acquisition of detailed structural data, however, these are tedious to obtain due to the several 
limitations encountered in the expression, purification and crystallisation of integral membrane 
proteins. To date, the 3D structures of only 93 membrane proteins are known in molecular detail, 
though several thousand structures of soluble proteins have already been solved. 
This work was directed towards the elucidation of the structure of a G-protein-coupled receptor 
(GPCR), the Saccharomyces cerevisiae alpha-factor receptor Ste2p, and a putative amino-acid 
transporter of Methanococcus jannaschii, designated Aatp. 
 
GPCRs comprise one of the largest superfamily of membrane proteins, and from the viewpoint of 
pharmacology, the most interesting one. They act as cell surface receptors responsible for the 
transduction of a remarkable diversity of exogenous signals (hormones, neurotransmitters, photons, 
ions, growth factors, odorants) into a cellular response by activating intracellular heterotrimeric G-
protein complexes. Only one 3D structure of a GPCR, namely of bovine rhodopsin, has been resolved 
so far. 
In the present work, Ste2p was modified to remove post-translational modifications, so as to obtain a 
homogenously yet functionally expressed protein product. It additionally carries both a FLAG- and 
His6-tag to facilitate immunodetection and affinity purification. The modified receptor was cloned, and 
homologously overexpressed in S.cerevisiae. It could be rapidly and efficiently purified, and the final 
purification protocol yielded about 5 mg of 90% pure protein from 10 litres of culture. Finally, purified 
receptor was subjected to 3D crystallisation trials in an attempt to obtain high quality crystals for X-ray 
crystallography. 
 
Hyperthermophilic proteins are of high interest for the biotechnological industry because of their 
stability at high temperatures (>60°C). In that sense, they are expected to be more stable 
crystallisation targets than mesophilic proteins. A special challenge is to understand the molecular 
mechanisms that confer thermostability. Until now, crystal structures of only a few proteins from 
thermophilic organisms have been determined, thus limiting the understanding of these features. 
The present study aimed at different hyperthermophilic transporters, in particular the amino acid 
transporter Aatp. Although all proteins were cloned in S.cerevisiae only Aatp was overexpressed. 
Aatp carries a hexahistidine tag at its C-terminus. A fast and efficient purification protocol was 
developed that yielded 6 mg of Aatp from 10 litres of culture. Aatp purified in this way was 
homogenous, monodisperse and 90% pure, which allowed 3D- and 2D-crystallisation trials for the 
production of high quality crystals for X-ray crystallography. 
  8 
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Introduction 
 
1. Structure and function of membrane proteins: challenges of the study 
1.1. Importance of membrane proteins 
The genome sequencing projects reveal that integral membrane proteins represent up to one third of 
the predicted proteins of all organisms examined so far. Furthermore, membrane proteins are the 
target of the large majority of drugs currently in use. About 80% of all cellular responses are thought 
to occur through proteins linked to the cell membrane. An ultimate understanding of their function 
depends on detailed structural data for each class of membrane proteins, such as transporters, 
receptors, channels and pumps. The structural information could also greatly improve the efficiency of 
drug discovery (Sachs and Engelman, 2006; Loll, 2003; Kuhn et al., 2002; Werten et al., 2002). To 
date, the 3D structures of only a tiny fraction of polytopic helical-type membrane proteins, 58 in total 
(in addition to 35 polytopic β-stranded and monotopic membrane proteins), are known in molecular 
details, though several thousand structures of soluble proteins have already been solved (source: 
http://www.mpibp-frankfurt.mpg.de/michel/public/memprotstruct.html). 
1.2. The difficulties in studying membrane proteins 
The lack of structural data on integral membrane proteins is mainly due to the difficulty to determine 
their 3D structure. This difficulty is most notably related to their hydrophobic nature and to their low 
natural abundance. They are usually expressed at comparably low levels and constitute less than 
0,1% of the total cellular proteins (McPherson, 2004). 
This requires to find an accurate and efficient overexpression system to produce sufficient amounts of 
protein for crystallisation experiments. In general, the term “overexpression” is used to describe the 
production of proteins at a level that exceeds the endogenous one, e.g., 10–100 mg of protein per litre 
of culture. Indeed, for systematic 3D crystallisation experiments, several tens of milligrams or more of 
highly pure protein are needed, however, few membrane proteins are abundant enough in natural 
sources. An expression level of 0,2 mg per 1 l of culture will rapidly be limiting, particularly when 
considering that the overall yield of the purification procedure is generally very low. 
 
Many membrane proteins are post-translationally modified. Since the modification is not always 
uniform, this is a source of inhomogeneity that interferes with successful protein crystallisation. 
Overexpression systems usually allow genetic engineering of the target protein in order to prevent the 
modification, that can, as long as the protein function is preserved, yield more homogeneous protein. 
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Other limitations for the study of membrane proteins are their transmembrane domains which result in 
sometimes extreme hydrophobicity. This makes them refractory to direct manipulation in aqueous 
solutions and necessitates the use of detergents for their functional solubilisation from the membrane 
and maintenance of their solubility throughout the purification process.  
 
The choice of the expression system is critical in order to obtain a functional protein product. An 
overexpression system can be either homologous or heterologous. Both systems have their specific 
advantages and limitations, like how promising successful overexpression of a given target 
membrane protein appears, the genetic characterisation, the amenability to manipulation, the costs, 
and so on. The organisms commonly used for protein overexpression are bacteria (Escherichia coli), 
yeasts (Saccharomyces cerevisiae, Schizosaccharomyces pombe, Pichia pastoris), bacculovirus/ 
insect cells, and mammalian cells.  
 
The advantages offered by E.coli are numerous, e.g., the homogeneity of recombinant proteins, no 
post-translational modifications, its short generation time (20 min), or its short delay of expression. 
However, E.coli is not the first choice organism for the overexpression of integral membrane proteins. 
Most importantly, E.coli cells simply do not contain enough membranes for the overproduction of 
membrane proteins. Moreover, the reductive environment of the bacterial cytoplasm can considerably 
slow down the production of functional integral membrane proteins, particularly if the correct folding of 
the protein requires formation of disulfide bridges (Sarramegna et al., 2003).  
 
Yeast  is an excellent alternative to E.coli for the production of recombinant proteins. It is more easily 
amenable to rapid genetic manipulation than other eukaryotic cell systems (Bill, 2001). Yeast can 
perform post-translational modifications which are often required for the proper function of a 
(heterologous) protein. This feature is exploited when foreign proteins are expressed in yeast in order 
to study their function in vivo. However, it plays a minor role for the overproduction of a protein for 
crystallisation where monodisperse preparations are required, and post-translational modifications 
can be a source of inhomogeneity.  
In particular, S.cerevisiae is a very attractive expression system, because of its capacity for high level 
protein production (including integral membrane proteins), its easy and usually inexpensive 
manipulation, its well-characterized genetics (the complete genome sequence is now available) as 
well as the availability of a large number of cloning vectors for the expression of foreign genes, and 
the short generation time (2 h) on very simple, low cost media.  
 
 
The recent successful structure determination of the oligomeric mitochondrial cytochrome bc1 
membrane protein complex from S.cerevisiae (Hunte et al., 2000) shows that the large-scale 
purification of membrane proteins from S.cerevisiae is feasible in a suitable form for crystallisation.  
Introduction 
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Other yeasts, like S.pombe and P.pastoris were also tested for production of membrane proteins. In 
particular, P.pastoris is a very efficient system for protein overproduction, however only few 
membrane proteins have been successfully expressed in P.pastoris so far (Lin-Cereghino and Cregg, 
2000). Moreover, certain disadvantages, e.g., a comparatively sparse palette of methods for genetic 
manipulation and limited knowledge of the biochemistry of that organism have still to be overcome .  
 
 
For this study, the yeast Saccharomyces cerevisiae was then chosen as the expression system.  
 
These features taken together make the development of methods for the study of membrane proteins 
lag far behind those of soluble proteins. Finally, one has to point out that large amounts of pure and 
homogeneous protein are absolute prerequisites to begin with crystallisation experiments. However, 
growing crystals with which to obtain high quality structural data is yet another story.  
2. Membrane protein families of interest 
Up to now, 58 polytopic membrane proteins from bacteria and eukaryotic cells have been solved. 
Among them are plant photosystems and bacterial reaction centres (7), bacterial rhodopsins (5), light 
harvesting complexes (14), potassium channels (5), aquaporins and glycerofacilitators (5) and diverse 
transporters (7). The structure of only one GPCR has as yet been solved (source: http://www.mpibp-
frankfurt.mpg.de/michel/public/memprotstruct.html). 
2.1. G-Protein Coupled Receptors 
GPCRs represent a superfamily of integral membrane proteins. They are highly conserved through 
evolution and expressed in nearly all organisms ranging from yeast to humans. Almost 1% of all 
human genes code for this receptor family. They are involved in a wide spectrum of hereditary and 
somatic disorders and diseases, and are, thus, of enormous importance for the pharmaceutical 
industry (Pausch, 1997). GPCRs are the targets of more than 50% of the drugs currently used in 
therapeutics (Sautel and Milligan, 2000; Gudermann et al., 1997), e.g., medicines such as beta 
blockers and anti-histamines, or drugs like opium and cannabis. 
 
GPCRs are located in the plasma membrane. Their highly conserved three-dimensional structure is 
characterised by a common hydrophobic core composed of seven transmembrane α-helices, linked 
with three extracellular and three cytosolic loops. The N-terminal domain is extracellular, the C-
terminal domain is cytosolic. The extracellular loops and the N-terminal domain are often 
glycosylated. All receptors cloned to date have at least one consensus sequence for N-linked 
glycosylation (Asn-X-Ser/Thr) in the extracellular domain. There are two highly conserved Cys 
residues in the second and third extracellular loops. The C-terminal domain usually contains a cystein 
residue attached to a lipid group. This group, often a myristoyl residue, is embedded in the membrane 
(Strader et al., 1994). 
Introduction 
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Fig. 1 presents the classification of the different sub-families of GPCRs, with their main features 
(Bockaert and Pin, 1999) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 1: Classification of the G-protein coupled receptors, according to Bockaert and Pin (1999) (coloured 
schematic representation: courtesy of J. Bockaert). Family 1: Rhodopsin receptors and similar. Family 1a: 
receptors binding small ligands and with a binding site located between the membrane domains constituting the 
GPCRs “central region”.  Family 1b: Receptors binding peptides, with a binding site located in the N-terminus 
and the upper part of the transmembrane domains. Family 1c: glycoproteic hormone receptors, binding site in 
the external N-terminus. Family 2: Peptidic hormone receptors (secretin and similar). The family 2 present a 
similar morphology to the family 1 but no sequence similarity. Family 3: mGluRs and Ca2+-detecting receptors, 
like the G0 coupled GABAB (metabotropic GABA receptor pheromone-receptors. LH: luteneizing hormone, TSH: 
thyroid stimulating hormone, FSH: follicle stimulating hormone, CG: chorionic gonadotropin, PTH: parathyroid 
hormone, VIP: vasoactive intestinal peptide, PACAP: pituitary adeny/y/ cyclase activating peptide, GHRH: 
growth hormone releasing hormone, CRF: corticotropin releasing hormone, II8: interleukine 8, PAF-acether: 
platelet-activating-factor-acether, GABA: gamma-amino-butyric acid. Green points in the family 3 are very well 
conserved cysteines in the metabotropic glutamate receptors.  
 
GPCRs are responsible for the direct communication between the surroundings and the cell. They 
relay various extracellular signals and stimuli from the periplasmic side into the interior of the cell by 
activation of intracellular, heterotrimeric G-protein complexes (guanine nucleotide-binding regulatory 
protein) (Schoneberg et al., 1999).  
Family 1 
1a 
1b 
1c 
Peptides 
Cytokines 
Il8 
Formyl Met-Leu-Phe 
(fMLP) 
PAF-acether 
Thrombin  
Glycoprotein 
hormones 
(LH, TSH, FSH, CG) 
Retinal 
Odorants 
Catecholamines 
Adenosine 
ATP, Opiates 
Enkephalines 
Anandamide 
Family 2 
Calcitonin 
Secretin  
PTH  
VIP 
PACAP 
GHRH 
CRF 
Family 3  
Glutamate 
metabotropic 
receptors 
Sensing Ca++ 
receptors 
GABAB receptors 
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The cues for these signals are as diverse as hormones, pheromones, growth factors, 
neurotransmitters, odorants, photons and ions ((Watson and Arkinstall, 1994).  
The signal is transmitted through the transmembrane helices to the cytosolic side where the G protein 
becomes activated and leads, usually through a cascade of kinase activations, to the initiation of gene 
transcription (Galvez and Pin, 2003; Gudermann et al., 2000; Bockaert and Pin, 1999; Bockaert and 
Pin, 1998; Gudermann et al., 1997; Strader et al., 1994; Strader et al., 1989) Dysfunction of GPCRs 
results in diseases as diverse as Alzheimer’s, Parkinson’s, diabetes, dwarfism, colour blindness, 
retina pigmentosa and asthma. GPCRs are also involved in depression, schizophrenia, 
sleeplessness, hypertension, impotence, anxiety, stress, renal failure, several cardiovascular 
disorders and inflammations (Schoneberg et al., 2002; Young et al., 2002; Spiegel, 2000; Schoneberg 
et al., 1999; Spiegel, 1996). 
About 1000 GPCR protein sequences are currently available in the publicly accessible databases, 
and about a dozen new sequences become available every month (e.g. the Swiss-Prot database). 
However, in contrast with this wealth of sequence data and in spite of their widespread occurrence in 
humans and other eukaryotes and tremendous importance to the pharmaceutical industry, only one 
structure of a GPCR is available, that was solved at sufficient resolution to reveal mechanistic details 
of ligand binding and signal transmission. This is the structure of bovine rhodopsin, determined by X-
ray crystallography at 2,8 Å resolution (Fig. 2) (Palczewski, 2006; Palczewski et al., 2000). Light 
activated bovine rhodopsin is the representative of a number of GPCRs in which the activating 
extracellular chemical stimulus is bound to a binding pocket within the bundle of the seven α-helices, 
in the plane of the lipid bilayer. 
Fig. 2 Representation of the 3D-structure of bovine rhodopsin. 
(Palczewski, 2006; Palczewski et al., 2000). View parallel to the 
plane of the membrane. The transmembrane domains are 
designated with roman numbers I to VII. 
 
 
 
 
 
 
 
 
Because of their central role in biological systems, detailed understanding of the process that controls 
the interaction of GPCRs with their ligands and associated G proteins is very challenging. This 
understanding would be greatly improved by high-resolution 3D structures of these receptors.  
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2.2. Hyperthermophilic transporters from Methanococcus jannaschii 
2.2.1. The archeon Methanococcus jannaschii (Methanocaldococcus jannaschii) 
Archaea, although they are prokaryotic organisms, share specific features with Eukarya, and they 
have now been recognized as their closest ancestors. Their unique phylogenetic position, and the fact 
that in many cases they actually bridge the gap between Eukarya and Bacteria, renders them an ideal 
system for genomic comparisons. 
 
Methanococcus jannaschii is the first archaeal organism whose genome has been completely 
sequenced (Bult et al., 1996).  
Discovered in 1983, strain JAL-1 was originally isolated from a sediment sample collected from the 
sea floor surface of a 2600 m-depth “white smoker” chimney, in the East Pacific Rise near the 
western coast of Mexico (Jones et al., 1983). Two similar strains were isolated from hydrothermally 
active sediments in the Guaymas Basin at a depth of 2000 meters (Jones et al., 1983). M.jannaschii 
is able to grow at high temperatures, ranging from 48 to 94 °C, with an optimum growth temperature 
at 85 °C. It also grows in habitats with pressures up to more than 200 Atm (Mombelli et al., 2002), and 
is adapted to moderate salinity as well. M.jannaschii is a hyperthermophilic methanogenic archaeon, 
and a typical  autotroph. Though it has not yet been demonstrated that M.jannaschii can fix nitrogen 
like a number of other methanogens, the sequencing of its genome revealed the presence of all the 
genes necessary for this pathway. It is a strict anaerobe organism, and, thus, it performs anaerobic 
respiration and obtains its energy by the reduction of CO2 with H2 to generate methane. Cells of 
M.jannaschii are irregular cocci (Jones et al., 1983). The cell envelope is composed of a cytoplasmic 
membrane and a protein surface layer. Polar bundles of flagella are also present. This morphology is 
common among methanococci. 
2.2.2. Hyperthermophilic proteins from M.jannaschii 
Proteins from hyperthermophilic organisms are of major interest for the biotechnological industry 
because of their enormous stability, especially against thermal denaturation (Perl, 2002 ; Jaenicke, 
1996; Gross and Jaenicke, 1994). 
Hyperthermophilic proteins are expressed and function optimally at high temperature, (60°C and 
higher), and they are in general thermodynamically more stable than mesophilic proteins, that are 
expressed at a temperature between 20 and 40°C.  
Understanding the molecular principles that furnish the proteins of extremophiles with stability at high 
temperatures, under high pressure or at extreme pH values would be very useful for future 
biotechnology. 
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Crystal structures of only a few proteins from thermophilic organisms have, until now, been 
determined. Due to limited 3D structural analysis data of hyperthermophilic proteins, it is difficult to 
determine the critical factors for protein thermostability. No general rules or definitive explanations for 
thermal stabilisation have been deduced so far from sequence  (Bohm and Jaenicke, 1994) and/or 
structural data (Jaenicke and Bohm, 1998). Nevertheless, reasons for high thermostability that have 
been suggested are hydrogen-bonds (Vogt and Argos, 1997; Vogt et al., 1997), hydrophobic 
interactions (Spassov et al., 1995), internal packing (Thompson and Eisenberg, 1999), salt-bridges  
(Chan et al., 1995; Yip et al., 1995; Kelly et al., 1993) and secondary structural features (e.g. intra-
loop, rop-loop, (Nagi and Regan, 1997)) .  
Comparison between thermophilic and mesophilic protein sequences shows that amino acid residues 
capable of forming hydrophobic, hydrogen or ionic bonds occur more frequently in hyperthermophilic 
proteins (Shiraki et al., 2001; Vieille and Zeikus, 2001; Thompson and Eisenberg, 1999; Vetriani et al., 
1998; Rice et al., 1996; Chan et al., 1995; Spassov et al., 1995; Szilagyi and Zavodszky, 1995). In 
integral membrane proteins, the bonds result in strong interactions between pairs of transmembrane 
domains (TM), and they are expected to add extra-stability to transmembrane domain interactions at 
higher temperatures (Schneider et al., 2002). 
Comparisons of the structure and of the conformational stability (by comparison of thermodynamics 
and unfolding profiles) between thermophilic and mesophilic proteins revealed that clusters of salt 
bridges may be an important factor contributing to high thermostability. Evidently, packing density 
enhanced by van der Waals interactions and additional networks of ion pairs and hydrogen bonds 
seem to play a major role in the thermal adaptation strategies. Indeed, owing to a tighter helical 
packing, thermophilic proteins are thought to be better able to resist denaturation due to the decrease 
of lateral pressure (Schneider et al., 2002; Shiraki et al., 2001). 
 
The glutamate transporter (GltT) from Bacillus stearothermophilus is an example of a highly stable 
thermophilic membrane protein (Wang et al., 2003). GltT constitutes an extremely stable protein in 
comparison to similar transporters from mesophiles. It remains dimeric from pH 4-9 in different 
detergents. When incubated at 37°C for 2h, GltT shows no aggregation or change in oligomeric state.  
 
As membrane proteins from thermophilic organisms are expected to be more stable in the detergent-
solubilised state than their mesophilic counterparts (Schneider et al., 2002; Shiraki et al., 2001), they 
are thought to represent ideal crystallisation targets.  
For this reason, we chose to study different membrane proteins from M.jannaschii.  
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3. Characteristics of the proteins of interest 
Considering the difficulties inherent to studies on membrane proteins and the small number of 3D-
structures of membrane proteins that are currently solved, a GPCR of S.cerevisiae, and several 
transporters of M.jannaschii were chosen for expression in yeast in order to select among them the 
best candidates for subsequent crystallisation experiments.  
3.1. Ste2p, a G-Protein Coupled Receptor of Saccharomyces cerevisiae 
We chose to study the alpha-factor pheromone receptor of Saccharomyces cerevisiae, Ste2p. We 
presumed it would be a good candidate for structural analysis, since Ste2p belongs to the class D 
pheromone family of G-protein coupled receptors. Ste2p has been frequently used as a model for 
studying the structure and function of GPCRs (Lee and Altenberg, 2003; Dohlman and Thorner, 2001; 
Leberer et al., 1997). 
3.1.1. Function of Ste2p  
S.cerevisiae haploid cells of either a- or α- mating-type, secrete peptide pheromones, the a- and α-
factors, which bind to their GPCRs, Ste3p or Ste2p, respectively that are located in the plasma 
membrane. Binding leads to activation of the mating signal-transduction pathway, which results in 
cell-cycle arrest in G1, morphological changes and transcriptional activation of genes involved in the 
pheromone response and mating process. Upon binding of the α-factor, a tridecapeptide pheromone 
(Trp-His-Trp-Leu-Gln-Leu-Lys-Pro-Gly-Gln-Pro-Met-Tyr), Ste2p initiates a cascade of intracellular 
events that lead to mating of haploid yeast cells. 
 
The molecular details of this pathway have been extensively investigated  (Dohlman and Thorner, 
2001; Versele et al., 2001; Pausch, 1997) (Fig. 3). After binding of their ligands, the pheromone 
receptors interact with a heterotrimeric G protein, (whose α-, β- and γ-subunits are encoded by GPA1, 
STE4 and STE18, respectively), that catalyses the exchange of GDP for GTP bound to the α-subunit.  
Subsequently, the β/γ-subunit complex dissociates from the α-subunit, and initiates a MAP kinase 
cascade by activation of the protein kinase Ste20p and the scaffold protein Ste5p. Ste5p forms the 
core of a signaling complex that contains the Ste11p MAPKKK, the Ste7p MAPKK and the 
Fus3p/Kss1p MAPK. Activated Fus3p/Kss1p then induces the transcription of several specific mating 
factor-inducible genes by activating the transcription factor Ste12p. The activation of Fus3p/Kss1p 
also leads to the cell cycle arrest at the G1/S transition by activating the inhibitor of the Cdc28-Cln 
kinase, Far1p (Posas et al., 1998). 
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Fig. 3: Saccharomyces cerevisiae pheromone response pathway. Involved proteins are represented in 
coloured blocks. Gα, Gβ and Gγ represent respectively the α, β and γ subunits of the heterotrimeric G-protein. 
PAK: Protein Activated Kinase, MPAK: Mitogen Activated Protein Kinase MAPKK: MPAK Kinase, MAPKKK: 
MPAK Kinase Kinase, TF: Transcription Factor.  
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3.1.2. Secondary structure of Ste2p  
Ste2p features 5 possible glycosylation sites, among which only the Asn32 and the Asn25 are used. It 
presents an endocytosis signal in the C-terminus (Fig. 4). 
 
Fig. 4: Topology model of Ste2p secondary structure. The model was established manually, based on the 
topology prediction of the software TMHMM. Ste2p features 471 amino-acids and a molecular weight of 
47848,7 kDa. Ste2p presents 7 transmembrane domains, between the amino-acids #49-#71, #79-#102, #132-
#154, #161-#183, #203-#225, #245-#267 and #275-#297. The N-terminal part NH2 is periplasmic, and the C-
terminal part COOH is cytosolic. The residues Asn25 and Asn32 are glycosylation sites. The mutant receptor 
used in this work was truncated after the residue Ser326. 
 
In fact, Ste2p shows no significant sequence similarity to human receptors of clinical interest. 
Nevertheless, previous biochemical studies on this receptor (mutational and homology modeling) 
revealed characteristics of GPCRs that highlight the underlying structural and functional similarities 
between the yeast and mammalian homologues (Eilers et al., 2005). An activation of mammalian G-
protein by Ste2p and a reciprocal activation of the yeast pheromone responsive pathway by 
mammalian GPCRs were demonstrated (Ladds et al., 2005; Yin et al., 2005; Ladds et al., 2003). 
These observations taken together made Ste2p a very attractive candidate for experimental structure 
determination and the study of GPCR signal transduction mechanisms. The elucidation of its structure 
should provide fundamental insights into the structure-function relationships of ligand-binding and 
activation of peptide-responsive human GPCRs.  
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3.2. Hyperthermophilic transporters from M.jannaschii 
We chose to overexpress five different types of putative membrane transporters from Methanococcus 
jannaschii: an amino-acid transporter (AAT), a sodium-dicarboxylate transporter (DASS), a sodium 
transporter (NSS), a potassium uptake protein (TRK) and a putative phosphate permease (PHOP). 
Their secondary structure pattern and selected biophysical parameters of the different membrane 
proteins, such as size, numbers of transmembrane helices and isoelectric point are outlined in Fig. 5. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 5: Secondary structure pattern of the proteins of interest. Prediction by the TMHMM software. 
 
Amino acid transporter (AAT) 
J0609, 435aa, 12 TM, 47,4 kDa, pI: 9,26 
Putative phosphate permease (PHOP) 
MJ0630, 297 aa, 7 TM, 32 kDa, pI: 9,52 
Sodium-dicarboxylate transporter (DASS) 
MJ0672; 432aa,13 TM, 47,5 kDa, pI: 8,88 
Sodium transporter (NSS family)                  
MJ1319, 492 aa, 12 TM, 53,5 kDa, pI: 8.66 
Potassium uptake protein (TRK) 
MJ1485, 474 aa, 10 TM, 52,5 kDa, pI: 9,27 
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4. Reasons for the overexpression of Ste2p and hyperthermophilic transporters in  
S.cerevisiae 
4.1. Expression of the GPCR Ste2p in S.cerevisiae 
The majority of heterologously expressed GPCRs are from murine and human origin and, therefore, 
require a specific lipid environment. Indeed, the activity of certain receptors such as the oxytocin 
(Gimpl et al., 1995), the transferrin  (Nunez and Glass, 1982) and human µ-opioid receptors  (Lagane 
et al., 2000; Hasegawa et al., 1987) strongly depends on the lipid environment. Obviously, 
mammalian cells represent the most appropriate expression system for these GPCRs, more so as 
they can provide the G proteins necessary for a functionality test of the expressed GPCR. However, 
these advantages are opposed by problems like relatively long generation times, the need for stable 
cell lines, that are expensive and time-consuming to generate, and the requirement of complex and 
costly culture media (Sarramegna et al., 2003). 
The expression level of a given GPCR can significantly vary in different expression systems. For 
instance, the human β2-adrenergic receptor is very efficiently expressed in almost every system, 
(Sarramegna et al., 2006; Opekarova and Tanner, 2003; Sarramegna et al., 2003; Sizmann et al., 
1996), whereas the human µ-opioid receptor is expressed at low levels in whatever system used 
(eukaryotic or prokaryotic,  (Sarramegna et al., 2003)). 
Of the 25 GPCRs expressed in yeast, 14 were expressed at a level above the minimal expression 
yield of 5 pmol/mg of total membrane protein. In E.coli, out of 25 expressed GPCRs, only 4 exceeded 
the minimal expression level as compared to 13 out of 60 in insect cells and 10 out of 55 GPCRs in 
mammalian cells (Shi et al., 2005; Yin et al., 2005). This survey which is far from being complete 
argues strongly for GPCR expression in yeast as it is the system in which the minimal expression 
yield was most frequently obtained. Yeasts are an attractive expression system also with regard to 
lipid environment since their membranes are composed of lipids similar to those of mammalian 
cells.Nevertheless, the optimal expression system has to be individually chosen for each single 
GPCR (Sarramegna et al., 2003; Chapot et al., 1990). 
 
The functional expression of a number of G-protein coupled receptors was demonstrated in yeast 
(Ladds et al., 2005; Reilander and Weiss, 1998; Grisshammer and Tate, 1995). Some of these 
receptors were expressed at good levels, like the human α2-adrenergic receptor subtype C2 (70 to 
350 pmol/mg membrane protein) (Sizmann et al., 1996; King et al., 1990) and the human β2-
adrenergic receptor (Sizmann et al., 1996; King et al., 1990). For other GPCRs the expression in 
S.cerevisiae was the only possible way. 
 
The S.cerevisiae α-factor receptor, Ste2p, was homologously expressed in S.cerevisiae for in vivo 
functional studies (Caponigro et al., 2003; Lee and Altenberg, 2003; Lin et al., 2003; Overton and 
Blumer, 2002; Parrish et al., 2002; Mentesana and Konopka, 2001; Konopka et al., 1988). 
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Homologously overexpressed Ste2p was purified and used in reconstitution and ligand binding 
experiments that demonstrated that the detergent-solubilised receptor retained its native structure 
(David et al., 1997). Although expression levels were the highest ever obtained for a GPCR (350 
pmol/mg membrane protein, (Sarramegna et al., 2003)), the yields of purified protein (1 mg of 
receptor at 95% purity from 20 litres of cell culture) were lower than expected, suggesting that the 
efficiency of solubilisation and/or purification can still be improved. Ste2p was also expressed in 
mammalian cells (Shi et al., 2005; Yin et al., 2005), however, even if the expressed proteins were 
functional, their expression levels were very low. This example clearly illustrates the importance of a 
native receptor environment. 
For protein crystallisation experiments, high amounts of pure and monodisperse protein are required, 
although automated crystallisation experiments by robots need only few nanoliters amounts of 
proteins. In order to obtain the required quantity, we decided to overexpress Ste2p in its native 
environment, the plasma membrane of S.cerevisiae. Furthermore, we modified the amino acid 
sequence of Ste2p in a way that excluded post-translational modifications but did not adversely affect 
the receptor activity. For facilitated purification, we fused the receptor to two affinity tags. 
 
4.2. Expression of the hyperthermophilic membrane proteins in S.cerevisiae 
The heterologous expression of thermophilic proteins in mesophilic hosts greatly facilitates the 
purification of the desired thermostable product. Non heat-stable proteins can be denatured and 
precipitated by a heat treatment step whereas the desired protein remains soluble and functional due 
to its inherent thermostability. Thermophilic archea use rare codons for translation. Thus, if E. coli is 
chosen as the expression host, it has to carry plasmids encoding tRNAs that recognise rare codons, 
whereas the same codons are frequently used by eucaryotic organisms. Some hyperthermophilic 
membrane proteins from Thermotoga maritima were expressed in E.coli, but a low levels (Columbus 
et al., 2006). 
 
The functional expression of hyperthermophilic membrane proteins has been demonstrated in 
S.cerevisiae, at good levels, like a H+-PPase and a V-PPase from Thermotoga maritima (López-
Marqués et al., 2005; Perez-Castineira et al., 2001) and the Ca2+-ATPase from M.jannaschii 
(Morsomme et al., 2002), and eight other membrane proteins from T.maritima (Columbus et al., 
2006)). It was also previously shown that the H+-PPase from T.maritima, overexpressed in 
S.cerevisiae, was resistant to yeast proteases (Perez-Castineira et al., 2001) and that 
hyperthermophilic proteins proved to be resistant to proteolyse (triosephosphate isomerase from 
Pyrococcus furiosus, (Mukherjee and Guptasarma, 2005). S.cerevisiae also proved to be efficient for 
the functional expression of Ca2+-signaling and Ca2+-transporting ATPases (Ton and Rao, 2004). A 
vacuolar-type H+-PPase from T.maritima and a plant H+-ATPase were as well functionally expressed 
and characterised in S.cerevisiae (Perez-Castineira et al., 2001; Lanfermeijer et al., 1998; 
Lanfermeijer et al., 1997). 
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For these reasons and because eukaryotic cells are generally better suitable for the expression of 
integral membrane proteins, S.cerevisiae was chosen for the expression of the M.jannashii 
membrane transporters. 
 
The general aim of this study was therefore the overexpression and isolation of membrane proteins in 
general, and Ste2p and Aatp specifically, in S.cerevisiae in order to initiate the approach for 3D-
structural elucidation by crystallisation. 
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Results 
 
In this study, the GPCR Ste2p was cloned, modified and homologously overexpressed in 
Saccharomyces cerevisiae. The receptor was purified by affinity chromatography, and crystallisation 
experiments were finally undertaken. We worked with a mutant form of the α-factor receptor Ste2p, 
designated Ste2mp. Ste2p was truncated at the C-terminus and site-specific amino acid mutations 
were introduced in order to avoid post-translational modification. Two-affinity-tags, a His6-tag and a 
FLAG-tag, were added to the C-terminal part of the truncated protein, to facilitate purification by 
affinity chromatography procedures. Activity assays were conducted to rule out a possible 
interference of the modifications with protein function. Three different plasmid constructs and several 
different culture conditions were tested in order to optimise Ste2mp expression. Once suitable 
overexpression conditions were implemented, several detergents were tested for Ste2mp 
solubilisation and affinity chromatography was customised for the purification of detergent-solubilised 
Ste2mp. After a final characterisation of the purified integral membrane protein it was subjected to 
preliminary crystallisation experiments. 
5. Homologous overexpression and isolation of the Saccharomyces cerevisiae  
α-factor receptor Ste2p in Saccharomyces cerevisiae 
5.1. Cloning strategy 
5.1.1. Ste2p amino-acid sequence alterations: mutations of N-glycosylations sites and 
truncation of the C-terminal part 
Eukaryotic cells are able to perform post-translational modifications, such as N-glycosylation, that, 
e.g., can influence protein folding and/or stability, or phosphorylation that is involved in signal 
transduction. Post-translational modifications, despite their biochemical importance can, however, 
lead to protein structure heterogeneities and subsequently problems during crystallisation. Previously, 
it had been shown that purified wild-type Ste2p displayed heterogeneity on SDS gels, which in part 
originated from N-glyclosylation of the receptor (Mentesana and Konopka, 2001). Ste2p is 
glycosylated at two consensus N-glycosylation sequences present at the extracellular N-terminal 
domain of the protein (Mentesana and Konopka, 2001). 
In order to obtain a homogenous protein preparation for crystallisation, all known post-translational 
modification sites were removed from Ste2p. Thus, the cytoplasmic C-terminal part of Ste2p was 
truncated at position Ser326 to remove endocytosis signals as well as residues that are phosphorylated 
in the receptor´s basal state (Konopka et al., 1988; Reneke et al., 1988).  
Out of the five potential N-glycosylation sites, Asn25, Asn32, Asn46, Asn105 and Asn205, only Asn25 and 
Asn32 are actually glycosylated (Mentesana and Konopka, 2001).  
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Thus, only these two were inactivated to prevent carbohydrate attachment by substituting the 
asparagine residues for glutamines. This modified Ste2p was designated Ste2pN25,32Q-T326-FT.HT, Ste2mp 
for short. 
5.1.2. Construction of the Ste2mp expression vector pT326 and the expression strain 
YpT326 
A vector was generated to express a C-terminally FLAG-His6 double-tagged variant of Ste2mp. 
The modified receptor gene was designated STE2N25,32Q-T326-FT.HT, ste2m for short, and inserted into the 
multi-copy E.coli / yeast shuttle vector pYES2 to yield expression vector pT326. The vector pT326 
carries the ampR and URA3 markers for selection in E.coli and S.cerevisiae, respectively. The 2 µ 
origin of replication allows multi-copy autonomous replication of the plasmid in yeast, and the strong 
galactose-inducible GAL1 promoter drives expression of the cloned ste2m gene. Successive in-frame 
C-terminal FLAG- and His6-tags facilitate purification by affinity chromatography. 
Transformation of the yeast uracil auxotrophic strain BJ5464 with vector pT326 yielded strain YpT326 
for the expression of the modified Ste2mp receptor. 
5.1.3. Alternative expression strains 
In order to push the expression level of Ste2mp, two additional expression strains were constructed. 
For the first alternative, the strain BJ5464 was transformed with a version of the expression vector 
pT326 that carries the ura3d selection marker instead of URA3 (pT326-ura3d). The resulting 
expression strain was designated YpT326-ura3d. Since ura3d is a promoterless selection marker, 
uracil auxotrophic yeast cells carrying pT326-ura3d can only grow on medium without uracil if they 
maintain the plasmid at high copy numbers (Loison et al., 1989). This is achieved in combination with 
the 2 µ origin of replication on pT326-ura3d, leading to very high copy numbers, and, expectedly, to 
increased Ste2mp expression. 
The second alternative expression strain, YpMEGA/pT326-ura3d, was generated by co-transforming 
BJ5464 with pT326-ura3d and the pMEGA vector (Sil et al., 2000). The pMEGA vector allows 
overexpression of the Gal3p, Gal80p and Gal4p switch proteins for enhanced transcription from the 
GAL1 promoter. Co-expression of these switch proteins in a strain already sustaining high copy 
numbers of pT326-ura3d was expected to boost Ste2mp expression even further. 
 
The features of the three expression strains are summarised in the Table 1. 
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Strain Plasmid Important features 
YpT326 pT326 - 2 µ origin of replication 
- URA3 selection marker 
YpT326-ura3d pT326-ura3d - 2 µ origin of replication 
- promoterless ura3d selection marker  
YpMEGA/T326-ura3d pT326-ura3d 
 
pMEGA 
- 2 µ origin of replication 
- promoterless ura3d selection marker 
- enhanced transcription from the GAL1 promoter 
Table 1: Denominations and important features of each construction. 
 
 
5.2. Selection of a suitable Ste2mp expression strain 
5.2.1. Selection by Ste2mp expression level 
The expression levels of Ste2mp were compared in the three different strains (see Table 1). The aim 
of this experiment was to test whether enhanced transcription of the ste2m gene by overexpression of 
the Gal transcription factors from the pMEGA vector leads to increased levels of Ste2mp expression. 
 
Expression strains YpT326, YpT326-ura3d and YpMEGA/T326-ura3d were inoculated to OD600 0,02 
and the cultures grew overnight at 30°C in non-inducing selective complete medium lacking uracil and 
leucine, and containing raffinose as the sole carbon source (Sc∅Uracil∅Leucine-4% raffinose pH 6; 
selective raffinose medium; see material and methods section, chapter 13.2.1). Cells were induced by 
the addition of 2% galactose at an OD600 of 1 to 2. Representative growth curves of the three different 
strains in selective raffinose medium are shown in Fig.6. 
Fig. 6: Growth curves of different Ste2mp expression strains. Ste2mp is a mutant Ste2p as explained in 
chapter 5.1.1. YpMEGA/T326-ura3d, YpT326-ura3d and YpT326 are detailed in Table 1; YWT, strain expresses 
the wild-type Ste2p. 
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The different Ste2mp expression strains grew indiscernibly which indicates that growth was not 
affected by overexpression. 
The expression levels of Ste2mp from isolated total membranes were analysed in three independent 
transformants (#1, #2, #3) of each strain by Western-blotting with a specific anti-His6 antibody. As is 
clearly evident from Fig. 7, Ste2mp expression varied noticeably in the different strains. 
 
Fig. 7: Comparison of the Ste2mp 
expression level in different yeast 
strains. Three independent transformants 
each were examined. 5 μg of isolated total 
membranes from the strains YpT326, 
YpT326-ura3d and YpMEGA/T326-ura3d 
were analysed for Ste2mp by immuno-
blotting. 
Arrows indicate oligomeric Ste2mp. 
 
 
 
 
As expected, the strain YpMEGA/T326-ura3d yielded the most prominent Ste2mp signal on the 
immunoblot as compared to YpT326-ura3d and YpT326.  
Obviously, the combination of a strong inducible promoter (GAL1) and consitutive overexpression of 
the GAL transcription factors with very high plasmid copy number (2 µ origin of replication plus 
promoterless ura3d selection marker) considerably improves Ste2mp expression. 
Consequently, the expression strain YpMEGA/T326-ura3d was chosen to express Ste2mp in all 
subsequent experiments. 
 
5.2.2. Alpha-factor functionality test I: the halo assay 
It was previously shown by others that the structural modifications (mutations of the N-glycosylation 
sites and truncation after Ser326) generated in Ste2mp do not alter receptor function or its subcellular 
localisation (Mentesana and Konopka, 2001; Konopka et al., 1988). 
A halo-assay was performed in order to determine whether the modified receptor Ste2mp was still 
functional in vivo. We exploited the fact that binding of α-factor ligand to a functional Ste2p receptor 
leads to the arrest of cell growth (see introduction section, chapter 3.1.1).  
Yeast cells were mixed with agar, as described in the Materials and Methods section (chapter 13.1.4), 
and poured into petri dishes. Various quantities of α-factor were spotted onto sterile filter paper disks 
that were positioned on the agar plates. After incubation at 30°C, the plates were inspected for halos 
around the α-factor filter disks. If halos were present, they would indicate areas where yeast cells had 
not grown due to diffusion of the α-factor into the agar; that means, halos indicate growth arrest of 
yeast cells. Growth arrests only if the α-factor receptor expressed by the yeast cells is functional and 
can bind its ligand, the α-factor, and relay the external signal to the cell interior.  
#1     #2     #3     #1    #2    #3     #1    #2     #3  
                                                 YpMEGA/ 
YpT326       YpT326-ura3d     T326-ura3d 
Strains 
Transformants 
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We intended to ensure that possible growth effects were dependent on the Ste2p mutants expressed 
and not on the endogenous wild-type Ste2p. Therefore, we transformed a Δste2 null mutant, a knock-
out strain that does not express Ste2p, with the plasmid constructs for expression of the desired 
Ste2p mutants (see Material and methods section, chapter 9.1.1.1). An untransformed Δste2 null 
mutant was used as negative control. In this case, no halos were observed (ΔSte2p, Fig. 8, lower right 
plate), confirming that Ste2p is implicated in and necessary for the growth arrest. On the petri dish 
inoculated with a yeast strain that expressed the unmodified Ste2p receptor (Ste2p, Fig. 8, lower left 
plate), halos were observed whose size was directly related in a proportional manner to the amount of 
α-factor peptide loaded onto the filter disk. A similar halo pattern was observed with a yeast strain 
expressing the unmodified receptor carrying His6- and FLAG affinity tags (Ste2pFT.HT, Fig. 8, upper 
right plate). The same halo pattern was observed in the case of yeast cells expressing Ste2mp, Fig. 8, 
upper left plate. In all cases, the modified Ste2p receptors could recognise and bind the α-factor 
ligand with the same sensitivity as the wild-type, and were able to mediate growth arrest in response 
to it. 
 
Obviously, the modifications in Ste2mp, i.e. the amino acid exchanges N25Q and N32Q, the truncation 
at Ser326 and the C-terminal attachment of the FLAG- and His6-tags, did neither alter nor compromise 
the in vivo functionality of the receptor. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 8: Halo-assay for assessment of the in vivo functionality of Ste2p and its mutant derivatives. Paper 
disks on each plate contain 0,1 µg, 0,5 µg, 1 µg and 10 µg of α-factor as shown in the cartoon on the lower 
right. Halo-assays were performed with BY4741, a strain expressing wild-type Ste2p; a strain unable to express 
functional Ste2p (ΔSte2); a strain carrying the vector for expression of Ste2p with the FLAG- and His6-tags 
(Ste2pFT.HT); and a strain expressing the modified Ste2mp (for vector construction details see above). 
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Ste2p ΔSte2 
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5.2.3. Alpha-factor functionality test II: the binding-assay, characterisation of binding 
properties Kd/Bmax 
In the halo assay, we had shown that Ste2mp is active. In a subsequent binding assay which 
employed radioactive [3H]α-factor we intended to assess the substrate binding constants and 
compare them to those of the wild-type Ste2p. [3H]α-factor binding was assessed by incubating 2 μg 
of stripped membranes from transformants of the strain YpMEGA/T326-ura3d with a saturating 
concentration of [3H]α-factor (300 nM final concentration), in the presence or absence of an excess of 
unlabelled peptide (Fig. 9). Specific binding was calculated by substracting the unspecific binding 
from the total binding in the presence of unlabelled peptide. We obtained a maximum binding capacity 
Bmax value of 91 ± 7 pmol/mg protein and a Kd of 87 ± 16 nM.. The Kd is 4-5-fold higher than reported 
for the wild-type (David et al., 1997). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 9: Binding of [3H]α-factor to isolated total membranes (stripped). Total binding was determined with six 
samples in the presence of a 1000-fold molar excess of non-radioactive α-factor. Specific binding (▲) was 
obtained by subtracting nonspecific binding (I) from total binding (■).  
 
5.2.4. Alpha-factor functionality test III: competitive inhibition assays, stereospecifity 
Having determined that the Ste2mp expression was effective and yielded active α-factor receptor 
function, it was necessary to demonstrate that the mutant receptor still retained its ability to 
discriminate between atomically identical (but stereochemically distinct) α-factor analogues (Fig. 10), 
as the unmodified receptor does in its native membrane environment. 
 
Competition studies were conducted with two different stereoisomers of the α-factor peptide, the 
[L-Ala9]α-factor and the [D-Ala9]α-factor.  
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These stereoisomers were chosen because of their identical atomic compositions and, thus, identical 
hydrophobicity. They were compared for their ability to displace the bound [3H]α-factor. Equilibrium 
curves for [3H]α-factor binding and its inhibition by the stereoisomers were determined (Fig. 10). 
These inhibition assays, carried out on stripped total membranes, showed that the modified Ste2mp 
has a 16-fold greater affinity for [L-Ala9]α-factor than for [D-Ala9]α-factor (IC50 of ~1600 and ~100 nM, 
respectively). These stereoisomers are reported to vary at least 400-fold in their affinities for the wild-
type Ste2p (IC50 of ~4000 and ~10 nM respectively, for the L- and D-isomers (David et al., 1997)).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 10: Competition assay: Displacement of [3H]α-factor bound to isolated membranes by 
stereoisomeric α-factor derivatives. Membranes were incubated with [3H]α-factor and increasing amounts of 
non-radioactive [L-Ala9]α-factor or [D-Ala9]α-factor as the competitor peptides. For the generation of the 
competitive curves, relative percentage occupancies for binding were determined for each competitor at each 
concentration relative to the specific binding.  
5.3. Culture and overexpression 
The first successful production of a GPCR in S.cerevisiae was reported in 1990. Here, S.cerevisiae 
was examined for the production of the human β2-adrenergic receptor and the Human M1 muscarinic 
acetylcholine receptor (King et al., 1990; Payette et al., 1990). 
We determined optimal growth conditions for Ste2mp overexpression in the YpMEGA/T326-ura3d 
strain (summarised in the Fig. 11). A starter culture of YpMEGA/T326-ura3d was grown for 48h until 
an OD600 around 11 was reached.  
The strain was then inoculated to an OD600 of 0,02 into 150 ml of selective complete medium 
containing raffinose as the sole carbon source or rich medium (for description of the media, see the 
Material and Methods section, chapter 13.2.1), and shaken at 30°C.  
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Fig. 11: Protocol for the determination of optimal growth conditions and concurrent high level Ste2mp 
expression 
 
From the 150 ml culture, 50 ml aliquots were withdawn at different timepoints during non-inducing 
growth, and transferred to fresh sterile flasks. 
 
The cultures were then supplemented with 2% galactose to induce gene expression for 5h, 8h or 12h. 
After the induction, yeast membranes were prepared, and the expression level of Ste2mp was 
analysed by radioactive α-factor binding assay.  
During the isolation of the membranes, a stripping step with 400 mM NaCl in the homogeneisation 
buffer was included in order to remove extrinsic membrane proteins and to enrich the sample in 
Ste2mp. 
A control immunoblot and its corresponding silver-stained SDS gel (Fig. 12) show that membrane 
stripping did not remove Ste2mp, as the same amount of protein was retained in the membranes after 
the stripping step, and almost none was present in the wash fraction.   
Transformant
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                            48h growth
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Fig. 12: Efficiency of the membrane stripping step and enrichment of 
Ste2mp. Silver-stained SDS gel and corresponding immunoblot of isolated 
membranes with or without a stripping-step during the isolation procedure: 
5 µg of membranes were loaded. M: Size marker, S.M: stripped 
membranes, W: wash after stripping, N.S.M: Non-stripped membranes. 
The arrow indicates monomeric Ste2mp with a calculated molecular weight 
of ~38 kDa. 
 
 
 
 
 
 
 
 
 
 
 
Isolated membranes from cells grown under different conditions were incubated with [3H]α-factor 
whose binding was assessed (pmol of [3H]α-factor/ mg of membranes). The quantification graph 
(Fig. 13) shows that the best expression level was obtained either after growth in selective complete 
medium ScRaff/ScGal, followed by 5h of induction with 2% galactose, or in complete medium 
YPD/YPGal and 8h induction.with 2% galactose. 
 
Fig. 13: Comparison of the Ste2mp 
expression levels under different growth 
conditions. A [3H]α-factor binding-assay was 
performed with isolated stripped membranes 
from YpMEGA/T326-ura3d transformants that 
grew in selective (ScRaff/ScGal) or rich 
(YPD/YPGal) medium. Gene expression was 
induced with 2% galactose for 5h, 8h or 12h. 
Two μg of isolated membranes were incubated 
with [3H]α-factor, the bound radioactivity 
mesured, and the concentration of Ste2mp in 
total membranes calculated (pmol of Ste2mp 
/mg of membranes). 
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5.4. Solubilisation of Ste2mp 
5.4.1. Solubilisation  
Once overexpression of the desired protein is achieved, the protein must be extracted from the 
membrane and purified. Binding experiments with detergent solubilised wild-type Ste2p demonstrated 
that the receptor solubilised in DDM (N-Dodecyl-β-D-maltoside) retained its native structure (David et 
al., 1997). For this reason, we preferentially chose DDM to solubilise the Ste2mp mutant receptor, 
although we also tested other non-ionic detergents: TX100 (Triton X-100), LDAO (N,N-
Dimethyldodecylamine-N-oxide), C12E9 (Polyoxyethylene-9-laurylether), OG (N-Octyl-β-D-
Glucopyranoside), NG (N-Nonyl-β-D-Glucopyranoside), FOS12 (N-Dodecyl-phosphocholine).  
For each detergent, solubilisation experiments were performed under identical conditions: Isolated 
stripped membranes were mixed with detergent at a protein/detergent ratio of 1:4, and incubated at 
4°C for 30 minutes. Subsequently, soluble material was separated from insoluble debris by a high 
speed spin (200 000 x g). The amount of Ste2mp present in the supernatant was compared to that in 
the pellet after ultra-centrifugation by immunoblotting with an anti-His antibody. 
Densitometric analysis on the Western-blot (Fig.14A) and its corresponding quantification graph 
(Fig.14B) show that among these detergents, DDM and LDAO most efficiently solubilised Ste2mp at 
50% and 38% respectively. FOS12 and TX100 were efficient (35% and 37% solubilisation, 
respectively (Fig.14B) and are far less expensive than DDM. However, they were not used in 
subsequent purification experiments since DDM solubilised the protein even more efficiently and had 
proved to keep the wild-type Ste2p in a native state (David et al., 1997). We therefore decided to go 
on with DDM and LDAO. 
 
 
 
 
Fig. 14: Solubilisation of Ste2mp with 
different detergents. 14A: Immunoblot 
showing the amount of Ste2mp in soluble or 
membrane fractions. Solubilisation from 2 mg of 
total membranes (final concentration: 5mg/ml). 
Pellets (P) were resuspended in the same 
volume as supernatants (SN) and equal 
volumes (15 µl) were loaded onto the gel. The 
anti-His6 antibody used to probe the blot 
specifically labeled Ste2mp. 14B: quantification 
graph of solubilised Ste2mp with the different 
detergents. DDM:  N-Dodecyl-β-D-maltoside, 
OG: N-Octyl-β-D-Glucopyranoside, NG: N-
Nonyl-β-D-Glucopyranoside,FOS12:N-Dodecyl-
phosphocholine,LDAO:N,N-Dimethyldodecyl-
amine-N-oxide,C12E9:Polyoxyethylene-9-lauryl-
ether,TX100: Triton X-100 
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The solubilisation was optimised with LDAO (Fig. 15), which included a protein/detergent ratio of 1/2 
to 1/4 and a final concentration of 1% to 2,5%, after a 30 minutes incubation at 4 °C. 
Fig. 15: Solubilisation in LDAO. Immunoblot 
showing the amount of Ste2mp in soluble or 
membrane fractions. Solubilisation from 10 mg 
of total membranes after a 30 min incubation in 
different final concentrations of LDAO (1% and 
2,5%), at different temperatures (RT, 4°C). M: 
Size marker, P: Pellet, SN: Supernatant. Pellets 
were resuspended in a volume corresponding 
to that of the supernatants and equal volumes 
(15 µl) were loaded onto the gel. The anti-His6 
antibody used to probe the blot specifically 
labeled Ste2mp. Arrows indicate oligomeric   
Ste2mp. 
 In order to optimise solubilisation with DDM we tested different concentrations of DDM (membrane 
protein/detergent ratios of 1/1, 1/2, 1/6, corresponding to final concentrations of 0,5%, 1% and 3% 
respectively) at 4°C (Fig. 16A) and room temperature (RT, Fig. 16B)) and for incubation times of 30 
minutes and longer. At 4°C, more proteins were found solubilised in the supernatant with 3% DDM 
(89%) than with 1% (73%) and with 0,5% (58%). The solubilisation was less efficient at RT than at 
4°C: with 3% and 1% of DDM, only 56% of proteins were solubilised at RT as compared to 89%  and 
73% at 4 °C, respecitvely. Only with 0,5% DDM more protein was solubilised at RT (64%) than at 4 °C 
(58%). Thus, the solubilisation was more efficient at 4°C than at RT. 
Fig. 16: Solubilisation of Ste2mp by dodecylmaltoside (DDM). Immunoblot showing the amount of Ste2mp in 
soluble or membrane fractions. Solubilisation from 10 mg of total stripped membranes after a 30 min incubation 
in different final concentrations of DDM (0,5%, 1% and 3%). M: Size marker, P: Pellet, SN: Supernatant. Pellets 
were resuspended in a volume corresponding to that of the supernatants and equal volumes (15 µl) were 
loaded onto the gel. The anti-His6 antibody used to probe the blot specifically labeled Ste2mp, whose monomer 
migrates with an apparent molecular weight of ~30 kDa, plus multiple bands of higher molecular weight 
(indicated by the arrows).16A: solubilisation performed at 4°C. 16B: solubilisation performed at room 
temperature (RT).  
 
The best solubilisation conditions with DDM were obtained with a protein/detergent ratio between 1/2 
and 1/6, for 30 minutes at 4°C. Solubilisation was not improved with longer incubation times. We 
finally chose an intermediate protein/detergent ratio of 1/4, given the fact that the amount of detergent 
should not be in surplus for the further crystallisation trials, and that DDM is relatively expensive. 
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Under these conditions, we could routinely solubilise around 60% of Ste2mp. The protein was 
solubilised in a heterogenous oligomeric state, as attested on the immunoblot by the several distinct 
bands of oligomeric Ste2mp. 
 
5.4.2. Presolubilisation 
Different detergents solubilise membrane proteins with varying efficiency. This can be exploited in a 
presolubilisation step where membrane proteins other than Ste2mp are removed from the membrane, 
and Ste2mp, is selectively enriched. A second solubilisation step is then performed to extract Ste2mp 
from the membrane. 
 
The presolubilisation test was performed with different detergents such as DDM, OG, NG, FOS12, 
LDAO and C12E9.  
Fig. 17 presents the results of the presolubilisation. 
The Coomassie-stained SDS gel in Fig. 17A shows the amount of total membrane proteins that were 
present in the supernatant (lanes designated SN) and the pellet (lanes designated P) after 
presolubilisation with these different detergents. The relative amounts of membrane proteins in the 
soluble and membrane fractions were quantified by densitometric analysis and are shown in the 
graph in Fig. 17D. The immunoblot in Fig. 17B shows the amount of Ste2mp present in the 
supernatant (SN) or the pellet (P) after presolubilisation and the according relative quantification is 
presented in Fig. 17C. The graphs in Fig. 17C and D show that all tested detergents were able to 
solubilise roughly 50% of the total membrane proteins. However, only NG and C12E9 solubilised also 
only minimal amounts, 12% and 28% respectively, of Ste2mp. On the contrary, DDM and LDAO 
specifically solubilised  Ste2mp (around 50%) which corroborates the results of the solubilisation trials 
described above. 
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Fig. 17: Presolubilisation with different 
detergents. Presolubilisation from 2 mg of total 
stripped membranes after a 30 min incubation at 
4°C, at a final concentration of 5 mg/ml and a 
protein/detergent ratio of 1/4. P: Pellets, SN: 
Supernatants. Pellets were resuspended in the 
same volume as supernatants and equal 
volumes (15 µl) loaded onto gels. The anti-His6 
antibody used to probe the blot labeled 
specifically Ste2mp. 17A and 17C Coomassie-
stained SDS gel and corresponding quantification 
graph showing the amount of total membrane 
proteins in soluble or membrane fractions. 17B 
and 17D: Western-blot and corresponding 
quantification graph showing the amount of 
Ste2mp in soluble or membrane fractions. 
 
 
 
 
 
 
 
 
 
 
 
Seizing the results of the presolubilisation trials, stripped membranes were treated with 2% NG or 2% 
C12E9, to remove contaminating total membrane proteins. After presolubilisation, remaining Ste2mp 
was solubilised from these membranes with DDM or LDAO. 
 
 
The analysis of these 2 consecutive solubilisation steps is shown on a Western-blot (Fig. 18) and the 
corresponding quantification graph (Fig. 18B). Briefly, after the presolubilisation in NG or C12E9 DDM 
and LDAO solubilised Ste2mp very inefficiently. Only between 7 and 21% of Ste2mp were extracted in 
the supernatant. 
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Fig. 18: Presolubilisation of total membrane 
proteins and subsequent solubilisation of 
Ste2mp with different detergents. 
Presolublisation from 2 mg of total membrane 
protein with NG or C12E9, after a 30 min 
incubation at 4°C, at a final concentration of 
5mg/ml and a protein/detergent ratio of 1/4. P: 
Pellet, SN: Supernatant. Pellets were 
resuspended in the same volume as 
supernatants and equal volumes (15 µl) were 
loaded onto the gel. After the presolubilisation, 
proteins still present in the pellet were solubilised 
with DDM or LDAO 18A: Immunoblot using anti-
His6 antibody that specifically shows the amount 
of Ste2mp in the soluble and membrane fractions 
after the two solubilisation steps. Arrows indicate 
oligomeric Ste2mp. 18B: Corresponding 
quantification graph. 
 
 
 
 
 
 
 
 
 
 
 
A noticeably lower amount of Ste2mp was obtained after presolubilisation with NG or C12E9 followed 
by treatment with DDM or LDAO (21 to 37% solubilisation) than with the latter detergents alone 
(~50% solubilisation). Thus, the overall benefit of the two-step solubilisation procedure was negligible 
and we decided to go on with a single solubilisation step using DDM or LDAO. 
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5.5. Purification 
5.5.1. One-step purification 
5.5.1.1. Metal-affinity chromatography, with Ni2+-NTA beads 
Metal-affinity purification using Ni2+-NTA beads as a matrix, was applied after a solubilisation of 15 mg 
of total membrane protein. The solubilised protein was incubated overnight at 4°C with 1 ml of Ni2+-
NTA beads. Beads were then packed in a column and the flow-through collected. The bound protein 
was treated with a gradient between 20 mM and 250 mM imidazole. Ste2mp eluted with approximately 
220 mM imidazole. A silver-stained SDS gel (Fig. 19A) shows that Ste2mp was retrieved quite pure in 
the eluate, although not homodisperse, as observed in the corresponding Western-blot (Fig. 19A). 
Densitometric analysis of the Western-blot (Fig. 19B) unveiled that more than 90% of Ste2mp could be 
recovered after the chromatography. Unfortunately, this result was not reproducible in up-scale 
experiments. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 19: Purification trial of Ste2mp by metal-affinity chromatography after solubilisation in DDM. 19A: 
Silver-stained SDS gel and corresponding Western-blot of the concentrated one-step purification samples after 
a solubilisation from 15 mg total membrane proteins with DDM. M: Size marker, P: pellet, SN: Supernatant, FT: 
Flow through, W: Wash, E: Eluate. Arrows indicate oligomeric Ste2mp. 19B: Estimation of the amount of Ste2mp 
in the purification samples by densitometric analysis of the Western-blot in Fig. 19A. 
 
A similar one-step purification was also performed after solubilisation in LDAO (Fig. 20). The silver-
stained SDS gel shows that the purification was not as efficient as after the solubilisation with DDM, 
as there were still a lot of contaminanting proteins in the eluate. 
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Fig. 20: Purification of Ste2mp by metal-affinity chromatography 
after a solubilisation in LDAO: Silver-stained SDS gel and 
corresponding Western-blot of the concentrated purification samples 
after solubilisation of 15 mg total membrane proteins with LDAO. M: 
Size marker, P: Pellet, SN: Supernatant, FT: Flow through, W: Wash, E: 
Eluate. Arrows indicate oligomeric Ste2mp. 
 
 
 
 
 
 
 
 
 
When different amounts of eluate from 50 μl of Ni2+-NTA beads were loaded onto an SDS-gel, we 
observed that two bands, a prominent one at slightly higher molecular weight and a faint lower band 
were visible around 30 kDa, as shown by arrows on Fig. 21A. Only the upper band was detectable on 
a Western-blot with an anti-His antibody (Fig. 21B), suggesting that this band would be Ste2mp, and 
the lower band was some unspecific contaminant. 
Fig. 21: Determination of the nature of the prominent purified band. 
Coomassie-stained SDS gel (21A) and corresponding Western-blot 
(21B) showing different amounts (1, 2 and 3) of the purification sample 
(M: Size marker). Arrows indicate the two bands of interest. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
In order to optimise the purification conditions, the effects of different parameters on the efficiency of 
the chromatography, i.e., Ste2mp purity and binding to the beads, were checked the beads volume, 
the β-mercaptoethanol concentration and the EDTA concentration. These trial experiments were 
performed in a small scale, i.e., in a final volume of 2 ml, after solubilisation of 10 mg of total 
membrane proteins in DDM. 
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5.5.1.1.1. Beads volume 
 The effect of the beads volume was assessed after solubilisation of Ste2mp from 10 mg of total 
membranes. Different volumes of beads were tested: 10 μl, 25 μl and 50 μl. A Western-blot (Fig. 22) 
showed that there was approximately no protein in the flow through when using 50 μl of beads, in 
contrast to 10 μl and 25 μl of beads. This demonstrated that 50 μl of beads seemed to be the minimal 
amount needed to bind all Ste2mp solubilised from 10 mg of total membrane protein. 
Fig. 22: Effect of different Ni2+-NTA beads volumes 
on the binding of Ste2mp. Comparison by 
immunoblotting of the Ste2mp binding to different 
amounts of Ni2+-NTA beads (10 μl, 25 μl and 50 μl). 
The beads were incubated with 2 ml supernatant after a 
solubilisation from 10 mg of total proteins. FT: Flow 
through, W: Wash, E1, E2: successive eluate samples. 
 
 
5.5.1.1.2. β-mercaptoethanol and EDTA concentration 
β-mercaptoethanol is generally used in purification buffers as a disulfide bridge reducing agent and an 
anti-oxydant, as many proteins are more stable in a reduced state. By reducing the disulfide bridges, 
the amount of oligomers can be decreased and, so, the heterogeneity. The adsorption of the protein 
to the matrix is also influenced by the reducing or oxidizing conditions, and an alteration of these 
conditions could promote the protein binding and/or elution (Hunte et al., 2000) EDTA is a proteases 
inhibitor. However, EDTA is a chelating agent for metal-ions, and can chelate and, hence, remove the 
Ni2+ ions from the matrix. EDTA can, therefore, be used to elute proteins by stripping the metal-ions 
from the matrix together with the bound proteins. We checked what EDTA concentration could be 
used as a protease inhibitor without impairing the binding of Ste2mp to the Ni2+-NTA beads. 
Ste2mp was incubated with the Ni2+-NTA beads in the presence of 20 mM β-mercaptoethanol and up 
to 0,75 mM EDTA. On a Western-blot (Fig. 23), we observed that neither 20 mM β-mercaptoethanol 
nor 0,25 mM EDTA during incubation with the Ni2+-NTA beads or 0,75 mM EDTA during wash and 
elution noticeably affected Ste2mp binding or heterogeneity in comparison to the standard conditions 
with in 1 mM β-mercaptoethanol and no EDTA. 
Fig. 23: Effect of β-mercaptoethanol and 
EDTA on the binding of Ste2mp to Ni2+-NTA 
beads and the heterogeneity. Comparison 
by immunoblotting of the binding of Ste2mp to 
50 μl of Ni2+-NTA beads, in the presence of 
20 mM β-mercaptoethanol, and of up to 
0,75 mM EDTA. Incubation with 2 ml of 
supernatant after a solubilisation of 10 mg of 
total proteins. FT: Flow through, W: Wash, E1, 
E2: successive eluate samples. Arrows 
indicate oligomeric Ste2mp. 
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With this volume of 50 µl of Ni2+-NTA beads, it was then checked if the addition of 20 mM β-
mercaptoethanol and 0,75 mM EDTA would improve the purity of Ste2mp. The coomassie-stained 
SDS gel in Fig. 24 shows that there was no difference in the number of higher molecular weight 
bands in addition to the one corresponding to Ste2mp monomer (~30 kDa). This suggests that the 
purity of Ste2mp was not affected by the addition of the indicated concentrations of β-mercaptoethanol 
or EDTA. 
Fig. 24: Effect of β-mercaptoethanol and EDTA on the purity of 
Ste2mp after the metal-affinity chromatography. Comparison of 
the purity of Ste2mp on a Coomassie-stained SDS gel under different 
conditions: after binding to 10 μl, 20 μl and 50 μl of Ni2+-NTA beads, 
and with 50 μl of Ni2+-NTA beads in the presence of 20 mM β-
mercaptoethanol (lane #1), or 0,75 mM EDTA (lane #2). The beads 
were incubated with 2 ml supernatant after solubilisation of 10 mg 
total membrane proteins. (M: Size Marker). 
 
 
 
 
5.5.1.1.3. Urea  
The several Ste2mp oligomers visible on Western blots as well as Coomassie-stained SDS-gels might 
have been due to aggregation of the Ste2m proteins. It is known, that SDS in some cases stabilises 
the secondary structure of membrane proteins. Therefore, we checked the effect of another native 
denaturing agent, urea, on aggregation of Ste2mp. We added 8 M urea to the purified Ste2mp after 
metal-affinity chromatography and to the separating gel (Fig. 25). There was no evident difference in 
the amount of oligomeric forms observed on the gel, indicating that urea was not able to prevent 
Ste2mp aggregation. Since neither reducing agents such as β-mercaptoethanol, nor denaturing 
substances as SDS or urea changed the appearance of oligomeric Ste2mp, this suggests that the 
observed oligomers were an artefact of the SDS gel. 
Fig. 25: Effect of urea on the heterogeneity of Ste2mp. Analysis of the effect of 
urea on the aggregation of Ste2mp as observed on a Coomassie-stained SDS gel 
after metal-affinity chromatography. M: Size marker, FT: Flow through, W1,W2: 
Wash1, Wash2, E: Eluate.  
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5.5.1.1.4. Deglycosylation 
As it was intended by its construction (see chapter 5.1.2), Ste2mp was not expected to be 
glycosylated. However, there is a third potential glycosylation site (Asn105) in Ste2p which is present in 
Ste2mp and may become glycosylated in the modified receptor (Mentesana and Konopka, 2001). 
Indeed, a smear and additionnal faint bands were observed running slightly higher than the one at 
~30 kDa supposed to correspond to the Ste2mp monomer. In order to check if this was an effect of 
some residual glycosylation, an attempt to deglycosylate Ste2mp was performed. Isolated membranes 
were treated with the enzyme PNGase F. PNGase F is an amidase from Flavobacterium 
meningosepticum that hydrolyses the N-glycans of glycoproteins. The Western-blot in Fig. 26 shows 
no difference in the Ste2mp signal between the treatment with or without amidase, suggesting that 
there is no clear evidence whether the smear above the Ste2mp band of ~30 kDa appearing upon 
overexposure was due to a residual glycosylation. We concluded that the prominent band on the gel 
was Ste2mp, and that Ste2mp did not present residual glycosylation. A positive control with the bovine 
fetuin, a serum glycoprotein known to contain neuraminic acid and O-linked sugars, was also 
performed that proved that the enzyme was working (data not shown).  
 
It is noticeable as well that the Western-blot in Fig. 26 does not show strong signals of oligomeric 
Ste2mp in addition to the single band corresponding to monomeric Ste2mp. This band pattern 
resembles that  on the Western-Blot with isolated membranes with or without stripping (Fig. 12). Both 
Western blots involving isolated membranes are in stark contrast to the band pattern of the Western-
blots showing Ste2mp after isolation, during solubilisation and purification. On these blots, oligomeric 
Ste2mp was always observed. This suggests that the several strong oligomeric bands observed on 
the immunoblots could be generated during membrane solubilisation and/or Ste2mp purification.  
Fig. 26: Analysis of the glycosylation state of Ste2mp. Immunoblot after treatment of 
Ste2mp with the deglycosylase PNGase F. 0,25 μg of membranes were loaded onto the 
gel. (-): membranes after treatment without enzyme, (+): membranes after treatment 
with enzyme, mb: membranes without treatment.  
 
 
5.5.1.2. Other metal-affinity purifications: Cu2+-NTA, Co2+-NTA, Zn+-NTA 
To optimise the purity and the homogeneity of Ste2mp, metal-affinity chromatographies were 
performed with different metal ions, Copper (Cu2+-NTA), Cobalt (Co2+-NTA) and Zinc (Zn+-NTA), using 
the same conditions as for the Ni2+-NTA purification. The different samples (flow through, wash and 
eluate) of each chromatography were then analysed on silver-stained SDS gels and immunoblots. 
The amount of Ste2mp in each sample was quantified from the immunoblots by denstitometric. 
The degree of purity of Ste2mp present in the eluate was not improved as observed on the silver-
stained SDS gels in Fig. 27A. The graph in Fig. 27C quantifies the efficiency of the different 
chromatographies in terms of recovery of Ste2mp from the supernatant (SN in Fig. 27A; set to 100%). 
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In the case of the matrices Cu2+-NTA, Co2+-NTA and Zn+-NTA, less Ste2mp was recovered in the 
eluate (47%, 12% and 35%, respectively) than with Ni2+-NTA (84%), and more Ste2mp was lost in the 
flow through and in the wash (53%, 73% and 30% respectively) than with Ni2+-NTA (16%).  
The quantification graph in Fig. 27D shows a comparison (by densitometric analysis of the Western-
blot in Fig. 27B) of the efficiency of the different chromatographies. The relative amount of Ste2mp in 
each purification samples (flow through, wash, eluate) is given as relative band intensity. The graph 
shows clearly that, although in the different chromatographies nearly the same amount of Ste2mp was 
lost in the flow through and the wash samples, the most efficient metal-ion chromatography was the 
Ni2+-NTA chromatography by which most Ste2mp was recovered in the eluate (1670 units versus 296, 
398 and 264 for the Cu2+-NTA, Co2+-NTA and the Zn2+-NTA chromatographies, respectively).   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 27: Comparison of the Ste2mp amount recovered in the 4 different metal-affinity chromatographies. 
27A: Silver-stained SDS gels of the purification samples of each different chromatography. SN: Supernatant, 
FT: Flow through, W: Wash, E: Eluate. 27B: Corresponding Western-blots of the purification samples, probed 
with a anti-His6 antibody labelling specifically Ste2mp. Arrows indicate monomeric Ste2mp. 27C: Quantification 
graph showing for each different chromatography the relative percentage of Ste2mp in each purification samples 
(flow through, wash, eluate). 27D: Quantification graph showing a comparison by densitometric analysis of the 
Ste2mp amount in each purification samples, between the different chromatographies. 
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5.5.2. Two-step purification 
In order to improve the purity and the homogeneity of Ste2mp, a two-step purification involving 
different chromatographies was performed. 
5.5.2.1. FLAG-affinity chromatography 
As outlined in chaper 0, Ste2mp carries a FLAG-tag in addition to the His6 tag. Thus, the pooled 
eluates from the first Ni2+-NTA step were submitted to subsequent FLAG-affinity chromatography. All 
Ni2+-NTA purification samples were analysed on a Coomassie-stained SDS-gel and a corresponding 
immunoblot (Fig. 28A). 
Three successive eluates (E1, E2 and E3) from the Ni2+-NTA purification were collected, pooled and 
loaded onto the FLAG-affinity matrix. After washing, bound Ste2mp was eluted with 50 µg/ml FLAG 
peptide. The eluate was collected, and the column was then stripped with 0,1 M Glycine-HCl pH 3,5 
to eventually elute residual Ste2mp. The FLAG-chromatography samples were analysed on a 
Coomassie-stained SDS-gel and a Western-blot (Fig. 28B). 
Fig. 28: Purification of Ste2mp by Ni2+-NTA-affinity chromatography (28A) and subsequent FLAG-affinity 
chromatography (28B). Coomassie-stained SDS-gel and corresponding Western-blot of the concentrated 
purification samples are shown. M: size marker, FT: flow through; W, W1, W2, W3, W4: successive washes 1, 
2, 3 and 4; E1, E2, E3: successive eluates from the Ni2+-NTA chromatography; E: eluate from the FLAG 
chromatography. Strip: flow through after the stripping of the column. Arrows indicate oligomeric Ste2mp. 
 
 
By comparing the purity and the heterogeneity of Ste2mp in the eluate of the Ni2+-NTA purification and 
that of the FLAG–affinity chromatography, it was clear that the FLAG-affinity chromatography did not 
improve the result: Neither could be the purity enhanced nor the heterogeneity reduced. Moreover, 
the stripping of the FLAG column revealed that elution was inefficient, since proteins were still 
desorbed by the stripping step. 
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5.5.2.2. Anion-exchange chromatography 
As the FLAG chromatography was inefficient, we tried another chromatography as the second step to 
further improve the purity of Ste2mp. We performed an anion-exchange chromatography after the Ni2+-
NTA chromatography. The concentrated Ni2+-NTA eluate was loaded onto an anion-exchange resin. 
Ste2mp appeared not to bind tightly to the resin and was eluted in the wash step. We, therefore, tried 
to optimise the binding conditions in small-scale trial experiments by testing different resin volumes 
(20 µl, 100µl), different buffers at different pH values (20 mM phosphate buffer at pH 6,5 and pH 7, 
20 mM HEPES buffer at pH 7,5 and pH 8, 20 mM Bicine buffer at pH 8,5) and different NaCl 
concentrations. 
In a batch procedure, for each condition 20 mg of total membranes were solubilised with 2% DDM. A 
Ni2+-NTA purification was performed, the eluate was concentrated and finally diluted in 500 µl of each 
of the following buffers: 20 mM phosphate buffer pH6,5, 20 mM phosphate buffer pH7, 20 mM 
HEPES buffer pH7,5, 20 mM HEPES buffer pH8, or 20 mM bicine buffer pH8,5. All buffers contained 
20 mM NaCl. Each sample was incubated with 20 µ or 100 µll of anion-exchange resin for 10 
minutes. After a gentle centrifugation step, the supernatants were collected and analysed on a 
Western-blot. The determination of the amount of Ste2mp in the supernatants relative to that in the 
Ni2+-NTA eluate allowed an evaluation of the binding quality. 
Fig. 29 shows that with 20 µl of resin, none of the tested buffers permitted an optimal binding of 
Ste2mp to the resin, as most of the Ste2mp was still present in the supernatants (comparison with the 
Ni2+-NTA eluate). A volume of 100 µl of resin seemed to be the minimal quantity required to efficiently 
bind Ste2mp solubilised from 20 mg of total membranes at a pH 7,5 to 8 (20 mM HEPES buffer). We 
then went on with these conditions. 
 
 
 
  
 
 
 
 
 
Fig. 29: Effect of the resin volume and the pH on the binding of Ste2mp to the anion-exchange matrix. 
The Ni2+-NTA eluate was incubated with different resin amounts, and in different buffers at different pH values. 
After centrifugation, the supernatants were collected and analysed on Western-blot E: Ni2+-NTA purification 
eluate. Arrows indicate oligomeric Ste2mp. 
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NaCl is used to elute the protein from the anion-exchange matrix, as its counterion Cl¯ competes by 
displacement with the protein. We determined the optimal NaCl concentration for elution of Ste2mp. 
After a solubilisation of 20 mg of total membranes with 2% DDM, a Ni2+-NTA purification was 
performed. We exchanged the buffer of the eluate to 20 mM HEPES buffer pH 7,5 containing different 
NaCl concentrations (50, 100, 150, 200, 250, 300, 350, 400, or 450 mM). All samples were then 
incubated for 10 minutes with 100 µl of anion-exchange resin. After the incubation, the samples were 
gently centrifuged and the supernatants analysed on a Western-blot (Fig.30). It appears very clearly 
that Ste2mp was desorbed from the resin in a buffer containing a NaCl concentration higher than 
0,3 M. 
Fig. 30. Optimisation of the NaCl 
concentration on the elution of Ste2mp 
from the anion-exchange resin. Ni2+-
NTA purified Ste2mp was incubated with 
the resin in different NaCl concentrations. 
After centrifugation, the supernatants were 
analysed on a Western-blot. E: Ni2+-NTA 
eluate (in phosphate buffer pH7 containing 
20 mM NaCl). Arrows indicate oligomeric 
Ste2mp. 
 
 
 
 
The extracted conditions for an optimal anion-exchange chromatography were, after solubilisation of 
Ste2mp from 20 mg of total membrane proteins and Ni2+-NTA chromatography, a 10 minutes 
incubation of the Ni2+-NTA eluate with 100 µl of anion-exchange resin, in 20 mM HEPES buffer pH 
7,5, performing a washing step with 100 mM of NaCl and the elution with 300 mM NaCl. 
 
Applying these conditions, the anion-exchange chromatography was performed after the Ni2+-NTA 
chromatography in a large scale purification involving solubilisation of 700 mg total membrane 
proteins with 2% DDM. The buffer of the Ni2+-NTA eluate was exchanged for a 20 mM HEPES buffer 
pH7,5 with 20 mM NaCl, and concentrated. The eluate was incubated for 10 minutes with the anion-
exchange resin, washed with the same buffer containing 100 mM NaCl, and the elution was 
preformed with 300 mM NaCl. Coomassie-stained SDS gel and corresponding immunoblot of the 
purification samples (Fig. 31) show that, although Ste2mp was inefficiently bound to the anion-
exchange resin and washed off with 100 mM NaCl. Almost no protein was recovered with 300 mM 
NaCl in the eluate. Therefore, we did not go on with the anion-exchange chromatography. 
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Fig. 31: Purification of Ste2mp by Ni2+-NTA 
and anion-exchange chromatographies. 
Analysis on a Coomassie-stained SDS gel and 
corresponding Western-blot of the concentrated 
purification samples after a solubilisation from 
700 mg of total membrane proteins with 
2% DDM. M: Size marker, P: Pellet, SN: 
Supernatant, FT: Flow through, W1,W2: 
successive wash1,wash2, E: Ni2+-NTA eluate, 
E1: anion-exchange eluate. Arrows indicate 
oligomeric  Ste2mp. 
 
 
 
 
 
 
5.5.2.3. Size-exclusion chromatography 
In order to separate the different oligomers of Ste2mp, size-exclusion chromatography (SEC) was 
performed. The eluate from the Ni2+-NTA purification was concentrated and loaded on a gel filtration 
column. The elution fractions corresponding to the single peak on the chromatogram were pooled and 
analysed for Ste2mp. After SEC, the amount of Ste2mp was insufficient for detection on a Coomassie-
stained SDS gel (Fig. 32, sample Ese). Nevertheless, it could be detected on the corresponding 
immunoblot (Fig. 32) which is more sensitive. The immunoblot shows that Ste2mp was still 
heterogenous and that the different oligomers were not separated by SEC. 
 
Fig. 32:.Purification of Ste2mp by Ni2+-NTA and size-
exclusion chromatography. 
Coomassie-stained SDS gel and corresponding 
Western-blot of the concentrated purification samples 
are shown. M: Size marker, P: Pellet, SN: Supernatant, 
FT: Flow through, W: Wash, E: Eluate, Ec: 
Concentrated eluate from the Ni2+-NTA purification, 
Ese: Eluate of the size-exclusion chromatography. 
Arrows indicate oligomeric Ste2mp 
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5.5.3. Final purification protocol  
A purification protocol with a single step was finally chosen, using a Ni2+-NTA chromatography with 
the conditions described in Fig. 33C. On the Coomassie stained SDS gel (Fig. 33A), apart from two 
major bands of higher molecular weight, only few contaminants were visible in comparison with the 
flow through and the wash samples, suggesting that an elevated concentration of imidazole (50 mM) 
during the wash step of the column removed a lot of them. Densitometric (Fig. 33B) of the Western-
blot revealed that, from the total amount of solubilised Ste2mp loaded onto the column, around, 85,5%  
was retrieved in the eluate, 14,5% were lost in the intermediate steps (12,5 in the flow through and 
2% in the wash). However, a Schägger and a Laemmli gel systems were used for the Western-blot 
and the Coomassie-stained SDS gel, respectively. This could have led to the different band patterns 
observed in the Coomassie-stained SDS-gel and the Western-blot. N-terminal sequencing of the 
proteins in the Ni2+-NTA eluate (see chapter 5.6.1), confirmed that the additional bands in the 
Coomassie-staind SDS-Gel as well as the Western-blot constitute oligomeric Ste2mp. The purity of 
Ste2mp in the eluate was estimated to be approximately 90%. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 33: Final purification protocol. 33A: Coomassie-stained gel and a Western-blot of the concentrated 
purification samples. M: Size marker, FT: Flow through, W1,W2: successive wash1,wash2, E: Eluate. Arrows 
indicate oligomeric Ste2mp. 33B: Quantification of the amount of Ste2mp in each purification sample by 
densitometric analysis of the Western-blot. 33C: Composition of the solubilisation and purification buffers. 
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5.6. Characterisation of Ste2mp 
5.6.1. N-terminal sequencing analysis 
The Ni2+-NTA eluate was analysed by N-terminal sequencing. It was found that the first 9 amino-
acids of the analysed protein sample exactly matched the first 9 amino-acids composing the N-
terminus of the Ste2mp sequence (MSDAAPSLS). This confirmed that the observed band on the SDS-
gel and the immuoblot was Ste2mp, and that the sample was 90% pure. 
5.6.2. MALDI-TOF mass spectrometric analysis 
All bands of the eluate were cut from an SDS-gel, digested with trypsin and analysed by MALDI-TOF 
mass spectrometry. On the Coomassie-stained SDS gel (Fig. 33B) the band corresponding to 
monomeric Ste2mp migrated around 30 kDa. MALDI-TOF confirmed the N-terminal sequencing result, 
attesting that this 30 kDa band corresponds to Ste2mp. Its molecular mass was determined to be 
38694 Da. 
5.7. 3D-crystallisation experiments: hanging-drop method  
Manual crystallisation trials were performed with several commercial solutions (purchased from 
Hampton Research), e.g., MembFac, Index, Crystal Screen 1 and Crystal Screen 2. The method used 
was the hanging-Drop method, as described in the Material and methods section (chapter 13.7.3.1).  
So far, no protein crystals were obtained.
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6. Heterologous overexpression of the hyperthermophilic putative amino acid 
transporter (Aatp) of Methanococcus jannaschii in Saccharomyces cerevisiae. 
Isolation and purification for crystallisation experiments. 
 
This work presents the cloning of the putative amino-acid transporter Aatp from Methanococcus 
jannaschii, its heterologous overexpression in Saccharomyces cerevisiae and its purification by 
chromatography to perform crystallisation trials. Two different expression constructs and several 
different culture conditions were tested in order to yield the best Aatp expression. For the purification 
of hyperthermophilic proteins, one usually takes advantage of their hyperthermostability. Indeed, by 
overexpression in a mesophilic organism, their purification can be greatly facilitated and optimised by 
heat treatment to which, in contrary to the mesophilic proteins, they are resistant. Previously, this 
purification procedure proved successful for other hyperthermophilic integral membrane proteins, for 
instance, for the Ca2+-ATPase of Methanococcus jannaschii (Morsomme et al., 2002) or the H+-PPase 
of Thermotoga maritima (López-Marqués et al., 2005). Both membrane proteins had been 
overexpressed in S.cerevisiae. 
 
6.1. Cloning strategy 
6.1.1. Construction of the Aatp expression vector pAAT and the expression strain 
YpAAT 
We intended to clone the AAT gene from Methanococcus jannashii genomic DNA. Routine cloning 
strategies allow DNA molecules to be precisely combined by ligation between suitable restriction 
endonuclease sites, which can be quite annoying if such sites are not available. Indeed, this is a 
crucial issue for genomic DNA sequences. An as yet largely unexploited approach for cloning genes 
directly from genomic DNA is gap-repair cloning, a method that uses in vivo homologous 
recombination in the yeast Saccharomyces cerevisiae. Gap-repair is a simple and inexpensive 
cloning method, in which a linearized yeast cloning vector bearing sequences at its termini 
homologous to the ends of a target genomic sequence (termed homology arms) is co-transformed 
into yeast cells with donor genomic DNA. The homology arms, which are usually ≤ 50 bps, are 
generated by PCR with tailed primers. The linear DNA strands that share sequence overlaps undergo 
recombination in vivo to incorporate the desired genomic sequence, e.g., a gene into the vector 
(Noskov et al., 2003; Bhargava et al., 1999). This method greatly simplifies the construction of cloning 
vectors. A sequence that is cloned in this manner is proofread by the yeast cell’s replication 
machinery (unlike that generated by PCR) and is unlikely to contain unwanted mutations. Using this 
method, we cloned the intronless AAT gene from the M.jannaschii genome. 
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The transporter gene AAT was inserted into the multi-copy E.coli / yeast shuttle vector pITy-QC to 
yield expression vector pAAT. Homologies to the 5’ and 3’ termini of the AAT gene were introduced 
into pITy-QC by PCR. M.jannaschii genomic DNA was digested with XhoI and co-transformed with 
the linear vector into yeast expression strain BJ5464. The resulting uracil-prototrophic expression 
strain was designated YpAAT. The expression of the cloned AAT gene is driven by the strong 
galactose-inducible GAL1 promoter. The pITy-QC in vivo cloning / expression vector carries the yeast 
2µ replication origin for stable plasmid maintenance in yeast. The promoterless URA3 selection 
marker (ura3d) triggers very high plasmid copy numbers per cell (Griffith et al., 2003; Okkels, 1996; 
Loison et al., 1989) The neomycin/canamycin-resistance gene neoR or canR allows selection in E.coli. 
The principle of the Aatp cloning is outlined in Fig. 34.  
Fig. 34: Schematic description of AAT cloning by homologous recombination. 1st step: Introduction of the 
short sequences homologous to the termini of the AAT gene (homology arms) by PCR of the pITy-QC plasmid. 
2nd step:. Co-transformation of the BJ5464 yeast strain with the PCR product and the XhoI digested 
M.jannaschii genomic DNA. The gap in the vector is closed by homologous recombination between the AAT 
gene and the homogy arms. ura3d: promoterless yeast selection marker, 2µ: yeast origin of replication, pGAL1: 
GAL1 promoter, tCYC1: terminator. gDNA: genomic DNA from M.jannaschii, previously digested with XhoI. For 
clarity, E.coli elements are not shown. 
 
pAAT leads to the expression of a C-terminally His6 tagged variant of Aatp. The Aatp expression 
cassette is presented in Fig. 35. 
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Fig. 35: Schematic representation of the Aatp expression cassette harbored on the pITy-QC plasmid. 
pGAL1: GAL1 promoter; AAT: coding sequence for Aatp; His6: coding sequence for the His6-tag; tCYC1: 
terminator; NeoR: neomycin resistance gene; ORI: E.coli origin of replication; 2µ ORI: yeast origin of replication; 
XhoI: restriction site; δ sequences: sequences which target chromosomal integration of the expression cassette 
to the 150-200 copies of the Ty δ sequence present in the yeast genome.  
 
6.1.2. Construction of a yeast strain for enhanced Aatp expression 
As for Ste2mp, we constructed an alternative expression strain in order to push the expression level of 
Aatp. For this, BJ5464 was co-transformed with the pAAT and pMEGA vectors (Sil et al., 2000) and 
the resulting expression strain was designated YpMEGA/AAT. As previsously explained, the pMEGA 
vector allows overexpression of the Gal3p, Gal80p and Gal4p switch proteins that enhance 
transcription of the GAL1 promoter. Co-expression of these switch proteins in a strain that already 
sustains high copy numbers of pAAT was expected to boost Aatp expression even further, like it did 
for Ste2mp. 
The features of the two expression strains are summarised in Table 2. 
Strain Plasmid Important features 
YpAAT pAAT - 2 µ origin of replication 
- promoterless ura3d selection marker  
YpMEGA/AAT pAAT 
 
pMEGA 
- 2 µ origin of replication 
- promoterless ura3d selection marker 
- enhanced transcription from the GAL1 promoter 
Table 2: Denominations and important features of each AAT expression strain. 
 
 
6.2. Selection of suitable culture conditions and the optimal expression strain for AAT 
In order to find conditions yielding an optimal expression level of Aatp, three transformants of the 
strain YpAAT were submitted to different conditions of growth and induction of gene expression. 
For each transformant, starter cultures were first established. They grew for 48h, until an OD600 
around 11 was reached.  
pITy-QC 
ura3d 2µ ORI δ sequences
XhoI 
His6 
XhoI 
AAT tCYC1 NeoR ORI pGAL1 
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The strains were then inoculated to an OD600 of 0,02 at 30 C into a volume of 200 ml of non-inducing 
selective medium containing raffinose, or rich medium containing glucose, as the sole carbon source 
(for description of the media composition, see the Material and methods section, chapter 13.2.1).  
 
From the 200 ml uninduced culture, 50 ml each were withdrawn at four different growth phases., i.e., 
at OD600 of 1 to 2, 4 to 5, 7 to 9, and in the stationary phase (indicated by arrows in Fig. 36). The 
growth curves in selective medium are shown in Fig. 36 (growth curves in rich medium presented no 
significant differences). The aliquots were then supplemented with 2% galactose to induce the 
expression of Aatp. After 4h of induction, 25 ml were collected from each culture, cells harvested and 
frozen. The remaining 25 ml were induced for a total of 8h before being harvested and frozen as well. 
The same procedure was performed in selective and rich medium for each transformant.  
Fig. 36: Growth curves of different YpAAT 
transformants in non-inducing selective medium. Data 
were obtained from three different transformants, #1, #2 
and #3. Arrows indicate the timepoints where samples 
were collected to be analysed as described above (OD600 
of 1 to 2, 4 to 5, 7 to 9, and ~12 in the stationnary phase). 
 
 
 
 
 
 
The protocol for the determination of the optimal growth and induction conditions is summarized in 
Fig. 37.  
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Fig. 37: Protocol followed to determine the optimal growth conditions and concurrent high level Aatp 
expression. 
 
After the induction, yeast membranes of each yeast cells samples were isolated, and the expression 
level of Aatp was analysed for each of them by immunoblotting, with an anti-His antibody directed 
towards the His6-tag of Aatp. During the isolation of yeast membranes, extrinsic proteins were 
removed by a stripping-step, to enrich the sample in Aatp. This was performed by adding 400 mM 
NaCl to the homogenisation buffer. 
 
We first compared the Aatp expression level in the membranes of yeast cells grown in rich medium, at 
different OD600 and after different induction times. From the Western-blot in Fig. 38A, it is clear that, in 
rich medium, the highest Aatp expression level was obtained when the induction was started at an 
OD600 of 6 to 9 and performed for 8h. Densitometric analysis of the Western blot signals yielded 
relative intensities of Aatp expression of ~8500 to ~9000 as indicated in the corresponding 
quantification graph (Fig. 38B).   
Transformant #1              Transformant #2           Transformant #3
 Identical procedure
as for transformant #1
   Starter culture
                            48h growth
OD600= 11
  200 ml yeast culture
     50 ml              50 ml               50 ml               50 ml
  OD600=1 to 2    OD600=4 to 5    OD600=7 to 9    OD600=11
 Induction with galactose for different times
    
        25 ml              25 ml            25 ml            25 ml
4h
 8h
4h
 8h
4h
 8h
4h
 8h
25 ml 25 ml 25 ml
Isolation of yeast membranes and quantification of the
expression level of Aatp by immunoblot
Expression culture in
selective medium ScRaff/Gal
Expression culture in
rich medium YPD/YPGal
Identical procedure as for
the expression culture in
selective medium
25 ml
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Fig. 38:Overexpression of Aatp under different growth conditions. Aliquots were collected from the cultures 
at different OD600 (2, 5, 6, 7, 9, 11), and induced for 4h or 8h with galactose. Ten µg of isolated total yeast 
membranes were analysed by Western-blot or dot-blot. 38A and 38B: Western-blot and corresponding 
quantification graph showing the amount of expressed Aatp at different times of growth in rich medium, after 
different times of galactose induction. Arrows indicate the best expression levels. 38C and 38D: Dot-blot and 
corresponding quantification graph showing the amount of expressed Aatp at different times of growth in 
selective medium, after different times of galactose induction. The arrow indicates the best expression level.  
 
 
The Dot-blot of Aatp expression in selective medium in Fig. 38C shows clearly that the best Aatp 
expression level was obtained when the cells were at an OD600 of 5 at the induction start and protein 
expression was induced for 8h. Densitometric analysis of the Dot blot signal yielded a relative 
intensity of ~7000 as pointed out on the corresponding quantification graph Fig. 398D). 
 
The best expression levels in the two different media were then directly compared on the same 
Western blot. (Fig. 39A). The blot and its corresponding quantification graph (Fig. 39B) show clearly 
that Aatp was better expressed in cells grown in selective medium than in rich medium, yielding 4500 
and 9000 relative units, respectively. 
 
The expression level of Aatp was also checked in the YpMEGA/AAT strain that carries the pMEGA 
vector for enhanced AAT expression from the GAL1 promoter. As for Ste2mp, it was expected that the 
constitutive overexpression of the Gal transcription factors from the pMEGA vector would lead to an 
increased transcription of the AAT gene and, consequently, to a higher Aatp expression level. 
The Western blot with total membranes isolated from YpMEGA/AAT that had been grown and 
induced under the same conditions as the YpAAT shows that Aatp expression is not boosted by 
coexpression of the GAL transcription factors (Fig. 39C).  
OD 6         OD 9        OD 11
4h    8h     4h     8h     4h     8h
38A OD 2  OD 5    OD 7  OD 11
4h
8h
38C
Expression level of AAT in selective medium 
0
2000
4000
6000
8000
relativ 
densitometry
4h        8h        4h        8h         4h        8h         4h        8h
    OD 2                OD 5                 OD 7                OD11
38D
relative
intensity
Relative quantification of the a ount of
expressed Aatp in selective medium
under different conditions
Expression of AAT in rich medium 
0
2000
4000
6000
8000
10000
38B
 4h        8h         4h         8h         4h        8h
    OD 6                  OD 9                 OD 11
Relative
intensity
Relative quantification of the amount
of expressed Aatp in rich medium
under different conditions
Results - Hyperthermophilic Aatp 
 
 
 57
The quantification graph of the densitometric analysis of the Western-blot signals (Fig. 39D) indicates 
a considerably lower intensity for Aatp expressed in the YpMEGA/AAT strain (~2000 units) than in 
YpAAT (~6500 units). 
Fig. 39: Comparison of the Aatp expression levels in cells grown in two different media and between 
different strains. Comparison from same amounts of total membranes (20 µg). 39A and 39B: Comparison 
between cells giving the best level of expression in each medium in the strain YpAAT: in rich medium: OD600 of 
6, induction 8h; in selective complete medium: OD600 of 4, induction 8h. 39A: Western-blot showing the 
expressed Aatp in cells grown in rich medium or selective complete medium. 39B: Corresponding quantification 
graph comparing the amount of expressed Aatp in the two different media. 39C: Western-blot showing the 
expressed Aatp in the YpAAT strain and in the YpMEGA/AAT strain. 39D: Corresponding quantification graph 
comparing the amount of expressed Aatp in the two different strains. 
 
 
From the results outlined above, we chose to express Aatp in YpAAT induced in selective medium at 
an OD600 between 4 to 5 and to induce gene expression with galactose for 8h. 
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6.3. Solubilisation of Aatp 
 Once overexpression of Aatp in S.cerevisiae was optimised, Aatp had to be extracted from the yeast 
membranes. 
Fig. 40: Solubilisation of Aatp with different detergents. Solubilisation of 2 mg of total membrane proteins 
with 2% detergent (protein/detergent ratio of 1/4) after a 30 min incubation at 4°C. P: Pellets, SN: Supernatants. 
Pellets were resuspended in the same volume as supernatants, and equal volumes (15 µl) of samples were 
loaded onto the gel. The anti-His6 antibody used to probe the blot specifically labeled Aatp. 40A: Western-blot 
showing the Aatp amount in soluble or insoluble fractions. 40B: corresponding quantification graph after 
densitometric analysis of the Western blot. 
In order to determine the conditions yielding the best solubilisation, different detergents were tested: 
N,N-Dimethyldodecylamine-N-oxide (LDAO), N-Dodecyl-phosphocholine (FOS12), Polyoxyethylene-
9-laurylether (C12E9), N-Dodecyl-β-D-maltoside (DDM), N -Dodecyl-α-D-maltoside (DM), N-Octyl-β-D-
Glucopyranoside (OG) and N-Nonyl-β-D-Glucopyranoside (NG). We intended to choose one that 
could solubilise at least 50% of Aatp. With all detergents, the solubilisation was carried out with 2 mg 
of total membrane proteins. A membrane protein/detergent ratio of 1/4 was chosen and the 
membranes were treated with the desired detergent for 30 minutes at 4°C. The soluble membrane 
fraction was then separated from the insoluble material by a 1h ultra-centrifugation at 200 000 xg. The 
amounts of Aatp present in the supernatant and in the pellet were compared by immunoblotting with 
an anti-His antibody specifically labelling Aatp. The Western-blot (Fig. 40A) and its densitometric 
analysis in the corresponding quantification graph (Fig. 40B) clearly show that all tested detergents 
very efficiently solubilised Aatp from the yeast membrane, i.e., between 94 and 100% Aatp was 
present in the supernatant after the ultra-centrifugation step. 
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6.4. Purification of Aatp  
6.4.1. One-step purification trial by heat treatment 
 Aatp was supposed to be the only heat-stable membrane protein expressed in S.cerevisiae. 
Therefore, the first purification attempt was performed by a heat treatment step that was expected to 
cause denaturation and precipitation of the endogenous S.cerevisiae proteins but not Aatp. 
Solubilisation was carried out with the detergents indicated above except LDAO and FOS12, and after 
a 1h centrifugation at 200 000 xg the supernatants containing solubilised Aatp (and other co-
solubilised yeast membrane proteins) were submitted to a 5 minutes heat treatment at 40°C, 70°C or 
90°C. After the heating step, the samples were kept on ice for 10 minutes in order to prevent an 
undesired renaturation of the denatured proteins. After a 1h centrifugation at 200 000 xg at 4°C to 
pellet aggregated denatured proteins, supernatants were analysed on a silver-stained SDS gel and a 
Western-blot (Fig. 41).   
 
Fig. 41: Aatp purification by heat treatment of the soluble membrane fraction. Western-blot and 
corresponding silver-stained gel, showing the amount of Aatp and total membrane proteins in the original pellet 
and in the supernatants after a 5 minutes heat treatment at 40, 70 or 90°C. P: Pellet, SN: Supernatant (without 
heat treatment), 40, 70 and 90: temperature in °C applied to the SN. Samples were heated for 5 minutes and 
then incubated on ice for 10 minutes. After a 1h centrifugation at 200 000 xg at 4°C, 10 µl of the supernatants 
were loaded onto the gels. Arrows indicate putative Aatp. 
 
In the case of solubilisation with OG, NG or C12E9, Aatp was denatured after 5 minutes at 90°C as no 
or only a faint Aatp signal was detected in the Western blot. No denaturation of Aatp was observed 
after solubilisation with DM or DDM. 
In order to determine how long Aatp remained native at high temperatures, the protein was solubilised 
with DM or DDM. and incubated at 90°C for 1, 3, 5, 7 or 10 minutes followed by incubation on ice for 
10 minutes to prevent undesirable renaturation of other denatured membrane proteins. After a 1h 
centrifugation at 200 000 xg at 4°C to pellet aggregated denatured proteins, supernatants were 
analysed on a silver-stained SDS gel and a Western-blot (Fig. 42). 
P  SN  40  70  90 P  SN  40  70  90 P  SN  40  70  90 P  SN  40  70  90 P  SN  40  70  90
DM   DDM      OG         NG         C12E9
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Fig. 42: Aatp purification by heat treatment of the soluble membrane fraction: time-course of the Aatp 
thermostability. Western-blot and silver-stained SDS-gel showing the amount of solubilised Aatp after heat 
treatment at 90°C for 1, 3, 5, 7, and 10 min. 3 mg of total membrane proteins were solubilised in DM or DDM. 
After a 1h centrifugation at 200 000 xg at 4°C, the supernatant was incubated at 90°C for different times, then 
let on ice for 10 minutes, and centrifuged for 1h at 200 000 xg at 4°C. Three µl of the supernatant were loaded 
onto gels. M: Size marker, P: Pellet, SN: Supernatatant, / :no heat treatment, 1´, 3´, 5´, 7´ and 10´: minutes for 
the heat treatment. Arrows indicate monomeric Aatp. 
 
The Western-blot shows that Aatp solubilised with DM was stable for 5 minutes at 90°C, and 
aggregated afterwards as indicated by the high molecular weight bands in lanes 5’, 7’ and 10’ 
(Fig. 42) and the correspondingly weaker Aatp signals in the same lanes on the Western blot. In 
contrast, Aatp remained in solution for 10 minutes at 90°C when solubilised in DDM. Surprisingly, the 
purity of Aatp was not increased by this heat treatment, as on the silver-stained gel many 
contaminating bands of other proteins (from S.cerevisiae) are still present in the soluble fraction after 
10 minutes at 90°C. In comparison to the silver-stained SDS-gels in Fig. 41, the silver-stained SDS-
gel in Fig. 42 present a lot more contaminating bands, this is probably due to a longer time of 
development in the silver-staining protocol. 
Taken together, the heat treatment did not result in the desired purity of Aatp and, therefore, was 
abandoned in favour of an alternative 2-step purification strategy. 
 
The calculated molecular weight of the His-tagged Aatp is around 48 kDa. However, in comparison to 
the size marker on the SDS-gels, it appears around 36 kDa. We used a different size marker for the 
immunoblot. On the immunoblot, Aatp appears to run around 25 kDa on Western-blots. The use of 
these different size-markers could explained this size discrepancy. Indeed, MALDI-TOF mass 
spectrometry analysis (see chapter 6.5.2) revealed that the protein in the bands running at these 
unexpected molecular weights was indeeed Aatp. 
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6.4.2. Two-step purification trials 
6.4.2.1. Purification by metal-affinity chromatography with Ni2+-NTA beads, and 
subsequent heat treatment 
Aatp carries a His6-tag. This allowed us to perform metal-affinity chromatography with Ni2+-NTA 
beads. The chromatography was performed with LDAO- or DDM-solubilised Aatp. Both detergents 
were chosen due to their efficiency (~100% of Aatp solubilised, Fig. 40), LDAO also for its cheap 
price, and DDM because it was proved efficient in the solubilisation and purification of other 
hyperthermophilic membrane proteins (Morsomme et al., 2002), (López-Marqués et al., 2005).  
 
6.4.2.1.1. Purification after solubilisation with LDAO 
Ni2+-NTA chromatography was performed after a solubilisation of 100 mg of total membrane proteins 
with 2% LDAO. Supernatants containing solubilised Aatp were prepared as outlined above and 
incubated overnight at 4°C with 1 ml Ni2+-NTA beads. The beads were then packed into a column, 
and the flow-through collected. Subsequently, the beads were washed and Aatp eluted with varying 
imidazole concentrations.  
 
 The second step of purification consisted in a heat treatment of the Ni2+-NTA eluates and the wash 
samples, at different temperatures and for different time spansAll Ni2+-NTA chromatography samples 
were analysed on a silver-stained SDS gel and a corresponding Western-blot. Densitometric analysis 
of the silver-stained SDS gel (Fig. 43A) showed that Aatp was retrieved around 70% pure in the 
eluate. However, most of the Aatp came off the column during the wash step. 
Fig. 43: Aatp purification trial by metal-affinity chromatography with Ni2+-NTA beads. 43A: Silver-stained 
SDS gel and corresponding Western-blot, showing the purification samples after solubilisation of 100 mg total 
membrane proteins with LDAO. M: Size marker, P: pellet, SN: supernatant, FT: Flow through, W: wash. Elution 
with different imidazole concentrations: 15, 20, 25, 250 or 500 mM). Arrows indicate monomeric Aatp. 43B: 
Composition of the purification buffers. 
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Unfortunately, the purity of Aatp in the Ni2+-NTA eluate was not reproducible when the purification 
procedure was up-scaled. Therefore, we performed a heat treatment with the Ni2+-NTA eluate after 
large scale purification. The eluate was heated to 65°C, 80°C or 90°C for 1, 2 or 5 minutes.  
Fig. 44 shows the analysis of the Ni2+-NTA eluate (E) after heat treatment, on a Coomassie-stained 
SDS gel and its corresponding Western-blot. It reveals that at 65°C, Aatp was stable for 5 minutes. 
Aatp did not sustain 80°C for 2 minutes as the signal on the Western blot was visibly weaker than in 
the original eluate (E), and it was completely denatured after 1 minute at 95°C. 
Taken together, Aatp does not stay in a native state at high temperatures for longer than 1 to 2 
minutes, under the conditions used above and when solubilised in LDAO. More importantly, the purity 
of Aatp was never improved by the heat treatment. 
 Surprisingly, after 5 minutes at 90°C, we could still detect a persistent band running around 17 kDa 
on the Coomassie-stained SDS gel. Both N-terminal sequencing and MALDI-TOF analysis identified it 
as the 60S ribosomal protein L28 (or L29) from S.cerevisiae. 
Fig. 44: Aatp purification trial by metal-affinity chromatography with Ni2+-NTA beads and subsequent 
heat treatment. Coomassie-stained gel and corresponding Western-blot, showing the Ni2+-NTA eluate after a 
heat treatment at 65, 80 and 90°C for 1, 2 and 5 min.  100 mg of total membrane proteins were solubilised with 
LDAO. M: Size marker, E: Ni2+-NTA Eluate. Arrows indicate monomeric Aatp or 60S ribosomal protein L28 (or 
L29) from S.cerevisiae. 
 
6.4.2.1.2. Purification after a solubilisation with DDM 
Since the two-step purification of LDAO solubilised Aatp with Ni2+-NTA and heat treatment was not 
satisfaying, the same procedure was tried after solubilisation with DDM. The metal-affinity 
chromatography was done as described above. A Coomassie-stained SDS gel and its corresponding 
Western-blot (Fig. 45A) show that 75% of loaded Aatp were retrieved, and recovered around 70% 
pure in the eluate (Fig. 45B). Only 25% were lost during the chromatography, 19% in the flow through 
and 6% during the wash. The heat treatment was carried out with the eluate at 90°C for 5, 10 and 15 
minutes. DDM-solubilised Aatp remained stable at 90°C for at least 10 minutes.  
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However, after 15 minutes the protein starts to aggregate since the signal on the Western blot 
becomes weaker. Due to this result, we decided to go on with the purification of Aatp after 
solubilisation in DDM. 
 
 On the SDS-gel in Fig. 45A the purity of Aatp is clearly improved in the heated Ni2+-NTA eluates 
(lanes 5’, 10’, 15’) as indicated by the decreased number of contaminating side-bands in comparison 
to the unheated eluate (lane /). Complete removal of the contaminating proteins, though, was not 
achieved and prolongued heating (15’ vs 5’) did not improve Aatp purity any further. 
Fig. 45: Aatp purification trial by metal-affinity chromatography with Ni2+-NTA beads and subsequent 
heat treatment. 45A: Western-blot and corresponding Coomassie-stained gel, showing the purification samples 
after a solubilisation of 100 mg of total membrane proteins with 2% DDM. Heat treatment of the eluate for 5, 10 
and 15 min at 90°C. The X-ray film was exposed 30 seconds or 2 minutes to the Western-blot. M: Size marker, 
P: Pellet, SN: Supernatant, B: Beads, FT: Flow through, W: Wash, E: Eluate. Arrows indicate monomeric Aatp. 
45B: Quantification of the amount of Aatp in each purification sample by densitometric analysis of the Western-
blot. 
 
Although quite a number of contaminting proteins were removed by the heating step, the eluate was 
still not pure enough for crystallisation attempts. In order to further improve the purity, another heat 
treatment was applied on the supernatant just after solubilisation, and on the eluate after the Ni2+-NTA 
chromatography. As it is shown on a Coomassie-stained SDSgel and the corresponding Western-blot 
(Fig. 46), it appears that Aatp denatured when submitted to a duplicate heat treatment, and in 
addition, its purity was not improved. Thus, Aatp was not heatstable enough to resist the duplicate 
heat treatment under the solubilisation and purification conditions we used. 
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Fig. 46: Aatp purification trial by metal-affinity chromatography with Ni2+-NTA beads and duplicate heat 
treatment. Coomassie-stained SDS gel and corresponding Western-blot, showing a three-step purification trial 
of Aatp after solubilisation of 100 mg of total membrane proteins with DDM: heat treatment of the soluble 
sample, Ni2-NTA chromatography, and heat treatment on the Ni2-NTA eluate at 90°C for 5 min, 10 min or 
15 min. SN: Supernatant, H.SN: Heated supernatant, FT: Flow-through, W: wash. Eluates 1, 2 and 3: were 
successively collected during elution. Arrows indicate monomeric Aatp. 
 
As it seemed inefficient in inproving Aatp purity, heat treatment was not further pursued. 
 
 
6.4.2.1.3. Purification of Aatp in different buffers 
In order to improve the efficiency of the Aatp purification, different buffer conditions were tested during 
the Ni2+-NTA chromatography. We carried out the solubilisation and the chromatography with buffers 
supplemented with 5 mM imidazole or without imidazole. Coomassie-stained SDS gels and the 
corresponding Western-blots show the samples of the two different purifications (Fig. 47A and Fig. 
47B). A higher amount of Aatp was retrieved in presence of 5 mM imidazole than without imidazole. 
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Fig. 47: Comparison of the efficiency of the Aatp purification in buffers with and without imidazole: 
Coomassie-stained SDS gel and corresponding Western-blot of the purification samples after a solubilisation 
and a purification in buffers containing 5 mM imidazole (47A) or without imidazole (47B). M: Size marker, P: 
Pellet, SN: Supernatant, FT: Flow-through, W: Wash, E: Eluate. Arrows indicate monomeric Aatp. 
 
The buffer usually used was 50 mM Na2HPO4, as common buffers like Tris-HCl (above 100 mM) are 
not indicated for the Ni2+-NTA matrix, because of the risk that secondary or tertiary amines reduce the 
nickel ions. However, we tested the influence of 50 mM Na2HPO4 and 50 mM Tris-HCl on the 
purification efficiency Same amounts of solubilised Aatp were incubated with Ni2+-NTA beads and the 
usual chromatography protocol was performed. Coomassie-stained SDS gel and the corresponding 
Western-blot of the two different purifications (Fig. 48) show that the purification was more efficient 
when performed in a 50 mM Na2HPO4 containing buffer than in a 50 mM Tris-HCl containing buffer, in 
terms of recovered amounts of Aatp in the eluate. Although the purity of the Aatp preparation was 
better in 50 mM Tris-HCl containing buffer we continued to purify Aatp in 50 mM Na2HPO4 containing 
buffer in order to increase the yield. 
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Fig. 48: Comparison of the 
efficiency of the Aatp purification in 
a phosphate and a Tris buffer. 
Purification carried out in 50 mM 
Na2HPO4 or in 50 mM Tris-HCl buffer. 
Coomassie-stained gel and 
corresponding Western-blot show the 
purification samples of a purification 
where same amounts of solubilised 
Aatp and used for the Ni2+-NTA 
chromatography in the two different 
buffers. M: Size marker, SN: 
Supernatant, FT: Flow-through, W: 
Wash, E: Eluate. Arrows indicate 
Aatp. 
 
6.4.2.2. Purification of Aatp by metal-affinity chromatography with Ni2+-NTA beads 
followed by size-exclusion chromatography 
As the purity of Aatp after Ni2+-NTA chromatography was not sufficient to proceed to crystallisation 
experiments, a second chromatographic purification step was performed. It was our goal to obtain 80-
90% pure Aatp in a homogenous state. This second step was a size-exclusion chromatography (SEC) 
with the concentrated and filtered Ni2+-NTA eluate. The Na2HPO4 buffer is inappropriate for 
crystallisation as phosphate crystals grow very easily, thus, we exchanged it for 50 mM Tris-HCl 
buffer during the size-exclusion step. 
The SEC samples were analysed on a Coomassie-stained SDS gel, and the peak observed on the 
chromatogram was correlated with the presence of a band corresponding to the calculated molecular 
weight of Aatp. The purest samples were pooled and concentrated. 
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Fig. 49: Aatp purification by size-exclusion chromatography. 49A: Chromatogram of the size-exclusion 
chromatography. 49B: Coomassie-stained gel analysing the collected fractions of the size-exclusion 
chromatography. M: Size marker, 1...28: successive collected fractions. 
 
6.4.3. Final purification protocol for Aatp 
All the samples of this two-step purification were analysed on a Coomassie-stained SDS gel and a 
corresponding Western-blot. This analysis permitted to define the final purification Aatp. 
 
The final purification protocol for Aatp involved two steps: Ni2+-NTA affinity chromatography followed 
by size-exclusion chromatography. Samples of this two-step purification were analysed on a 
Coomassie-stained SDS gel and its corresponding Western-blot (Fig. 50A). Purification conditions are 
described in Fig. 50C. 
 
As shown in the quantification graph (Fig. 50B), appoximately 100% of Aatp were solubilised in DDM. 
During Ni2+-NTA affinity chromatography, DDM-solubilised Aatp efficicently bound to the beads: only 
1% of the protein was lost in the flow through. Aatp bound tightly to the Ni2+-NTA beads as only 4% 
were lost in the washing step. Almost 95% of the loaded Aatp were retrieved in the eluate. Elution 
was 100% efficient and no Aatp retained on the beads after elution (0%). Finally, the eluate was 
concentrated and filtered, and subjected to size-exclusion chromatography. After SEC, approximately 
90% pure Aatp (as estimated by densitometric analysis of the Coomassie gel) was retreived in 50 mM 
Tris-HCl buffer. 
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Fig. 50: Final purification protocol for Aatp. 50A: Coomassie-stained SDS gel and corresponding Western-
blot showing the purification samples. M: Size-marker, P: Pellet, SN: Supernatant, B: Beads, FT: Flow-through, 
W: Wash, E: Eluate from the Ni2+-NTA chromatography, Ese: Eluate from the size-exclusion chromatography 
(gel filtration). 50B: Corresponding quantification graph. 50C: Composition of the purification buffers. All buffers 
contained 20% glycerol as chemical chaperone for Aatp. 
 
 
6.5. Characterisation of Aatp 
6.5.1. N-terminal sequence analysis 
The major single band of the eluate (Fig. 50A) was cut from an SDS gel and analysed by N-Terminal 
sequencing. On the Coomassie-stained SDS gel (Fig. 50A) the band corresponding to the putative 
Aatp migrated around 36 kDa. N-terminal sequencing determined that the 6 first amino-acids of the 
sequence of this band were MELKNK, which exactly matches the first 6 amino-acids of the sequence 
of Aatp. This confirmed the nature of the band. 
 
6.5.2. MALDI-TOF mass spectrometry analysis 
The major single band of the eluate (Fig. 50A) was cut from an SDS gel, digested with trypsin and 
analysed by MALDI-TOF mass spectrometry. On the Coomassie-stained SDS-PAGE (Fig. 50A) the 
band corresponding to the putative Aatp migrated around 36 kDa. MALDI-TOF confirmed the N-
terminal sequencing result, attesting that this 36 kDa band corresponded to Aatp. Its molecular mass 
was determined to be 48149 Da. 
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6.6. Crystallisation of Aatp 
In order to optimise the protein preparation for the crystallisation experiments, as much detergent 
(DDM) as possible hat to be removed. As DDM can not be dialysed, it was removed by incubation 
with absorbent biobeads, and a time-course of the Aatp stability against removal of DDM was 
established. 
After Aatp had been purified with the two-step procedure described above (see Fig. 51A for the 
analysis of the purification samples on an SDS-gel), the SEC eluate was incubated with biobeads with 
gentle agitation. After 15, 30, 45 minutes, 1h, 1h30, 2h or 2h30, the agitation was stopped to sediment 
the beads, aliquots of the supernatant were collected and analysed on a Coomassie-stained SDS gel 
(Fig. 51B). It shows that the amount of Aatp in the supernatant decreased after 30 minutes of 
incubation with biobeads. After 1h no Aatp band was detected which indicates that too much DDM 
had been withdrawn from Aatp by adsorption to the beads. 
Finally, we continued with a 15 minutes incubation with the biobeads for removal of excess DDM. 
 
 
 
 
 
 
 
 
 
 
Fig. 51: Aatp solubility during removal of DDM. 51A: Coomassie-stained SDS gel of the purification samples 
from the final purification procedure. P: Pellet, SN: Supernatant, FT: Flow-through, W: Wash, Eni: Eluate of the 
Ni2+-NTA chromatography, Ef: Eluate Eni Filtered, Ese: Eluate of the size-exclusion chromatography. 51B: 
Coomassie-stained SDS gel showing the amount of Aatp still in solution at the indicated time points during 
incubation with biobeads. 
 
6.6.1. 3D-Crystallisation experiments 
6.6.1.1. Manual 3D-crystallisation 
We carried out manual crystallisation experiments with several commercially available crystallisation 
kits: MembFac, Index, Crystal Screen 1 and Crystal Screen 2. The method used was the hanging-
Drop method, as described in the Material and methods section (chapter 13.7.3.1). 
So far, no protein crystals were obtained. 
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6.6.1.2. Automated 3D-crystallisation 
Automated crystallisation experiments covering 576 different conditions were performed by Crelux 
GmbH. 
No protein crystals were obtained with any of those conditions. 
6.6.2. 2D-crystallisation experiments 
2D-crystallisation experiments were performed on a Ni2+-lipid monolayer. The principle of this 2D-
crystallisation method is based on the use of a Ni2+-lipid layer spread at an air-buffer interface. 
Proteins present in this lipid phase are concentrated by specific interactions with Ni2+ residues carried 
on the lipid molecules. The Ni2+-chelating lipid is employed as an adapter molecule to bind histidine 
residues of His6-tagged modified proteins. Thus, a rigid mixed protein-lipid monolayer is formed on the 
surface. The monolayer rigidity is directly correlated with the amount of protein bound to it. The more 
rigid the monolayer, the more proteins are bound and the better ordered they are, which leads to a 
better chance to obtain protein crystals. 
This method consumes only very little pure protein and has already been successful for 2D-
crystallisation of different macromolecules and membrane proteins (Lebeau et al., 2001; Asturias and 
Kornberg, 1999; Brisson, 1999; Levy et al., 1999; Leuther et al., 1996).  
 
Pure Aatp was sent to Dr. Patrick Bron, UMR-CNRS 6026 “Interactions cellulaires et moléculaires”, 
Rennes, France for preliminary 2D-crystallisation experiments. The trials were performed according to 
the protocol of Levy and coworkers (Levy et al., 1999). 
Unfortunately, too few proteins were bound to the monolayer and no order was observed at the 
surface of the monolayer. Consequently, no protein crystals formed. 
 
Classical 2D-crystallisation experiments with proteoliposomes were also performed. For this, DDM-
solubilised Aatp was reconstituted into liposomes made of a classical mixture of E.coli. lipids. 
However, no crystals were observed under all tested conditions (see Materials and Methods section 
for details). 
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7. Overexpression of other putative membrane transporters of Methanococcus 
jannaschii in Saccharomyces cerevisiae 
Four other membrane transporters of Methanococcus jannaschii were as well studied: a putative 
phosphate permease transporter (designated Phopp), a sodium-decarboxylate transporter 
(designated Dassp), a sodium transporter (designated Nssp) and a potassium uptake protein 
(designated Trkp). These four transporters were cloned using the same method as for Aatp, and we 
tried to heterologously overexpress them in Saccharomyces cerevisiae, with the final aim to purify 
them and perform crystallisation trials. As for Aatp, the hyperthermophilic nature of these transporters 
was expected to facilitate the purification in a heat treatment step. 
7.1.1. Expression constructs 
As with the AAT gene, each transporter genes PHOP, DASS, NSS and TRK were inserted into the 
multi-copy E.coli / yeast shuttle vector pITy-QC resulting in expression vectors pPHOP, pDASS, 
pNAA and pTRK (see the section material and methods, chapter 13.1.1.2). The constructs were 
generated so as to encode a C-terminally His6 tagged variant of each gene for facilitated purification 
by metal-affinity chromatography. Yeast expression strain BJ5464 was transformed with all of these 
constructs.  
7.1.2. Selection of suitable culture conditions by expression level 
The expression of the 4 putative membrane transporters was tested unter the same conditions as 
those described for Aatp (see chapter 6.2): growth in selective medium to an OD600 between 4 to 5, 
and induction with galactose for  8h. 
As with Aatp, total membranes were isolated from each induced yeast strain and stripped under high 
salt conditions in order to remove extrinsic proteins, and to enrich the sample in the desired transport 
protein. On a Western-blot, the total (stripped) membranes were analysed for expression of the 
transporters and total stripped membranes of a strain expressing Aatp were used as the reference in 
the densitometric analysis (Fig. 52). There is clear evidence that Phopp, Dassp, Trkp and Nssp were 
extremely poorly expressed in comparison to Aatp. 
Fig. 52: Comparison of the expression level of Aatp with that of Phopp, Dassp, Trkp and Nssp in total 
stripped yeast membranes. Total membranes were isolated from induced expression strains and 5 µg were 
loaded on a Western-blot gel. The anti-His6 antibody used to probe the Western-blot labeled specifically the 
proteins of interest. The negative control presents membranes from untransformed yeast cells. 
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In the expression system and under the conditions we used, none of the 4 putative membrane 
transporters of Methanococcus jannashii was overexpressed, or even expressed at a level sufficient 
to obtain enough material for further investigations. It seems that our Saccharomyces cerevisiae 
expression system was only efficient for Aatp. 
 
 
In consequence, we did not perform further investigations with these four transporters.   
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Discussion 
 
Membrane proteins are vital elements in the communication of the cell with its environment. 
 
Among them, the G-protein coupled receptors (GPCRs) have raised a great deal of interest lately 
since they comprise around one third of the pharmaceutically promising drug targets. Their 
structural analysis is of outstanding medical and pharmaceutical interest in order to understand the 
mechanism of drug action. However, we have limited knowledge of membrane protein structure 
and function in general and of GPCRs in particular. So far, there is only one 3D-structure of a 
GPCR resolved, which is that of the bovine rhodopsin (Palczewski et al., 2000). 
 
The membrane proteins from extremophiles such as hyperthermophilic archaea are also of 
scientific interest. It was found that many of them could be phylogenetically related to membrane 
proteins of eukaryotic organisms. As these membrane proteins naturally function in organisms that 
are extremely resistant to high temperatures, high pressure and extreme pH, they are expectedly 
more robust than their mesophilic counterparts. This robustness can be very useful to overcome 
the problems usually encountered during solubilisation and purification of integral membrane 
proteins. 
 
Hyperthermophilic proteins usually contain a higher proportion of amino-acid residues capable of 
forming intrinsic forces of stabilisation like salt bridges, hydrogen bonds or hydrophobic 
interactions, this leading to an expected higher stability of the transmembrane domain interactions 
under high temperatures (Shiraki et al., 2001; Jaenicke and Bohm, 1998; Vetriani et al., 1998; 
Jaenicke et al., 1996). For example, a comparison between the glutamate dehydrogenase of the 
hyperthermophile Thermococcus litoralis and the one from Pyrococcus furiosus showed that the 
less stable T.litoralis enzyme has a decreased number of ion pair interactions, modified patterns of 
hydrogen bonding, and substitutions that decrease its packing efficiency (Britton et al., 1999). 
Hyperthermophilic membrane proteins are also thought to present a better helical packing, making 
them more resistant to the decrease of lateral pressure (Engelman et al., 2003; Schneider et al., 
2002). 
 
So, thermostability is possibly caused by numerous subtle sequence differences modifying the 
intrinsic stabilisation forces in the proteins. If these forces are disturbed during the solubilisation 
and/or the purification procedure, loss of hyperthermostability would result (Arnott et al., 2000). 
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Until now, several soluble proteins from hyperthermophilic organisms have been overexpressed, 
purified and crystallised. However, only 7 structures of hyperthermophilic membrane proteins 
(López-Marqués et al., 2005; Ferreira et al., 2004; Van den Berg et al., 2004; Kamiya and Shen, 
2003; Jiang et al., 2002b; Jiang et al., 2002a; Nogi et al., 2000; Soulimane et al., 2000b; 
Soulimane et al., 2000a)), and only one structure of a hyperthermophilic amino-acid transporter, 
the glutamate transporter homologue from Pyrococcus horikoshii (Yernool et al., 2004) have as yet 
been resolved. 
 
Though there is plenty of experience with the expression, purification and crystallisation of soluble 
proteins, we are indeed far from having the same possibilities for membrane proteins. Only few 
generally applicable methods and protocols have been developed that can be referred to, so that 
the field of membrane protein study appears rather vague, and every new study is actually 
pioneering work. The challenge to produce high amounts of correctly folded, biologically active, 
and pure protein for biophysical, biochemical and structural analyses becomes even more 
demanding with integral membrane proteins that are naturally low abundant and whose 
overexpression is confined to the biomembrane as the natural environment. 
This study’s goal was to acquire high resolution 3D structural data of integral membrane proteins. 
For the crystallisation experiments, we had to provide chemically and structurally homogenous, 
and highly purified membrane protein preparations in high quantities (mg). 
8. Overexpression of integral membrane proteins in S.cerevisiae 
The choice of a suitable organism for the overexpression of recombinant membrane proteins is an 
important determinant for its success. In this study, Saccharomyces cerevisiae turned out to be an 
ideal host organism for the overexpression of two integral membrane proteins from different 
kingdoms of life. 
 
8.1. Overexpression of Ste2mp and assessment of its functional activity 
The S.cerevisiae alpha-factor pheromone receptor Ste2p, a GPCR, was previously functionally 
overexpressed in S.cerevisiae, and successfully purified (David et al., 1997). Mentesana and 
Konopka observed that wild-type Ste2p is glycosylated at two consensus N-glycosylation 
sequences present in the extracellular N-terminal domain of the protein (Mentesana and Konopka, 
2001). In addition, they observed on immunoblots a high molecular weight band, due to 
phosphorylation in the receptor´s C-terminal domain. These post-translational modifications were 
shown to cause heterogeneity of the Ste2p preparation (Mentesana and Konopka, 2001), which is 
especially undesirable for protein crystallisation experiments.  
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However, post-translational modifications, in particular N-glycosylations and phosphorylation, are 
essential for some membrane proteins and GPCRs for proper folding, regulation and/or stability 
(Katada et al., 2004; von Zastrow, 2002; Imperiali and O'Connor, 1999; O'Connor and Imperiali, 
1996; Imperiali and Rickert, 1995), and activation (Duran-Avelar et al., 2001). Obviously, the 
modifications are not essential for Ste2p function since unphosphorylated and/or unglycosylated 
(truncated after Ser326 and/or mutated at Asn25 and Asn32) Ste2p mutants could be functionally 
expressed in S.cerevisiae. Mutation of the two Asn glycosylation sites into Gln, and removal of the 
phosphorylation sites does not alter receptor function or subcellular localisation (Mentesana and 
Konopka, 2001). Although the truncation of the C-terminal part after Ser326 reduces the receptor 
ability of mating projection orientation (Vallier et al., 2002), this modification results in a 4- to 5-fold 
increase in cell surface expression and a 10-fold increase in the cell sensitivity to pheromone 
(Mentesana and Konopka, 2001). The truncation is supposed to remove residues that are 
phosphorylated in the receptor´s basal state (Konopka et al., 1988), and it was shown that it does 
not affect the G-protein activation (Chen and Konopka, 1996). Dhami and coworkers (Dhami et al., 
2002) showed that the phosphorylation of an other GPCR, the metabotropic glutamate receptor, 
was also prevented by the truncation of its C-terminus. 
Taken these observations together, we mapped out a strategy to homologously overexpress an 
unglycosylated and unphosphorylated mutant Ste2p receptor, Ste2mp, in S.cerevisiae. We aimed 
at the production of high amounts of protein that would facilitate purification and permit subsequent 
crystallisation studies. 
In accordance to the literature and in order to prevent carbohydrate attachment at the two N-
glycosylation sites, Asn25 and Asn32 were exchanged to Gln residues. We also truncated the C-
terminal part containing the phosphorylation sites, after Ser326. Two different affinity tags were also 
introduced at the C-terminus of Ste2mp for facilitated protein purification by affinity-
chromatography, and detection on immunoblots. 
We attached the FLAG- and His6-tags to the C-terminus of Ste2mp since Lee and Altenberg had 
previously shown that FLAG- or His6-tags at the C-terminus have no effect on the expression of the 
multidrug-resistance protein 1 (MRP1) in S.cerevisiae, whereas they impair it when hooked onto 
the N-terminus (Lee and Altenberg, 2003). Moreover, signals for protein translocation and 
localisation to the target membrane are usually included in the N-terminal part of integral 
membrane proteins (Jackson et al., 1985). 
 
The ste2m gene was cloned into a yeast expression vector, downstream of the galactose-inducible 
GAL promoter (pGAL). We pursued two different strategies to optimise Ste2mp expression: 
Two expression strains were constructed in order to test whether increased pGAL-ste2m copy 
numbers alone or in combination with overexpression of the GAL transcription factors would lead 
to improved protein expression.  
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One strain harboured the pGAL-ste2m-expression plasmid with a promoterless ura3d selection 
marker instead of the standard URA3 marker. Uracil-auxotrophic ura3 yeast strains that carry 
plasmids with the ura3d marker must replicate the plasmid in higher copy numbers in order to be 
able to grow on uracil-free medium. Expectedly, gene expression is pushed by plasmid copy 
number. The second strain was co-transformed with the same pGAL-ste2m-ura3d expression 
plasmid and the pMEGA plasmid (Sil et al., 1999), which allows simultaneous and constitutive 
overexpression of the GAL transcription factors or “switch proteins“ Gal4p, Gal80p and Gal3p. 
S.cerevisiae responds to galactose as the sole carbon source by activating the GAL genes that 
encode the enzymes of the Leloir pathway. The switch from repressed to activated gene 
expression involves the interplay of the three galactose-dependent switch proteins and two small 
molecules, galactose and ATP (Sil et al., 1999). Gal4p, the activator, binds to the upstream 
activating sequence (UASgal) in the promoter of GAL-regulated genes. However, gene expression 
is not activated as long as Gal4p is bound to its repressor Gal80p. In the absence of galactose, 
Gal80p binds to Gal4p and prevents it to activate transcription, whereas in the presence of 
galactose and ATP, galactose interacts with the inducer Gal3p and the complex binds to Gal80p in 
an ATP-dependent manner. When Gal3p binds to Gal80p, it relieves the inhibition of Gal4p and 
transcription from the GAL promoter is induced. Sil and coworkers showed that cells co-
transformed with the pMEGA vector express 15- to 20-fold more Gal4p and 30 to 40-fold more 
Gal3p and Gal80p (Sil et al., 2000). They also showed that high levels of the switch proteins do not 
perturb the integrity of galactose-inducible regulation, though their expression levels must be 
balanced. Indeed, Platt and Reece  suggested that Gal3p must still be present in excess over 
Gal4p levels for the induction process to occur (Platt and Reece, 1998). 
 
Optimal cell growth conditions were established in order to accumulate cell mass for subsequent 
strong induction of ste2m gene expression. We grew the two different expression strains in 
selective and rich growth media and tested different growth phases for induction. After varying 
induction times with galactose, the expression level of Ste2mp was assessed during a time-course. 
As expected, we obtained the best expression level with the strain that retained high copy numbers 
of pGAL-ste2m-ura3d in selective growth medium. The co-expression of the GAL switch proteins 
clearly optimised Ste2mp expression even further. David and co-workers expressed the wild-type 
Ste2p in S.cerevisiae at 350 pmol/mg of total membrane proteins (David et al., 1997). This was the 
highest expression level ever obtained for a GPCR in yeast. Comparable, though lower expression 
levels were found for the human β2-adrenergic receptor (115 pmol/mg), and the human µ-opioid 
receptor expressed in Pichia Pastoris at 100 pmol/mg (Sarramegna et al., 2003). In comparison to 
those, the expression level of 143 ± 14 pmol Ste2mp/mg of total membrane proteins that we 
obtained is superior.  
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Why we did not achieve similar expression levels as David and co-workers might be due to the 
glyceraldehyde-3-phosphate promoter (GAP or GPD) they used, which is noticeably stronger than 
the inducible GAL1 promoter (Romanos et al., 1992). However, we cannot rule out that the C-
terminal truncation in Ste2mp adversely affects its expression. 
 
Binding of the pheromone ligand to its functional receptor leads to the arrest of cell growth (see 
introduction section, chapter 3.1.1). In order to demonstrate that Ste2mp was functional, we 
performed a halo assay that assesses the ability of a yeast strain to undergo growth arrest in 
response to α-factor, the natural ligand of Ste2p. The inhibition of cell growth is indicated by halos 
that form around an α-factor soaked filter disk which is placed on agar mixed with haploid yeast 
cells. With constant α-factor concentration the halo size mirrors α-factor receptor activity. 
The halos formed by yeast cells expressing either full length Ste2p fused to a FLAG- and a His6-
tag or the modified Ste2mp receptor with the same tags were comparable in size to the halo formed 
by wild-type yeast cells. This indicates that all mutants responded with a comparable sensitivity to 
α-factor than the wild-type receptor did. This indirectly demonstrates that the truncation after 
Ser326, the mutation of the N-glycosylation sites and the introduction of the FLAG- and His6-tags at 
the C-terminal part of Ste2p did not alter the in vivo function of the receptor. 
The result of the halo-assay demonstrates that Ste2mp is not only able to bind its ligand but also to 
couple the G-protein. Almost all GPCRs so far expressed in yeast were shown to bind their ligand, 
however, coupling of the G-protein was only rarely observed (Erickson et al., 1998; Kajkowski et 
al., 1997; Price et al., 1995; King et al., 1990). 
 
In order to test the ligand binding activity of Ste2mp in vitro, we performed activity assays with 
native membranes from the Ste2mp expression strain or membranes that were stripped of 
peripheral membrane proteins, and tritium-labelled α-factor. [3H]α-factor binding-assays showed 
that Ste2mp in stripped membranes bound approximately twice the amount of labelled ligand in 
comparison to Ste2mp in unstripped membranes (143 ± 14 versus 73,8 ± 5,4 pmol/mg protein 
respectively). This suggests that the Ste2mp is active in isolated membranes and, moreover, the 
stripping-step results in an enrichment of Ste2mp by effectively removing extrinsic and peripheral 
(membrane) proteins. 
 
The Kd of 87 nM for Ste2mp is 4- to 5- fold higher than that reported by David and coworkers for the 
wild-type Ste2p (David et al., 1997)., suggesting that the modifications that we introduced into the 
receptor do affect its ligand binding capacities. The findings of Dosil and coworkers who observed 
that the integrity of the Ste2p C-terminus affects pheromone binding affinity (Dosil et al., 2000) 
confirm our conclusion.  
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The slightly different ligand binding capacities of mutant and wiltd-type pheromone receptors might 
have been obscured in the halo assays in which we observed similar halos with cells expressing 
either mutant or wild-type Ste2p. However, the apparently lower affinity of the mutant receptor 
could be due to the high ionic stripping-step which David and coworkers did not apply when they 
assessed the Kd of Ste2p. The stripping may have removed, in addition to peripheral membrane 
proteins, the peripheral membrane G-protein, thus accounting for the observed lower affinity of the 
mutant receptor to its ligand. This had indeed previously been observed with Ste2p in isolated 
stripped yeast membranes, where the physical removal of G proteins during receptor purification or 
the addition of a non-hydrolysable GTP analog results in a decreased affinity for the ligand (Blumer 
and Thorner, 1990). 
It is also possible that the presence of even very small populations of inactive receptors may 
adversely affect ligand binding affinity. 
 
Competitive ligand binding studies were performed in order to assess the stereoselectivity of 
Ste2mp. The capacity of Ste2mp to distinguish between two chemically identical but stereoisomeric 
competitors of the natural α-factor was tested with D-Ala9 and L-Ala9 α-factors. In these ligands the 
Gly at position 9 is mutated to Ala either in D- or L-conformation, thus they display identical 
hydrophobicities. 
The observed apparent affinity of Ste2mp for D-Ala9 (Kd of 102 ± 38 nM) was lower than that of the 
wild-type Ste2p (Kd of ~ 10 nM, (David et al., 1997)), and the affinity for L-Ala9  (Kd of 1580 ± 210 
nM) was higher (David and coworkers, Kd of ~ 4000 nM). There is a 16-fold difference in affinity of 
Ste2mp for these peptides in contrast to the ~ 400-fold difference observed for Ste2p by David and 
coworkers. Nevertheless, the affinity of Ste2mp for the competitors was lower than for the α-factor 
(Kd of 102 and 1580 nm versus 87 nM), which is similar to the results of Xue (Xue et al., 1996; Xue 
et al., 1989) and Liu (Liu et al., 2000) for the interaction of Ste2p with other competitors. Taken 
together, Ste2mp still can still distinguish between two stereoisomeric competitors, though the 
modifications introduced into the receptor do alter its stereoselectivity. 
 
A possible explanation for the altered ligand binding affinity and stereoselectivity of Ste2mp might 
be offered by the mutated N-glycosylation sites Asn25 and Asn32 in the N-terminal part of the 
receptor (Mentesana and Konopka, 2001). The ligand binding-site of Ste2p is actually located in its 
N-terminal part, similar to most other GPCRs (Bockaert and Pin, 1999). Since Ste2p interacts with 
the C-terminus of the α-factor peptide, the overall topology of the receptor N-terminus relative to 
the α-factor C-terminus is critical for strong receptor binding (Naider and Becker, 2004). 
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In the native Ste2p, the glycosyl-moieties at Asn25 and Asn32 might be involved in ligand binding, 
thus, the mutations could have altered the shape of the binding pocket and/or the access of the 
ligand. Indeed, point mutations, such as the exchange of two highly conserved Cys residues for 
Val in the second and third extracellular loops of rhodopsin and the β-adrenergic receptor resulted 
in a destabilisation of the tertiary structure of these GPCRs and altered their ligand binding 
characteristics (Dohlman and Thorner, 2001). 
 
8.2. Overexpression of the hyperthermophilic putative transporter Aatp 
We intended to overexpress five putative transporters from the hyperthermophilic organism 
M.jannashii in S.cerevisiae. Obviously, only AAT was expressed in sufficient amounts to allow 
subsequent purification. 
Full length wild-type Aatp was produced in S.cerevisiae with a similar overexpression system as for 
Ste2p, exploiting a promoterless ura3d selection marker for high plasmid copy number, strong 
inducible transcription intitiation by the GAL promoter and constitutive and simultaneous 
overexpression of the GAL transcription factors from the pMEGA plasmid. The AAT gene was 
cloned directly from genomic M.jannashii DNA into a suitable expression vector by homologous 
recombination in S.cerevisiae. In the final expression construct AAT carried a FLAG- and a His6-
tag at its C-terminus. 
However, in contrast to Ste2mp, co-expression of the GAL transcription factors did not improve 
Aatp expression. Although overexpression was not analyzed at the transcription level, we 
speculate that AAT mRNA is instable and prematurely degraded, which leads to no obvious 
overexpression. Premature degradation might be due to the altered GC base content of 
M.jannaschii genes in comparison to those from mesophilic organisms, although we did not find 
any examples in the literature that could corroborate this speculation. 
 
As the proteome is the entire complement of cellular proteins at a given time under certain 
environmental conditions, Aatp expression was assessed during a time-course under various 
growth conditions and gene expression was induced in different growth phases. We observed that 
the amount of Aatp produced in the cells varied substantially with the used conditions. 
Aatp was best expressed in selective medium when galactose was added at an OD600 of 4 to 5 and 
gene expression induced for 8h. After overexpression and purification, we obtained approximately 
6 mg of pure Aatp from 10 litres of culture. 
 
Since Aatp is a putative amino-acid transporter of which the substrate is entirely unknown, we were 
unable to assess whether the protein was functionally expressed in S.cerevisiae. Most probably, 
the development of a functionality test would have gone beyond the scope of this thesis. 
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9. Solubilisation  
The purification and characterisation of membrane proteins rise several problems usually not 
encountered with soluble proteins. Since the techniques used to liberate integral membrane 
proteins from the membrane destroy or at least disturb the native membrane structure, it is 
important to preserve the membrane-associated function of the protein. 
 
Membrane proteins are extracted from their native membranes by solubilisation with detergents. 
The biophysical features of the detergent molecules are similar to those of the lipids forming the 
lipid bilayer: both species present a hydrophobic tail and a hydrophilic head. Above their critical 
micelle concentration (CMC), detergent monomers self-assemble into micelles that can penetrate 
the lipid bilayer and form mixed protein-lipid-detergent micelles without denaturing integral 
membrane proteins (Garavito and Ferguson-Miller, 2001). 
Choosing a suitable detergent for the solubilisation of an integral membrane protein in the native 
and functional form is a matter of balancing its efficiency with the capability to preserve the 
functional properties of the protein. Non-ionic detergents are preferred because they contain 
uncharged hydrophilic head groups and are generally considered mild and relatively non-
denaturing. They efficiently break lipid-lipid and lipid-protein interactions rather than protein-protein 
interactions. This facilitates solubilisation of membrane proteins in their biological active form 
without affecting their structural features. 
As detergents solubilise membrane proteins with varying efficiencies (Schuck et al., 2003), the 
appropriate compound is to be screened for each membrane protein. Efficient protein solubilisation 
corresponds to successful crystallisation of membrane proteins (Rosenow et al., 2002). 
 
In ligand binding assays, David and coworkers (David et al., 1997) demonstrated that the wild-type 
Ste2p retained its native structure when they solubilised the protein in 2% N-Dodecyl-β-D-
maltoside (DDM). Indeed, DDM was the most successful detergent for the solubilisation of half of 
the 45 GPCRs solubilised to date (Sarramegna et al., 2006). Moreover, it proved very efficient for 
the solubilisation and the isolation of two hyperthermophilic membrane proteins, the Ca2+-ATPase 
from M.jannaschii (Morsomme et al., 2002) and the H+-PPase from T.maritima maritima (López-
Marqués et al., 2005; Perez-Castineira et al., 2001). 
DDM is generally very popular for the solubilisation of membrane proteins, since it is appropriate 
for crystallisation studies as well as for reconstitution experiments. However, DDM does present 
some disadvantages, e.g. it cannot be dialysed because of its low CMC (0,2 mM), the working 
temperature is to be kept at 4°C, and, last but not least, the detergent is rather expensive. The 
commercially available detergent is quite pure which allows its use for chromatography.  
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For reconstitution experiments, that normally require high CMC detergents allowing dialysis, low 
CMC detergents such as DDM can still be used, since it is possible to remove them fast and 
efficiently with polystyrene beads (Biobeads) (Lanfermeijer et al., 1998; Lanfermeijer et al., 1997; le 
Maire et al., 1987). 
 
DDM was the first choice for solubilisation of both, Ste2mp and Aatp, though we screened as well 
other detergents such as N-Dodecyl-α-D-maltoside (DM), N,N-Dimethyldodecylamine-N-oxide 
(LDAO), N-Octyl-β-D-Glucopyranoside (OG), Polyoxyethylene-9-laurylether (C12E9), Triton X-100 
(TX100), N-Nonyl-β-D-Glucopyranoside (NG) and N-Dodecyl-phosphocholine (FOS12). 
While almost no differences were observed in the solubilisation efficiency of Aatp (around 100% of 
the protein were solubilised) with any of these detergents at the standard concentration of 2% 
(w/v), there were clear differences in the solubilisation efficiency of Ste2mp. Again, DDM solubilised 
Ste2mp most efficiently, around 50%, while the other detergents were far less efficient. 
We can only speculate on the inability of the other detergents to solubilise Ste2mp efficiently. The 
solubilisation capacity of a given detergent might be dependent on the lipid environment of the 
membrane protein to be isolated. Ste2mp was homologously expressed, that means, in its native 
lipid environment. This might represent the ideal environment in terms of hydrophobic interactions 
between protein and lipid which are only inefficiently broken by the other detergents. Aatp, on the 
other hand, was heterologously expressed and easily extracted from the membrane with all tested 
detergents. This could indicate that the yeast membrane provides a suboptimal hydrophobic 
environment for Aatp and the interactions with the neighbouring lipid molecules are, thus, easier 
broken. 
 
A second explanation for the efficiency differences of the detergents can be related by their 
interaction with the used buffers. For example, phosphate may cause some detergents to 
precipitate. In addition, other detergents like OG or NG, although described in the literature as mild 
and efficient for solubilisation of membrane proteins, possess a more abrasive nature, implying that 
proteins have to be robust enough to survive the solubilisation process in their native form. This 
was maybe not the case for Ste2mp, upon interaction with, e.g. OG or NG, the protein denatured, 
aggregated and subsequently precipitated which rendered solubilisation with these detergents 
inefficient. 
 
For all the reasons outlined above, DDM was ultimately chosen as the detergent to extract Aatp 
and Ste2mp from the yeast membranes. 
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A presolubilisation step with NG or C12E9, aimed at the removal of contaminating membrane 
proteins and concomitant enrichment of Ste2mp failed. Probably, the membrane was too much 
disturbed after the first extraction step with NG or C12E9. which might have caused unordered yet 
very strong hydrophobic interactions between the membrane lipids and the remaining Ste2mp 
molecules that could not be dissolved in the second solubilisation step with DDM. However, the 
presolubilisation strategy seems to be ineffective with GPCRs since it failed as well with the 
olfactive receptor OR5 (Eva Lemker, personnal communication). 
 
10. Purification 
Even if the overexpression and solubilisation of an integral membrane protein are successful, 
usually one has to run the gauntlet in terms of preserving its native function during the subsequent 
purification procedure. With the lipid molecules more or less quantitatively replaced by detergent 
molecules, the native hydrophobic environment of the protein is indeed severely modified. The 
lipid-substituting environment is not only a mediocre preserver of protein structure integrity, it also 
cannot protect the protein against the attack of endogenous proteases as does the intact lipid 
bilayer, thus necessitating the addition of protease inhibitors to all used buffers. Moreover, the 
covert abrasive or denaturing nature of the detergents can lead to aggregation of solubilised 
membrane proteins, which reduces the efficiency of most separation techniques. 
10.1. Purification of Ste2mp 
Affinity chromatography was performed by exploiting the presence of the FLAG and His6 affinity 
tags genetically engineered into the protein. 
10.1.1. Ni2+-NTA chromatography 
With an optimised Ni2+-NTA chromatography procedure, we obtained 90% pure Ste2mp. Although 
only 50% of the protein could be solubilised from the yeast membranes, roughly 85% of the 
material loaded onto the chromatography column was recovered after a single purification step. 
Around 5,6 mg of pure Ste2mp were regularly obtained per 10 litres of yeast culture. This equals 
1 mg from 1,8 litres, a yield superior compared to that obtained by David and coworkers, who could 
purify 1 mg of the wild-type Ste2p only from 20 litres of yeast culture (David et al., 1997). However, 
although the group of David managed to overexpress twice as much Ste2p per mg total membrane 
protein as we did with Ste2mp (350 versus ~145 pmol pure protein per mg of total membrane 
protein, respectively), they ended up with far less pure protein in the end (~0.05 versus ~0.6 mg of 
pure protein per litre of yeast culture, respectively). 
 
When we separated the Ni2+-NTA purified Ste2mp preparation on SDS-gels, we always observed 
two prominent bands of ~30 kDa and ~60 kDa and other oligomers which were multiples of 
30 kDa. A similar band pattern was detected on immunoblots with a monoclonal anti-His antibody. 
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Mass-spectrometric analysis of the Ste2mp preparation confirmed that the sidebands were not 
contaminating yeast proteins but Ste2mp oligomers. We sought to diminish this heterogeneity in 
order to optimise the Ste2mp preparation for subsequent crystallisation. 
The purification conditions, such as the concentrations of β-mercaptoethanol, EDTA, NaCl and 
urea, and the amount of Ni2+-NTA beads were thus varied in order to prevent protein aggregation. 
Unfortunately, we were unable to increase the homogeneity of the Ste2mp preparation by any of 
these means, indicating that the heterogeneity neither resulted from ionic interactions (which would 
have been disturbed by the high salt conditions we applied) nor did it involve disulfide bridges 
which would have been broken by high β-mercaptoethanol concentrations. Addition of the mildly 
denaturing agent urea as well did not prevent aggregation of Ste2mp. 
One might speculate that the persistent band pattern of the Ste2mp preparation was the result of 
residual glycosylation of the protein. Indeed, in addition to the two N-glycosylation sites Asn25 and 
Asn32, Mentesana and Konopka identified three other potential N-glycosylation sites (Asn46, Asn105 
and Asn205) in the consensus sequence Asn-X-Ser/Thr by detailed sequence inspection of the 
extracellular domains of Ste2p (Mentesana and Konopka, 2001). By systematically mutating the 
putative glycosylation sites, they demonstrated that Asn25 and Asn32 were exclusively glycosylated 
in Ste2p. Our deglycosylation experiment with Ste2mp confirmed their result, which excludes 
residual glycosylation as the cause for the high molecular weight sidebands in the Ste2mp 
preparation. 
 
All purification buffers contained 20% glycerol to protect Ste2mp protein structure and integrity. 
When the glycerol concentration was lowered to 10% for facilitated concentration of the protein 
preparation, this led to a substantially lower yield of purified Ste2mp suggesting a chemical 
chaperone role of glycerol for Ste2mp. 
 
Although the purity of the Ste2mp preparation was satisfying after the one step purification with 
Ni2+-NTA beads, we sought to improve the heterogeneity of the product by further chromatography 
steps. Affinity chromatographies with other metal-ions than Ni2+, FLAG-affinity chromatography, 
cation-exchange chromatography and size-exclusion chromatography were tested to achieve the 
goal. 
Unexpectedly, FLAG-affinity chromatography did neither improve the purity of Ste2mp nor decrease 
the heterogeneity, as it did, for example, with the human dopamine D2S receptor (de Jong et al., 
2004). A possible explanation is that the Ste2mp did not efficiently bind to the matrix-immobilised 
anti-FLAG antibody due to the arrangement of the FLAG- and the His6-tags in the recombinant 
protein. As FLAG is inserted upstream of the C-terminal His6-tag in Ste2mp, it might have been 
poorly accessible for binding by the antibody on the matrix.  
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However, there is an example for the efficient purification of the dopamine D1A receptor from 
S.cerevisiae with the same combination of the two tags (Andersen and Stevens, 1998). 
Metal ions, such as Ni2+, Cu2+, Co2+ or Zn2+ interact with His-tagged proteins with varying 
selectivity. We intended to exploit this selectivity to favour binding of Ste2mp over other yeast 
background proteins. For example, in comparison to Ni2+, Co2+ displays a higher affinity for His6-
tagged proteins, yet a lower affinity for untagged proteins (Yip et al., 1989; Porath and Olin, 1983; 
Porath et al., 1975). His6-tagged proteins bound to Co2+-NTA can therefore be eluted under less 
stringent conditions than from Ni2+-NTA. A disadvantage of divalent cations other than Ni2+ is their 
non-specific binding to other amino-acids like Cys, Asp, or Glu. 
Affinity chromatographies with immobilised Cu2+, Co2+ or Zn2+, unfortunately, did not lead to an 
improvement of Ste2mp recovery nor homogeneity. 
 
Ion-exchange chromatography with Ste2mp was also inefficient. This is in contrast to reports on 
other GPCRs like the rat and human olfactory receptors, which could be readily purified with this 
method (Nekrasova et al., 1996). Even optimised separation conditions, such as pH, resin volume, 
or NaCl concentration, would not improve the ion-exchange performance. The main problem was 
that detergent-solubilised Ste2mp did not bind efficiently to the matrix. Most probably, the detergent 
molecules masked possible surface charges of Ste2mp. 
 
Surprisingly, size-exclusion chromatography did not separate oligomeric forms of Ste2mp from the 
desired monomers. The probability that this heterogeneity was due to persistent ionic interactions 
was low, since the running buffer contained 400 mM NaCl and, in addition, 1 mM β-
mercaptoethanol to reduce disulfide bridges. Most probably, the Ste2mp oligomers were held 
together by hydrophobic interactions that could not be broken by the non-denaturating detergent 
DDM. Not even boiling the sample in the strongly denaturing detergent SDS would disintegrate the 
aggregates as the oligomers were well detectable on denaturing protein gels. 
The numerous oligomeric forms of Ste2mp are in stark contrast to the band patterns of Ste2p 
observed by David’s group and by Mentesana and Konopka. They also detected multiple protein 
species in their purified samples, however, these were due to post-translational modifications such 
as glycosylation or phosphorylation and did not originate from oligomerisation of the receptor. 
Possibly, the removal of the hydrophilic C-terminus exposed previously obscured hydrophobic 
domains in Ste2mp. If these were only insufficiently solubilised by DDM this could have led to the 
observed aggregation of adjacent receptors by hydrophobic interactions during the extraction from 
the yeast membrane. This notion is corroborated by the detection of predominantly monomeric but 
very little dimeric Ste2mp on immunoblots of isolated yeast membranes. Blumer and coworkers 
made similar observations with wild-type Ste2p (Blumer et al., 1988) 
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Neither FLAG-affinity chromatography, nor cation-exchange chromatography, metal-affinity 
chromatography with alternative metal ions nor size-exclusion chromatography were effective in 
diminishing Ste2mp heterogeneity. Thus, the purification protocol for Ste2mp finally comprised a 
one-step Ni2+-NTA chromatography. Ste2mp purified in that way was pure and monodisperse 
enough to subject it to crystallisation experiments. 
Further optimisation of the Ste2mp purification procedure might deal with other high affinity-tags, 
such as the Streptavidine-tag, or a bulkier tag, like the glutathion-S-transferase (GST). A longer 
poly-histidine tag including 10 or 12 residues as well as insertion of the affinity tag at the N-
terminus, though not too promising for the reasons outlined above, could be worth trying. 
 
10.2. Purification of Aatp 
With our developed purification protocol, we routinely obtained 0.6 mg of ~ 90% pure and 
homogenous Aatp from 1 litre of yeast culture. Although this yield was lower than that for the 
M.jannaschii Ca2+-ATPase (1,6 mg/litre (Morsomme et al., 2002)) and the T.maritima H+-PPase 
(1,5 mg/litre (López-Marqués et al., 2005)), our preparation fulfilled the requirements for 
subsequent crystallisation experiments. 
 
10.2.1. Single-step purification by heat treament on solubilised protein 
To purify Aatp, we tried to take advantage of its thermal stability. The optimal growth temperature 
for M.jannaschii is 85°C whereas S.cerevisiae thrives at 30°C. Thus, the proteins of the 
hyperthermophilic archaeon are expected to withstand high temperatures at which S.cerevisiae 
proteins would grossly denature. We assumed that a drastic heat treatment of the detergent-
solubilised protein extract from yeast membranes would denature most of the yeast proteins and 
cause them to aggregate, so that they would be easily separated from Aatp. 
Previously, heat treatment had turned out as a fast and convenient tool for the purification of other 
hyperthermophilic membrane proteins, such as M.jannaschii Ca2+-ATPase (Morsomme et al., 
2002) and T.maritima H+-PPase (López-Marqués et al., 2005).  
In this study, DDM-solubilised Aatp was stable at 90 °C for 10 min, whereas it appeared more 
heat-labile in all other tested detergents. 
However, the heat-shock of the DDM-solubilised membranes did not yield pure Aatp, as numerous 
contaminanting sidebands were detected in the soluble fraction on Coomassie-stained SDS-gels. 
These bands could originate from yeast proteins that expose hydrophobic domains during the heat 
denaturation step. These domains may interact with excess detergent molecules in the sample, 
leading to their solubilisation instead of aggregation and separation from Aatp. 
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10.2.2. Multistep purification by Ni2+-NTA chromatography and heat treatment 
As the heat treatment resulted in very low purity of the Aatp preparation, we combined it with a 
Ni2+-NTA chromatography, thus, exploiting the His6-tag on the Aatp C-terminus. 
Two different protocols were performed: first, we tried Ni2+-NTA chromatography after the heat 
treatment of DDM-solubilised Aatp; in the second attempt not only the solubilisate but also the Ni2+-
NTA eluate was heated. 
Unfortunately, none of both protocols improved the purity of the Aatp sample. Conversely, Aatp 
appeared to become heat-labile after Ni2+-NTA chromatography. Possibly, the high imidazole 
concentration from the elution step adversely affected the stability of the detergent-solubilised Aatp 
at elevated temperatures. 
10.2.3. Ni2+-NTA chromatography and size-exclusion chromatography 
Since the heat treatment of detergent-solubilised Aatp did not meet our expectations, we chose to 
quit this strategy and focussed our efforts on the Ni2+-NTA chromatography . Although the on-step 
purification yielded quite pure Aatp, we performed a subsequent size-exclusion chromatography, 
which has been a popular “polishing” step in the purification procedures of other hyperthermophilic 
membrane proteins (López-Marqués et al., 2005; Morsomme et al., 2002; Lanfermeijer et al., 
1998). 
The combination of both chromatographies indeed facilitated the production of highly pure, 
homogenous and monodisperse Aatp, as attested by a single band on the Coomassie-stained 
SDS-gel and its corresponding immunoblot. These results allowed us to undertake crystallisation 
trials with purified Aatp. 
 
Although N-terminal sequencing and Mass-spectrometry analysis confirmed that the band on 
Coomassie-stained SDS-gels and immunoblots was Aatp, it is obvious that the protein runs at 
much lower size, e.g., ~36 kDa on SDS-gels and ~25 kDa on immunoblots, than expected from its 
calculated molecular mass of ~48 kDa. The discrepancy between SDS-gels and immunoblots can 
be explained by the use of two different molecular weight standards. We tested different 
commercially available molecular weight markers and observed that standard bands signifying the 
same molecular weight do not necessarily display the same mobility in SDS-gels. However, it is 
well known, that in some instances SDS does not entirely denature integral membrane proteins. 
On the contrary, the detergent stabilises the helical transmembrane domains leading to only partial 
disintegration of the three-dimensional structure of the protein (le Maire et al., 2000). Thus, the 
incompletely unfolded molecule shifts to higher mobility in SDS-gels than one would expect from its 
calculated mass. 
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11. Crystallisation  
Although several thousand 3D-structures of cytosolic proteins are resolved, only 93 structures of 
membrane proteins are to date described, most of them are structures of bacterial proteins. This 
amount discrepancy is clearer when one consider that 20 to 30% of all ORFs from bacteria, archea 
and eukaryote code for membrane proteins (Wallin and von Heijne, 1998).  
These figures mirror the technical challenge of crystallising integral membrane proteins. 
 
X-ray crystallography is one of the most efficient methods to determine high resolution structures of 
membrane proteins. Electron microscopy is also a powerful technique, along with NMR (Rigaud, 
2002; Hasler et al., 1998; Walz and Grigorieff, 1998). The rate-limiting step in the process of 
structure determination is usually the production of crystals suitable for diffraction experiments. 
 
Several prerequisites lead the way to a successful crystallisation process of membrane proteins 
(Caffrey, 2003). In general, the high hydrophobic segments of membrane proteins hamper the 
efforts to stably keep them in a native state, and the challenge is to find a suitable temporary 
environment that preserves their structure and function until they are fixed in a crystal lattice. By 
any means, the structural integrity of the protein has to be maintained (conformational 
homogeneity) and there should not be non-specific aggregates. The protein must not denature 
during the process. Heterogeneities by post-translational modifications are also interfering, and in 
addition, in a protein-detergent complex, it is crucial that the non-protein components of the 
complex are homogenous (Wiener, 2004; Caffrey, 2003; Wiener, 2001). It is of outstanding 
importance that the membrane protein to be crystallised is very pure and available in high 
concentration, ideally, 5 to 15 mg/ml. 
Taken together, these prerequisites absolutely require a systematic search for ideal crystallisation 
conditions. 
 
3D-crystallisation experiments with purified Ste2mp and Aatp were performed manually using the 
hanging-drop method,. Alternatively, the sitting-drop method was chosen in automated trials. 
During the course of this PhD study, these 3D-crystallisation trials have not succeeded in the 
growth of Ste2mp or Aatp crystals so far under the conditions we used. Although automated 
crystallisation experiments allow to screen thousands of different crystallisation conditions in a 
reasonable time (Stevens, 2000b; Stevens, 2000a), this approach was unsuccessful in our case. 
 
For membrane proteins, 2D-crystallisation is a convenient alternative to the classical 3D-
crystallisation. This method, first described in technical detail by Levy and collaborators (Levy et 
al., 2001; Levy et al., 1999), was originally developed by the group of Kornberg (Kornberg, 1991) 
and further developed by other groups (Courty et al., 2002; Brisson, 1999; Brisson et al., 1994).  
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In principle, a Ni2+-lipid monolayer is set up to enhance the formation of crystals. Detergent-
solubilised His6-tagged membrane proteins selectively attach to a Ni2+-lipid monolayer. Fixing the 
His6-tagged proteins to the Ni2+ residues of the monolayer enriches and orders them, which 
favours the formation of a crystal lattice. A major advantage is the minute amount of protein 
needed, e.g., a concentration of 1 mg/ml is enough to get crystals. 
This method proved to be especially successful for the crystallisation of membrane proteins such 
as, e.g., FhuA, a phage receptor from E.coli, the F0F1-ATP synthase from Bacillus PS3 (Levy et al., 
1999), or the H+-ATPase from the plant plasma membrane (Lebeau et al., 2001). 
We tried 2D-crystallisation with Aatp. Unfortunately, Aatp hardly bound to the monolayer, no order 
was observed in the vesicles formed at the surface. 
In order to exchange the detergent for a more native lipid environment, reconstitution experiments 
were also performed with Aatp, using lipids from E.coli. However, reconstituted protein did not yield 
better results in the 2D-crystallisation experiments. Other membrane proteins that had been 
heterologously and functionally expressed in S.cerevisiae, like the rabbit Ca2+-ATPase SERCA1a 
(Jidenko et al., 2005) or the dog kidney Na+/K+-ATPase (Mohraz, 1999) could be successfully 
crystallised from reconstituted proteoliposomes. 
 
We have several explanations for the so far unsuccessful crystallisation experiments with Ste2mp 
and Aatp. We added 20% (v/v) glycerol as a stabiliser to the purification buffers and a lower 
concentration (10%) was not appropriate during the purification process. This concentration of 20% 
could, however, have complicated the crystallisation, as glycerol can behave either as a precipitant 
or an additive, and, therefore, severely influence the outcome of a crystallisation experiment. 
Even traces of phosphate in the protein sample can interfere with crystallisation, cause protein 
precipitation under certain screening conditions or promote the formation of salt crystals. As 
phosphate buffer was used for Ni2+-NTA chromatography of Aatp, we cannot rule out that the final 
protein preparation contained trace amounts of phosphate that negatively affected crystallisation. 
Temperature is also an important variable for crystal growth. Although proteins in high salt 
solutions are generally better soluble at cold than at warm temperatures, maybe the proteins were 
not stable at 18°C, the temperature we used, although it is a common temperature for 
crystallisation. 
The introduction of excess detergents into the crystallisation sample can also present a problem for 
the growth of crystals, so that one has to choose specific additives like salts or precipitants to aid 
the crystallisation (Caffrey, 2003; Rosenbusch, 2001; Rosenbusch et al., 2001; Rosenbusch, 
1990). Although the Aatp preparation was depleted for excess detergent by treatment with 
Biobeads, which is a common procedure for detergent removal from membrane protein 
preparations (Mosser, 2001; Rigaud et al., 2000; Lacapere et al., 1997; Rigaud et al., 1997), there 
might still have been to much DDM for the crystallisation process to succeed. 
Discussion 
 
 91
More importantly, although we carefully optimised the purification conditions, our protein 
concentrations never exceeded 2,5 mg/ml and crystal growth occurs very slowly in insufficiently 
concentrated protein solutions. 
 
Taken together, more elaborate screening of crystallisation conditions is still to be done for Ste2mp 
and Aatp, which would have gone beyond the scope of this PhD thesis. 
 
General conclusion 
To conclude, in this study, we have developed a successful system for the efficient overexpression 
of two membrane proteins from different kingdoms of life in S.cerevisiae. We set up a fast large-
scale purification protocol that permits the isolation of milligram quantities of homogeneous and 
monodisperse protein at a purity around 90%. Solubilisation of Ste2mp and Aatp from yeast 
membranes with DDM was 50% and 100% efficient, respectively. This protocol involves a one step 
purification by metal-affinity chromatography for Ste2mp and a two step procedure for Aatp (metal-
affinity chromatography followed by a size-exclusion chromatography). Applying these purification 
strategies, we routinely recovered 85 to 95% of the solubilised proteins, corresponding to 5,6 mg of 
pure Ste2mp and 6 mg Aatp from approximately 10 litres of yeast cell culture. 
Preliminary crystallisation experiments indicate that more crystallisation conditions need to be 
explored.
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12. Organisms, vectors and oligonucleotides 
12.1. Organisms 
Strain Relevant geno or phenotype Reference  
Saccharomyces cerevisiae BJ5464  
 
 
 
Saccharomyces cerevisiae BY4741 
 
 
 
Escherichia coli Dh5α 
MATα; ura3-52; trp1; leu2Δ1; 
his3Δ200; pep4::HIS3; prb1Δ1.6R; 
can1; GAL1 
 
Mat a; his3Δ1; leu2Δ0; met15Δ0; 
ura3Δ0; YIL015w::kanMX4; YFL026w 
(STE2)::LEU2 
 
FΦ80d/lacZ M15 (lacZYA-argF)  
U169 recA1 endA1 hspR17 (rk-mk+) 
supE44 λ thi-1 gyrA96 
 
ATCC #208288 
 
 
 
Euroscarf #Y00000 
 
 
 
Hanahan, D., 1983 
Table 3: Genotype of the organims used 
 
12.2. Vectors 
Plasmids Relevant features Source 
pYES2-FT.HT 
 
 
pYES-ura3d-FT.HT 
 
 
pMEGA2-ΔURA3 
 
 
pITy-QC 
2µ, URA3, ORI, AmpR; GAL1, 
tCYC1, FLAG- and His6-tags 
 
2µ, ura3d, ORI, AmpR; GAL1, 
tCYC1, FLAG- and His6-tags 
 
Gal4p, Gal80p, Gal3p, 2µ, ΔURA3, 
LEU2, AmpR 
 
δ-integration vector; 2µ; ura3d; ORI, 
canR; GAL1, tCYC1 
Invitrogen 
 
 
Dr. James Hopper 
 
 
Dr. Douglas Griffith 
 
 
Jason Burbank 
Table 4: Main features the vectors used 
 
 
Maps of the vectors are represented above (Fig. 53).  
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Fig. 53: Maps of the vectors pYES2-FT.HT, pYES2-ura3d-FT.HT and pMEGA2-ΔURA3 
 
12.3. Oligonucleotides used for the cloning of the hyperthermophilic proteins 
Cloning of the M. jannaschii integral membrane proteins into an expression vector was based on a 
direct homologous recombination strategy. The target genes were directly cloned from genomic 
DNA of M.jannaschii which was purchased from ATCC (#43067), Wesel, Germany.  
 
PYES-ura3d-FT.HT 
5400 bp 
PMEGA-ΔURA3  
21141 bp 
U R A 3d
pYE S-U R A3d-(FT.H T)
(5400bps)
ura3d
PYES-ura3d-FT.HT 
5400  
PYES2-Ft.HT  
5888 bp 
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The expression vector pITY-QC was modified by PCR based introduction of 45bp/50bp 
homologies to the target genes on either side of the expression cassette. The integral membrane 
proteins were expressed with a C-terminal His6-tag 
 
The following primer pairs were used to generate the receiving expression vector pITY-QC for the 
cloning of MJ0609 (AAT), MJ0630 (PHOP), MJ0672 (DASS), MJ1319 (NSS), and MJ1485 (TRK). 
 
Primers combinations for each proteins:  
MJ0609 (AAT): DG204 / DG209 
MJ0630 (PHOP):  DG205 / DG210 
MJ0672 (DASS):  DG206 / DG211 
MJ1319 (NSS):    DG207 / DG212 
MJ1485 (TRK):   DG208 / DG213 
 
 
DG204        5‘-AGA AAC AGC TTC CCA CAA ACT AAG CTT TTT ATT TTT TAA CTC CAT TTT TTT AAT  
MJ0609          ATT CCC TAT AGT GAG TCG TAT TAC AG -3‘ 
 
 
DG205         5‘-ACT TAT GAT TAG CTC TAA ATT TAT AGA AAT CTC TAT AGT AAT CAT TTT TTT AAT  
MJ0630           ATT CCC TAT AGT GAG TCG TAT TAC AG -3‘ 
 
DG206         5‘-AGC TGT AAT TAT CCC TAA GCC TAT AAA TTC TTT GGA TAA TCT CAT TTT TTT AAT 
MJ0672           ATT CCC TAT AGT GAG TCG TAT TAC AG -3‘ 
 
 
DG207         5‘-AAA TCC CAA GTT AGA GCT CCA GCT TTC TCT TTC CAT ATA ACT CAT TTT TTT AAT 
MJ1319            ATT CCC TAT AGT GAG TCG TAT TAC AG -3‘ 
 
 
DG208         5‘-TAA AAT TCC TTC AAT GTC TTT TTT TGT TAA TCT ACA GAT TCC CAT TTT TTT AAT  
MJ1485           ATT CCC TAT AGT GAG TCG TAT TAC AG -3‘ 
 
Table 5: Forward primers used for the cloning of the hyperthermophilic proteins 
 
DG209        5‘-ATA GAA AAG TAA CAA AAA GAA CAT TCT CCA ACA ATA TGT ATG TTA AAA GC GAT  
MJ0609           TAT AAA GAT GAT GAT GAT AAA ACT GGT-3‘ 
 
 
DG210         5‘-TAG CTC CAA TAA TAG CTT TAA TAA TTG GTT TTA TAA TAA ATA GGA TGA TA GAT  
MJ0630           TAT AAA GAT GAT GAT GAT AAA ACT GGT-3‘ 
 
 
DG211        5‘-TAT CAA TAC TAT CTG CAG CTG TAA TAA CTC TAT ATT CCA TTC TTT ATC TA GAT  
MJ0672          TAT AAA GAT GAT GAT GAT AAA ACT GGT-3 
 
 
DG212         5‘-CGT TTG TTG TAA GTG TAA TTC TTC AAA AAA TGA AAA CGA TTA AAG GTT GG GAT 
MJ1319           TAT AAA GAT GAT GAT GAT AAA ACT GGT-3‘ 
 
 
DG213         5‘-TTG TTT TAT TTG CTA CTT TGT ATT TTA AAA CTC TGA GAC TTT TAA AAA AA GAT  
MJ1485           TAT AAA GAT GAT GAT GAT AAA ACT GGT-3‘ 
 
Table 6: Reverse primers used for the cloning of the hyperthermophilic proteins 
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13. Methods 
13.1. Molecular biology methods 
13.1.1. Cloning method  
13.1.1.1. Cloning of the G-Protein Coupled Receptor Ste2mp 
The procedure was carried out by Dr. Douglas Griffith (2001, Max-Planck-Institute of Biochemistry, 
Martinsried, Germany) with the following procedure:  
The multicopy vector for the expression of functional C-terminally tagged Ste2p was constructed 
using a modified version of plasmid pYES260 (purchased from EUROSCARF, Frankfurt, 
Germany). Two sequences functioning as affinity tags, encoding a FLAG-tag (FT) and a His6-tag 
(HT), were ligated into HindIII/NotI-digested pYES260. The 484-bp PstI fragment containing the 
entire URA3 selection gene promoter was removed. The XhoI site in the vector was then removed 
by XhoI digestion, T4 polymerase fill-in and religation which eventually led to the modified 
expression vector pYES-ura3d-FT-HT, into which the STE2 gene was cloned. The STE2 gene was 
amplified by polymerase chain reaction (PCR). All constructs were confirmed by dye terminator 
sequencing.  
 
The STE2 gene was cloned into pYES2-FT.HT by in vivo homologous recombination in yeast. It 
was amplified by PCR from yeast genomic DNA (from strain S288C; Research Genetics, 
Huntsville, AL, USA) using a commercially available kit (High Fidelity PCR Master; Roche Applied 
Science, Mannheim, Germany) according to the manufacturer’s instructions, and the primers: 
5’-CTGTAATACGACTCACTATAGGGAATATTAAAAAAATGTCTGATGCGGCTCCTTCAT-3’ 
(forward) and 5’-ACCAGTTTTATCATCATCATCTTTATAATCTAAATTATTATTATCTTCAGTCCAG 
AACTTTCTG GC-3’ (reverse). 
These primers added 30-bps of sequence to the 5’ and 3’ ends of the gene that targeted it to the 
desired point of insertion in pYES2-FT.HT. The forward primer also introduced five A nucleotides 
(underlined) immediately preceding the gene’s initiation codon (in bold) to provide an optimal 
nucleotide context for start codon recognition by yeast ribosomes. The reverse primer, lacking the 
gene’s stop codon, directed the fusion of the STE2 sequence to that for the tags. pYES2-FT.HT 
was prepared for recombination-mediated cloning by digestion with SmaI. BJ5464 was then 
transformed to Ura+ with 0.1 µg of SmaI-cut pYES2-FT.HT and 1 µg of the STE2 PCR product by 
electroporation using a Bio-Rad Gene-Pulser. This method results in > 98% of yeast transformants 
harbouring a vector with insert. Total yeast DNA was prepared from a pool of approximately 2000 
Ura+ transformants and used to transform E.coli.  
 
Plasmids (pDG-STE2) were isolated from ampicillin-resistant colonies and the integrity of the 
expression cassette (GAL1 promoter-STE2 gene-CYC1 terminator) verified by sequencing.  
Material and methods 
 
 97
Codon 269 of STE2 was AAA (Lys) and not GAA (Glu), potentially as a result of phylogenetic 
variation. The STE2 gene was cloned into the plasmid pYES2-ura3d-FT.HT in an identical manner 
to generate pDG-ura3d-STE2. 
The Ste2p-N25/Q32-T326 sequence was constructed from two overlapping PCR products. A small 
portion of the 5’ end of the STE2 gene, whose entire length is 1.296 bps, was amplified from pDG-
STE2 with the forward primer used to clone the wild type gene and 5’-
GGTAGATCCCTGCCCATATATGGAAGTGTACTGAATGGTGCTTTGACCAGG-3’ which straddled 
the two Asn codons (25 and 32) in the two utilised N-glycosylation sequences. The product had at 
its 5’ end a sequence homologous to that at the desired point of insertion downstream of the GAL1 
promoter in the pYES2-FT.HT and pYES2-ura3d-FT.HT vectors. A portion of the 3’ end of the 
gene, lacking 315 bps encoding the last 105 amino acids of the protein’s C-terminus, was amplified 
with primers 5’-CCTGGTCAAAGCACCATTCAGTACACTTCCATATATGGGCAGGGATCTACC-3’ 
and 5’-ACCAGTTTTATCATCATCATCTTTATAATCGCTAGACAGCGTGCCTGGATAAAAC-3’. 
This PCR product overlapped with the first at its 5’ end and had at its 3’ end 30 bps that allowed 
fusion to sequences encoding the tags in the vectors. Underlined in the primers are the mutated 
Asn codons which were originally AAC and AAT for Asn25 and Asn32, respectively, and were 
replaced by the Gln codon CAG. The expression vectors pDG-Ste2p-N25/Q32-T326 and         
pDG-ura3d-Ste2p-N25/Q32-T326 were assembled by cotransformation of BJ5464 with 1 µg each 
of the two PCR products and 0.1 µg of SmaI-digested pYES2-FT.HT and pYES2- ura3d -FT.HT, 
respectively.  
The plasmid pMEGA2-ΔURA3 was generously provided by James Hopper (Pennsylvania State 
University, USA).  
The BY4741bar1ΔSte2Δ strain was constructed by Dr. Douglas Griffith with the following 
procedure: The STE2 gene in BY4741 bar1Δ was deleted by a PCR-mediated method. Primers to 
incorporate the genomic flanking sequences of the STE2 gene (5’-
ACTTAAAAATGCACCGTTAAGAACCATATCCAAGAATCAAAAATGCTGTGCGGTATTTCACACC
GC-3’ and 5’-CCGAAGGTCACGAAATTACTTTTTCAAAGCCGTAAATTTTGATCAGCGGCATCGA 
GCAGATTGTACTGAG–3’), were used to PCR amplify the LEU2 selection marker from the 
pRS405 plasmid (ATCC, # 87516) with a commercially available kit (High Fidelity PCR Master; 
Roche Applied Science, Mannheim, Germany) according to the manufacturer’s instructions. The 
PCR product was used to transform BY4741 bar1Δ to Leu+ by a high-efficiency lithium acetate 
method.  
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13.1.1.2. Hyperthermophilic transporters Aatp, Phopp, Dassp, Trkp and Nssp.  
13.1.1.2.1. Construction of the original vector pITy-QC 
The construction of the pITy-QC vector was performed by Dr. Douglas Griffith (2001, Max-Planck-
Institute) with the following procedure:  
Plasmid construction steps were performed using standard methods for recombinant DNA work 
(Sambrook, 1989) in E.coli strain DH5α and by recombination in BJ5464. A 50 µl aliquot of 
transformation competent BJ5464 cells was co-transformed with 0,1 µg of vector and ~ 1 µg of 
DNA fragments. Recombinant plasmids from yeast transformants were shuttled into E.coli as 
described previously by Hoffman and coworkers  (Hofmann, 1993). A recombination competent 
version of pITy-3 (provided by Karl Wittrup, Massachusetts Institute of Technology, USA; (Parekh 
and Wittrup, 1997; Parekh et al., 1996)) was constructed by introducing the 2µ sequence and 
promoterless ura3d marker from plasmid pYES2-ura3d-FT.HT, amplified by PCR as a single 
product containing flanking XhoI sites, at the unique XhoI site in pITy-3 (unique XhoI site of a 
fragment carrying the yeast 2µ replication origin). This fragment also contained a promoter-less 
URA3 selection marker (ura3d). The portion of the pITy vector containing the multiple cloning site 
(MCS) between the end of the NeoR gene and start of the δ sequence was then replaced with a 
sequence comprising the GAL1 promoter and the tCYC1 terminator separated by a SmaI site and 
sequences encoding FLAG and His6 affinity tags (pGAL1-SmaI-tCYC1). This was done by 
recombination between a PCR amplified pGAL1-SmaI-tCYC1 fragment from pYES2-ura3d-FT.HT 
and SphI/KpnI-digested vector. The PCR primers used added 30 bp homology arms to the 5’ and 
3’ ends of the pGAL1-SmaI-tCYC1 product that targeted it to the desired point of insertion in the 
vector. The integrity of the pGAL1-SmaI-tCYC1 sequence was confirmed by dye-terminator 
sequencing.  
 
Another dispensable sequence supF encoding a tRNA suppressor that can on multicopy 
expression inhibit E.coli cell growth was also deleted by recombination between BamHI/EcoRI-
digested vector and a 50 bp double stranded DNA linker (formed from primers SupF-del-F and 
SupF-del-R) with homologies to the sequences flanking SupF. Deletion of this sequence removed 
one unwanted SmaI site. The last unwanted SmaI site in the vector, in the canamycin resistance 
(NEO) gene, was destroyed by a single silent mutation. Finally, using the QuickChange Site-
Directed Mutagenesis Kit (Stratagene, La Jolla, CA, USA) and primers SmaI-del-F plus SmaI-del-
R, the SmaI site within the coding sequence of the NeoR gene was removed with a single base 
substitution causing a silent mutation in a glycine residue. 
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13.1.1.2.2. Linearisation of the plasmid pITy-QC 
The linearisation of the pITy-QC vector was achieved with the restriction enzyme SmaI ,a blunt 
cutter. The reaction was carried out with buffers and enzymes purchased from New England 
Biolabs, Frankfurt am Main, Germany. 
 
Reaction setup for 1 µg of pITy-QC vector, total volume 20 µl:  
 
pITy-QC vector   3,6 µl (stock at 0,28µg/µl) 
SmaI restriction enzyme 1 µl (stock at 20 u/µl)) 
NEB 4 buffer 10x  2 µl  
H2O    13,4 µl 
 
The reaction was incubated at 25°C for 1h, following the digestion the enzyme was heat 
inactivated at 60°C for 20 minutes. One µl of the reaction was analyzed by agarose gel 
electrophoresis (0.7% agarose, 60 min at 60 V) to test for success and completeness of the 
reaction.  
13.1.1.2.3. PCR of pITy-QC 
The PCR was performed with the High Fidelity PCR Master from Roche Diagnostics GmbH, 
Penzberg, Germany. Fifty ng of template vector was used with oligonucleotides at a final 
concentration of 0,3 µM.  
 
 
Reaction setup, total volume: 50 µl:  
pITy-QC pector (linearized) 1 µl (50 ng)  
Forward primer  2 µl (stock at 7,5 µM) 
Reverse primer  2 µl (stock at 7,5 µM) 
H2O    20 µl 
Roche Master Mix  25 µl 
 
Cycling conditions 
 
1. Initial denaturation   94 °C  3 min 
2. denaturation  94 °C  30 sec 
3. annealing   55°C  30 sec 
4. elongation   68°C  4 min repeat 9 times from step 2 
5. denaturation  94°CV  30 sec 
6. annealing   55°C  30 sec 
7. elongation/polymerisation 4 min + 5 sec/cycle repeat 24 times from step 5 
8. polishing   68°C  10 minutes 
9. storage   4°C  ∞ 
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13.1.1.2.4. PCR purification of pITy-QC  
All solutions were from the PCR purification kit purchased from Qiagen, Hilden, Germany. The 
purification was performed with slight modifications of the supplied PCR purification protocol from 
Qiagen. Three 50 µl PCR mix were pooled and added to 5 volumes (750 µl) of binding buffer. A 
volume of 450 µl was placed onto a spin column and spun down once by a 30 seconds 
centrifugation at 14000 rpm, and after reloading with the remaining 450 µl, a second time for 60 
seconds. A volume of 750 µl of wash buffer was then added and the suspension was centrifuged 
twice at 14000 rpm for 60 seconds, after having discarded the flow through from the first spin. 
Products were eluted by adding 53 µl of low salt elution buffer (EB, 10 mM Tris at pH 8,5) to the 
centre of the Qiagen column membrane, and let stand for 60 seconds, to be finally spun down for 
60 seconds at 14000 rpm. 
13.1.1.2.5. Analysis and quantification of PCR products 
The analysis and the quantification of the PCR products was performed by loading a 1 µl sample of 
the reaction (added to 4 µl of loading buffer (LB-XL composition)) onto a 0.7% agarose gel which 
was run for 90 minutes at 45 V. The standards used for the quantification were at the following 
concentrations: 200 ng/µl, 100 ng/µl, 50 ng/µl and 10 ng/µl. One µl of each standard was loaded 
onto the gel in order to densitometrically determine the dsDNA concentration of the sample. 
13.1.1.2.6. BJ5464 strain culture 
Five ml of YPD medium were inoculated with 10 µl of a BJ5464 freezer stock, and cells were 
grown overnight at 30°C under agitation (220 rpm). 
13.1.1.2.7. Digestion of genomic DNA (gDNA) 
Two µg of M.jannaschii genomic DNA was digested with restriction endonuclease to release the 
fragments bearing the genes of interest (XmnI for PHOP and DASS, HindIII for TRK and NSS) to 
be cloned into pITY-QC.  Note: AAT was cloned from undigested genomic M. jannaschii DNA.  
 
Reaction setup, final volume 50 µl:  
 
M.jannaschii gDNA   10 µl (~2 µg) 
BSA (100x)   0,5 µl 
Restriction enzyme  5 µl (stock at 10 u/µl)) 
NEB 2 buffer 10x  5 µl  
H2O    29,5 µl 
 
The suspension was incubated overnight at 37°C, the endonuclease was inactivated by a 20 
minutes incubation at 60°C. 
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13.1.1.2.8. Transformation in BJ5464 yeast strains, plasmid construction via  
homologous recombination 
Fifty ml of YPD were inoculated with overnight starter culture to give an intial OD600 of 0,2. The 
culture was then incubated at 30°C and agitated at 220 rpm for 3,5 h until an OD600 of around ~ 1 
(anywhere between 0,8–1,2) was reached. Cells were then spun down for 5 min by a 4000 rpm 
centrifugation at room temperature. The supernatant was discarded and the pellet resuspended in 
25 ml sterile H2O. Cells were spun down again, the supernatant discarded, and the pelleted cells 
resuspended in 1 ml of 100 mM Lithium acetate (LiAc). Cells were spun down a third time by a 
brief 15 second centrifugation at 4000 rpm at RT, the pellet was finally resuspended in ~ 450 µl of 
100 mM LiAc, to reach a final volume of 500 µl (allowing up to 10 transformations). The 
suspension was divided into 50 µl aliquots, these were again centrifuged for 15 seconds at 
14000 rpm at RT. After removing of the supernatant from the transformation competent cells, a 
transformation mix was sequentially (see table: from top to bottom) added to the pellet.  
                                          Plates 
Chemicals 
protein Empty Trafo 
control
PEG 50% (w/v) (µl) 240 240 240 
LiAc 1M (µl) 36 36 36 
SSS-DNA (µl) 10 10 10 
pITy-QC (at 25 ng / µl) (µl) 4 4 --- 
digested M.jannaschii genomic 
DNA (at 40 ng / µl) (µl) 
25 --- --- 
pCD-P2 (µl) --- --- 1 
H2O (µl) 45 70 73 
Vtotal (µl) 360 360 360 
Table 7: Composition of the transformation mix. PEG: Polyethylene glycol, LiAc: Lithium acetate, SS-
DNA: Salmon Sperm DNA, pCD-P2: transformation control plasmid 
Cells were then vortexed until they were „more or less“ resuspended, and incubated first 30 
minutes at 30°C, then 60 minutes at 42°C. They were spun down for 15 seconds by a 7000 rpm 
centrifugation at RT. The transformation mix was discarded and the pelleted cells very carefully 
resuspended in 1 ml of YPD medium. The culture grew overnight at 30 °C and 220 rpm.  
The transformed cells were then spun down and resuspended in 500 µl of sterile water. 
SCØUracil/ 2% Glucose plates were inoculated with 250 µl of culture and incubated at 30°C for 3 
to 4 days until colonies appeared.   
13.1.1.2.9. Colony plasmid rescue of the transformant BJ5464+pITy-QC into E.coli 
One ml of sterile H2O was added on plates to resuspend the cells. Cell suspension was then 
centrifuged 1 minute at 14000 rpm. Supernatants were discarded and the pelleted cells 
resuspended in 100 µl of buffer TSN-TE8 (Tris-HCl 50 mM/EDTA 50 mM pH 8). The suspension 
was then mixed with glass beads (1/3 of the volume) with an addition of 50 µl phenol and 50 µl 
chloroform. The mixture was vortexed for 10 minutes at 14000 rpm at 4°C, and finaly centrifuged 
for 5 minutes at 14000 rpm at RT. The 50 µl of the aqueous phase was collected. 
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13.1.1.2.10. Transformation of E. coli cells by electroporation  
E.coli DH5α competent cells were transformed with the aqueous solution of the phenol/choroform 
extraction from the previously described colony plasmid rescue, to test if the recombination 
reaction was successful. From the 50 µl extract (DNA and plasmid), 5 µl were used (the resting 
45 µl were stocked at –20°C) and added to 70 µl of competent DH5α cells. The mixture was 
transfered in a pre-chilled electroporation cuvette and cooled 10 minutes on ice. The 
electroporation was then performed in a BioRad Gene Pulser with one pulse, at 1.5 kV, 400 Ω, 
25 µF. Then 0.5 ml of cold LB media were immediately added. Cells were carefully resuspended 
and incubated 45 minutes at 37°C, to allow regeneration of the cells, without selective pressure. 
Two LB/amp100 plates were inoculated with the cell suspension (with selective pressure), each with 
250 µl of cell suspension, and the plates were incubated overnight at 37°C, and let afterwards at 
4°C until sufficient growth.  
13.1.1.2.11. Colony PCR of plasmids rescue into E.coli, analyse on agarose gel 
Since the yeast colony PCR appears to be neither very robust nor reliable, the plasmids from the 
yeast transformation/homologous recombination gap closure cloning (gapture) experiments were 
previously shuttled into E.coli DH5α.  
Extensive screening is thought to facilitate the reliable detection of successfully gaptured plasmids. 
The number of insert positive clones might not reflect the true transformation efficiency in yeast. 
DG29 and DG30 oligonucleotides were used to help discrimination between parental plasmid or 
non-homologous end joined (NHEJ) plasmid.  
 
Colony PCR reaction mix: 
10 x Taq buffer  55 µl 
DG 29 (stock 182.5 µl) 1.51 µl 
DG 30 (stock 141.8 µM) 1.94 µl 
dNTPs (stock 4 mM)  27.5 µl 
Taq. pol. (5.5 U / µl)  11 µl 
H2O    343.1 µl 
Loading buffer  110 µl 
 
Each reaction has a 10 µl final volume, colonies were picked with sterile toothpicks, restreaked 
onto LB/kan100 and subsequently rolled in the reaction mix.   
Name        Sequence                                                                  bps      Tm     
 
DG29        5‘- GGG TAA TTA ATC AGC GAA GCG –3‘             21      ~ 61    
 
DG30        5‘-GCG TGA ATG TAA GCG TGA CA –3‘                20       ~ 61 
 
Table  8: Primers used for the colony PCR 
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PCR cycling conditions  
1.melting  96°C  120’’ 
2.melting  96°C  30’’ 
3.annealing  55°C  30’’ 
4.elongation  72°C  150’’   repeat 39 x from 2. 
5.polishing  72°C  600’’ 
6.storage  4°C  ∞ 
 
The entire reaction mix was loaded onto a 7% agarose gel, the migration was performed for 1h at 
60V. 
13.1.1.2.12. Culture of positive clones 
After identifying positive clones from the colony PCR, the restreaked colonies were used to 
inoculate 6 ml of LB/kan100 medium. The cultures grew overnight at 37°C / 200 rpm.  
 
13.1.1.2.13. Mini-preparation of E.coli and sequencing for verification 
Minipreps were prepared from each culture (4,5 ml) according to the protocol of Qiagen. A volume 
of 1,5 ml was kept for freezer stocks (925 µl culture + 75 µl DMSO). 
To further verify the proper insertion of the genes, sequencing was performed. To verify that the 
gene of interest was captured during homologous recombination, the appropriate PCR primers 
(DG29 and DG30) were used, further to verify the homologous recombination junctions (HR 
junctions), the promoter and the terminator (the primers will read into the genes from outside the 
promoter and terminator respectively). 
Reaction setup: 
Primer dilutions at 3,2 pmol/µl , 50 µl (3,2 µM) 
   1 rxn     42 rxn 
 
Big DyeV3.1:  2 µl    84 µl 
5M betaine:  2 µl    84 µl 
Seq. Buffer (2.5x) 2 µl    84 µl 
H2O:   2 µl    84 µl 
 
Eight µl were dispensed into each PCR tube, then mixed with 1 µl of oligonucleotide and 3 µl of 
plasmid (~ 500 ng). 
 
cycle sequencing conditions: 
1. denaturation:  95°C  3‘ 
2. denaturation:  95°C  30‘‘ 
3. annealing:  55°C  30‘‘ 
4. elongation:   60°C  4‘  repeat 50 x from step 2  
5. storage:  4°C  ∞ 
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13.1.1.2.14. Purification of sequencing products 
Ten µl of sterile H20 were added to the 10 µl of the cycle sequencing reaction. Nucleotide and 
enzyme removal was done with Autoseq G-50 micro-spin columns (Amersham Biosciences, 
Freiburg, Germany) The columns were vortexed to mix the gel-matrix, and centrifuged for 1 minute 
at 2000 g. The 20 µl volume was then placed on the top of the column, without disturbing the 
matrix. The column was centrifuged again, and the supernatant discarded. Samples were dryed in 
a speed vac for 20 min and then sent to the in-house sequencing service.  
The yeast cells were afterwards retransformed with positive plasmids (whose the sequence was 
confirmed).  
13.1.2. Turbidity measurements 
An Ultrospec 200A Spectrophotometer (Amersham Biosciences, Freiburg) was used to determine 
the culture turbidity at a wavelength of 600 nm. In general the samples were diluted with a 1:40 
ratio in H2O and measured in a disposable plastic cuvette with 10 mm pathlength, the blank was 
H2O. 
13.1.3. Agarose gel 
We routinely used TAE electrophoresis buffer, whose composition is described below: 
 
Buffer Tris-Acetate (TAE)  
 
Working solution1x : Tris-Acetate 0,04 M 
                                  EDTA  0,001 M 
 
Concentrated Stock (per Litre) 50x:  Tris base  242 g 
                 glacial acetic acid 57,1 ml 
EDTA (pH 8.0)  100 ml 0,5 M 
 
For a 1% gel in the small mold (10 x 7 cm), 3 g Agarose (Sigma-Aldrich, Munich, Germany) were 
mixed to 300 ml of 1xTAE to it. Agarose boiled in microwave, until being completely dissolved. It 
was then cooled down on the bench for a few minutes. From this molten agarose, 40 ml were 
transferred to a 50 ml centrifuge tube and ethidium bromide was added to a final concentration of 
0,5 µg/ml. The mixture was then poured into the small mold and left to set for 15 minutes. The gels 
were run routinely for 1h at 60 V. 
 
Preparation of the samples:  
Glycerol 87%  5.8 ml  
H2O    3.8 ml  
Bromophenol Blue  100 µl (saturated solution in water) 
Xylencyanol   100 µl (saturated solution in water) 
1 M Tris-HCl,pH 7.5 200 µl (20 mM final) 
Material and methods 
 
 105
13.1.4. Pheromone halo-assay for growth arrest in S.cerevisiae 
The response of yeast cells expressing the mutant Ste2mp to α-factor was analysed by halo-assay. 
This method was compiled from a number of different sources: Dohlman Lab protocols 
(http://www.med.unc.edu/~hdohlman/haloassay.html); (Liu et al., 2000; Abel et al., 1998a; Abel et 
al., 1998b; Raths et al., 1988)  
This method requires to use sterile techniques and sterile solutions throughout.  
Four starter culture of different yeast strains were grown at 30oC and 150-250 rpm until saturation. 
Saturation is important because cell density can affect the size of the halos. Sterilised solution of 
2% Noble agar (containing 2% glucose, rich medium YPD or appropriate selective medium Sc) 
was microwaved until melted and placed in a 55oC to 60oC water bath.  
Four paper disks (Difco) were distributed into a sterile petri dish, and spotted each with 5 to 15 µl 
of α-factor (from 1 to 5 mg/ml), corresponding to 0,1 μg, 0,5 μg, 1 μg and 10 μg of α-factor 
respectively. Immediately before performing the assay, a small volume of the four different 
saturated starter cultures was transferred into a 15 ml sterile centrifuge tube containing 2,4 ml of 
sterile water, 200 µl of culture from selective medium and 20 µl from rich medium (~ 1x106 cells). 
To this suspension, 1,6 ml of the 2% agar solution were added, the tube was inverted a few times 
and poured onto a pre-warmed plate containing the appropriate solid media, evenly covering the 
plate by swirling. The disks impregnated with α-factor were then placed on the plate. The plates 
were then let at 30oC until a lawn of cells appeared, halos are usually clearly visible after 24h for 
most strains. Differences in halo size are normally detected by eye.  
Fours plates were tested, they were inoculated with different ste2p complemented BY4741Δste2p 
strains. The ste2p constructs used for complementation were the wild type Ste2p, the FLAG- and 
His6-tag Ste2pFT-HT, and the mutated and tagged Ste2pN25,32Q-T326FT.HT. An untransformed strain 
ΔSte2p was used as negative control. 
13.2. Yeast culture and overexpression 
13.2.1. Culture media for S.cerevisiae 
Two different media were used: a selective medium and a complete rich medium, whose 
composition is described below: 
 
Selective complete medium for the culture of yeast cells expressing Ste2mp, lacking Uracil 
and Leucine: Sc ØUra Øleu    
For 1 litre 
Yeast Nitrogen Base Ø amino-acids  6,7 g  
Drop-out supplement medium  1,4 g  
Tryptophan     76 mg 
Histidin     76 mg 
Glucose     40 g 
0,5 M sodium phosphate buffer, pH 6,0 100 ml 
Material and methods 
 
 106
Selective complete medium for the culture of yeast cells expressing Aatp, lacking Uracil: 
Sc ØUra      
For 1 litre 
Yeast Nitrogen Base Ø amino-acids  6,7 g  
supplement medium Øuracil   1,92 g  
Tryptophan     76 mg 
Raffinose     40 g 
0,5 M sodium phosphate buffer, pH 6,0 100 ml 
 
Complete rich medium YPD (or YEPD – yeast extract peptone dextrose) 
For 1 Litre: 
Yeast extract    10 g (1%) 
Bacto-peptone   20 g (2%) 
Dextrose    20 g (2%)  
 
13.2.2. Culture conditions for the growth of yeast cells and protein expression 
Precultures were carried out by inoculation of 10 ml of growth medium (selective or rich) with 
100 μl of yeast transformant. Cells grew in preculture at 30°C for 48h until OD600 8 to 9 was 
reached, cultures were then diluted at 0,06 OD600 units in 1,5 litre of the same growth medium 
supplemented with 2% glucose or 4% raffinose. Yeast cells grew under constant agitation (130 
rpm) at 30°C for 24h until the desired OD600 was reached (1 to 2, 4 to 5, 6, 7, 9 or 11 to 12 the 
stationary phase). Expression of the protein of interest was induced at different points in time by 
addition of 2% galactose to the medium. In the case of the complete medium, as glucose inhibits 
the GAL1-promoter, glucose had to be removed from the medium before the addition of galactose. 
We therefore spun down the cells for 7 minutes at 5000xg, washed the pellet with sterile water, 
spun down the cells again, and repeated the protocol 3 times, and finally resuspended the pelleted 
cells in the induction medium. The induction was carried out for different intervals (4h, 5h, 8h or 
12h). After the specified interval cells were finally harvested by centrifugation for 10 minutes at 
5000xg at 4°C. The pelleted cells were washed one time with one volume of ice-cold sterile water, 
collected, frozen quickly in liquid nitrogen and stored at – 80°C. 
 
For all different growth conditions, aliquots of cells were collected, and total yeast membranes 
were isolated and analysed. 
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13.3. Biochemical methods 
13.3.1. Isolation of yeast total membranes 
 
Buffers used:  
Homogenisation buffer:   
50 mM Tris-HCl pH7,5 
  1 mM EDTA 
  1 mM β-mercaptoethanole 
    10% (w/v) glycerol 
 
Solubilisation buffer:    
  50 mM Tris-HCl pH7,5 
400 mM NaCl 
    1 mM β-mercaptoethanole 
      20% (w/v) glycerol) 
 
All manipulations were performed at 4°C, and all buffers contained the following protease inhibitors 
at these final concentrations: 1 μg/ml leupeptin, 17,4 μg/ml phenylmethylsulfonylfluoride and 
1 μg/ml pepstatin A.  
 
Cell pellets were thawed and resuspended in a ratio of 0,25 to 0,5 g (wet weight) per ml of ice-cold 
homogenisation buffer. Cells were then broken in a homogeniser, kept cool at 4°C (bead-beater, 
purchased from Roth Diagnostics GmbH), by vortexing with glass beads (Ø425-600 µm, Sigma 
Aldrich), in the proportion of 2,5 g of glass beads per ml of cell suspension. Glass beads were then 
sedimented by placing the homogeniser on ice, and the supernatant transferred to a fresh pre-
cooled centrifuge tube. Glass beads were washed twice in 5 ml of ice-cold homogenisation buffer / 
grams of cells. Samples were then centrifuged at 1600xg for 5 minutes to pellet unbroken cells and 
cell debris. Supernatants were centrifuged at 200 000xg (Beckman Type 45 Ti or 60 Ti rotors) for 
1h to sediment total membranes. The pellet consisting of sedimented crude membranes was 
resuspended in 1 volume of solubilisation buffer, in which the 400 mM NaCl permitted to strip 
peripheral membrane proteins.  
Membranes were then harvested for 1h by a 200 000xg centrifugation. The final pellet containing 
the crude stripped total membranes was resuspended in solubilisation buffer, and divided in 2 ml 
aliquots. An estimation of the concentration was made by micro-BCA assay in the presence of 
0,5% SDS using bovine serum albumin as standard. Aliquots were quickly frozen in liquid nitrogen 
and stored at – 80°C.  
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13.3.2. Quantification by micro-BCA assay 
Protein concentration was determined by quantitative calorimetric determination of proteins in 
dilute aqueous solutions. We used the Micro-BCATM Protein-assay Reagent Kit purchased from 
Pierce (Perbio Science Deutschland GmbH), and followed the protocol implemented by Pierce, 
without modifications. The reagent utilises bicinchoninic acid (BCA) as the detection reagent for 
Cu+, which is formed when Cu2+ is reduced by protein in an alkaline environment. The purple-
coloured reaction product is formed by the chelation of two molecules of BCA with one cuprous ion 
(Cu+). This water-soluble complex product exhibits a strong absorbance at 562 nm that is linear 
with increasing protein concentrations.  
 
13.3.3. Gel electrophoresis: denaturing SDS-PAGE (Tris-Tricine “Schägger” Gels) 
The separation of denaturated proteins with sodium dodecyl sulfate (SDS) was performed using 
the protocol as described by Schägger, H., and von Jagow, G. (Schägger, 1987). For separation of 
proteins in the desired range a 8% SDS-polyacrylamide gel was used. 
The acrylamide stock solution was Protogel (mixture 30% Acrylamide, 0,8% Bisacrylamide) 
purchased from National Diagnostics (Medco Diagnostika GmbH, München, Germany). 
The ammonium persulfate (APS) solution and the N,N,N´,N´,-Tetramethylethylendiamin (TEMED) 
catalysing the polymerisation reaction were purchased from Sigma (Munich, Germany).  
 
Stock solutions were prepared as described in Table 9 and Table 10.  
       Chemicals 
 
Buffers 
Tris-HCl 
 
SDS 
(w/v) 
Tricine 
(w/v) 
Glycerol 
(v/v) 
Bromophenol 
blue (w/v)       
(Serva-blue G) 
β-mercapto 
ethanol 
(v/v) 
Dithiothreitol
(w/v) 
Anode-buffer      
pH 8,9 
25 mM -- -- -- -- -- -- 
Cathode-buffer 
pH 8,25 
10 mM 0,01% 10 mM -- -- -- -- 
Gel buffer 
pH 8,45 
3 M 0,3% -- -- -- -- -- 
Loading-buffer 
6X, pH 6,8 
350 mM 10% -- 30% 0,1% 12% 9,3% 
 
TCA 
resuspension  
buffer, pH 11 
100 mM 3% -- -- -- -- 3 mM 
Table 9: Composition of the buffers for Tris-Tricine SDS-PAGE 
Material and methods 
 
 109
 
 Separating 
gel 
Stacking 
gel 
Protogel 1,13 ml 0,23 ml 
Gel buffer 1,34 ml 0,44 ml 
Glycerol 87% 0,4 ml -- 
ddH2O 1,32 ml 1,12 ml 
APS 10% (w/v)      28,3 µl         12 µl 
TEMED        5,8 µl        2,8 µl 
Final volume 4,3 ml 1,8 ml 
Table 10: Composition of stacking, and separating solutions for one Shägger gel (8%). 
 
All solutions were mixed in screw-capped centrifuge tubes with very gentle rocking. For solutions 
containing glycerol, glycerol was mixed with the gel buffer and water before addition of the 
acrylamide stock solution. 
 
The separation gel polymerised for 30 minutes in the electrophoresis apparatus, with a layer of 
isopropanol overlaid, to fasten the polymerisation by avoiding contact with oxygen.  
Then, after having rinsed with sterile H20, the stacking gel was poured and polymerised for 45 
minutes. After loading of the samples on the polymerised gels, they migrated at 100 mV for around 
1h30.  
For sample preparation, we mixed the 6X loading buffer at a ratio sample/buffer 3/1 to maintain an 
excess of SDS. The samples were heated immediately after adding sample buffer for 10 min at 
37oC, subsequently insoluble material was removed by centrifugation (17 000xg for 2 min) and the 
samples were then loaded immediately. 
13.3.4. TCA precipitation 
Protein precipitation is used to concentrate samples for gel analysis in a polyacrylamid-gel or to 
remove detergent, that can have negative influence on the migration of the protein in the SDS- 
PAGE.  
To the sample of protein solution, an equal volume of 20% trichloroacetic acid (TCA) was added, to 
get a 10% final concentration. It was mixed and kept for 15 min at –20ºC and then for 15 min at 
4ºC. The sample was then spun down 15 min at 14000 rpm and 4ºC. The supernatant was 
carefully discharged, the pellet retained and dried by inversion on tissue paper. For SDS-PAGE, 
the sample was resuspended in a minimal volume of TCA resuspension buffer (Table 9) and when 
in solution, with 6X loading buffer (Table 9). The presence of some TCA can give a yellow colour 
as a consequence of the acidification of the sample buffer. In this case we titrated with 1 N NaOH 
or 1 M TrisHCl pH 8.5 until obtaining the sample at an alkaline pH indicated by a blue colour of the 
sample buffer. 
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13.3.5. Deglycosylation  
To check for glycosylation of the protein, a deglycosylation attempt was performed with the 
enzyme PNGase F (“N-Glycosidase F”, New Englands Biolabs, Frankfurt am Main, Germany). 
PNGase F is an amidase from Flavobacterium meningosepticum (purcahsed from , that hydrolyse 
the N-Glycan of a glycoprotein. The experiment was performed with 20 µg of YpMEGA/T326-ura3d 
membranes. Membranes (8,7 µl) were mixed with 1 µl of 10x denaturing buffer ( 0,5% SDS, 1% β-
mercaptoethanol) and 0,3 µl H20, and incubated 10 minutes at 37°C. Then 1 µl of NP-40 
(detergent Nonident P-40), 1 µl of G7 buffer (0,5 M sodium Phosphate, pH 7,5) and ± 1 µl 
PNGase F enzyme were added and the reaction was carried out for 1h at 37°C. A positive control 
was performed with bovine fetuin (purchased from Sigma) to check if the enzyme was active.  
13.3.6. Concentration of the purification samples 
To concentrate the samples, we used the filter unit centricon YM-50 (Millipore, Schwalbach, 
Germany). Centricon tubes were centrifuged at the recommended speed (1500 rpm) repeatedly  
for 5 to 10 minutes until the desired volume or concentration was reached. This was depending on 
the quantity of proteins and the intial sample volume.   
 
13.3.7. Staining of proteins in gels 
13.3.7.1. Coomassie-blue staining, modified (Weber, K. and Osborn, M., 1969) 
The following solutions were used for the staining (Table 11). 
       Chemicals 
Buffers 
Serva-blue 
G-250 (w/v) 
Acetic acid
(v/v) 
Ethanol
(v/v) 
Glycerol 
(v/v) 
Staining 0,25% 10% 5% -- 
Destaining -- 10% 40% -- 
Drying -- -- 10% 5% 
Table 11: Composition of the buffers for Coomassie-blue staining 
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13.3.7.2. Silver-staining 
The following solution were used for the staining (Table 12). The same drying protocol as for the 
Coomassie-blue staining was followed. 
 Solutions Incubation time
Fixation 40% ethanol, 10% acetic acid 30 min 
Sensitising 30% ethanol 
0,5% (v/v) glutaraldehyde 
0,2% (w/v) Na2S2O3  
0,5 M sodium acetate  
30 min 
Wash H2O 3 x 5 min 
Staining 15 mM silver nitrate 
0,04% (v/v) formaldehyde 
20 min 
Wash H2O 2 x 1 min 
Developing 0,236 M sodium carbonate 
0,02% (v/v) formaldehyde 
2 to 30 min 
Stop 36 mM Na2 EDTA x 2 H2O 10 min 
Wash H2O 3 x 5 min 
Conservation 10% ethanol, 5% glycerol  30 min 
Table 12: Composition of the buffers for silver-staining 
 
13.3.8. Immuno-blot analyse  
As stock buffer, we used a 10X PBS (0,58 M Na2HPO4, 0,17 M NaH2PO4, 0,68 M NaCl). 
The blocking reagent is the I-BlockTM purchased from Perbio Science Deutschland GmbH.  
       Chemicals 
Buffers 
PBS Tween-20 Blocking 
reagent 
Blocking 1X 0,1% 0,2% 
wash 1X 0,1% -- 
Table 13: Composition of the buffers for Western-blotting or dot-blotting 
13.3.8.1. Western-Blot analysis 
Proteins were transferred from gel onto nitrocellulose membrane (ProtranBA 83, Schleicher & 
Schuell, Dassel)in a blotting tank apparatus for 1h at 100 V. A Towbin-buffer (25 mM Tris, 192 mM 
glycine, 0,1% SDS, 40% methanol, pH8,2-8,4) was used to pretreat the membrane, the gel and the 
filter paper. (Whatman, Maldstone, GB) After the transfer, the membrane was briefly rinsed with 
PBS 1X, and afterwards incubated in Blocking-buffer.  
13.3.8.1.1. Dot-Blot analyse 
A PVDF membrane (Westran®S PVDF-Membrane, Schleicher & Schuell, Dassel), pretreated with 
methanol, was placed onto the Dot-Blot apparatus. The samples were pipetted on the membrane. 
When dry, the membrane was incubated in Blocking-buffer, and the usual detection procedure was 
then followed.   
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13.3.8.1.2. Detection procedure 
The membrane was incubated in 10 ml of Blocking-buffer for 45 minutes to 1h. It was afterwards 
incubated for 45 minutes with the primary antibody (anti-penta-His antibody, Qiagen), diluted 
(1:5000) in 10 ml Blocking-buffer. Two washes of 5 minutes (20 ml each wash) were then 
performed with the wash-buffer. The membrane was then incubated for 45 minutes with the 
secondary antibody (Goat anti-mouse, IGG, Qiagen), diluted in 10 ml Blocking-buffer (1:20000), to 
be washed afterwards three times 5 minutes in 20 ml wash buffer. Membranes were then drained 
before being overlaid for 5 minutes by the substrate solution (1 ml for a 6x9 cm membrane). The 
substrate solution used to elicit the signal by chemiluminescence was a mix Luminol/Enhancer 
Solution at a ratio 1/1 (supersignal West Pico chemiluminescent Substrate, Perbio Science 
Deutschland GmbH, Bonn, Germany). To verify the efficiency of the transfer, the polyacrylamide 
gel was collected after the transfer and Coomassie-blue stained to verify the absence of proteins. 
The membrane was then placed under a plastic transparent slide in a dark room, a film was placed 
on top for various times (12 seconds to 4 minutes), and the photographic film (Kodak X-OMAT-AR, 
Kodak AG) was processed in a automated developer (Kodak X-OMAT 1000 processor). 
After scanning of the gel or the film, densitometric analysis of all gels and immuno-blots were 
performed with the PC-software “Scion image” (Scion corporation, Maryland, USA, release Beta 
4.0.2). The distribution of the signal intensity was determined with the help of the pixel evaluation 
algorithm and the peak surface was calculated by surface integration. 
 
13.4. Solubilisation 
All finally chosen manipulations were performed at 4°C unless stated otherwise, and all buffers 
contained a protease inhibitor cocktail at final concentrations of 1 μg/ml leupeptin, 17,4 μg/ml 
phenylmethylsulfonylfluoride and 1 μg/ml pepstatin A.  
 
The pellet of crude total membranes was incubated within the following different detergents: 
Dodecylmaltoside (DDM) 
N,N-Dimethyldodecylamine-N-oxide (LDAO) 
Polyoxyethylene-9-laurylether (C12E9) 
Triton X-100 (TX100) 
N-Octyl-β-D-Glucopyranoside (OG) 
N-Nonyl-β-D-Glucopyranoside (NG) 
N-Dodecyl-phosphocholine (FOS12) 
 
The incubation was carried out in solubilisation buffer, with or without 5 mM imidazole, under 
gentle rotation for different times (30 minutes and longer) at 4°C or RT, at a total membrane 
protein concentration of 5 mg/ml, with detergent at a ratio protein/detergent of 1/4, 1/2, 1/4 or 1/6 
(w/w). The suspension was centrifuged at 200 000xg for 1h and 4°C to remove unsolubilised 
material.  
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A presolubilisation was performed in the case of Ste2mp under the conditions previously defined 
(30 minutes, 4°C, ratio 1/4), chosing a detergent solubilising a high amount of total membrane 
proteins other than Ste2mp. After the ultra-centrifugation, the pellet was incubated with detergent 
solubilising low amount of total membrane proteins and high amount of Ste2mp. After the second 
ultracentrifugation, the pellets and supernatants were analysed. 
 
13.5. Purification 
13.5.1. Ste2mp purification 
13.5.1.1. Affinity chromotography  
13.5.1.1.1. Ni2+-NTA chromatography 
Ni2+-NTA beads (Amersham Pharmacia) were prepared by three wash steps in sterile H20, then 
pre-equilibrated with three wash steps with solubilisation buffer containing a concentration of DDM 
slightly above the CMC (0,2%).  
After the solubilisation and the last centrifugation, the supernatant containing the solubilised 
material was incubated with a gentle rotation at 4°C overnight with the prepared Ni2+-NTA beads 
(ratio: 100 mg of total membrane protein with 1 ml of beads). Ni2+-NTA beads were loaded onto a 
column, and the flow through collected. Beads were washed with wash buffer, that was collected 
for analysis. After the washing-step, proteins were eluted with elution buffer.  
 
Different chromatography parameters were checked for optimisation of the purification (binding to 
the beads, purity and homogeneity): the beads volume, the concentration of β-mercaptoethanol, 
the EDTA concentration, and the effect of urea. These trials were done on small scale, in a final 
volume of 2 ml, after a solubilisation from 10 mg of total protein within DDM.  
The effect of the beads volume was tested by using volumes of 10 μl, 25 μl or 50 μl of beads.  
We also tried various concentrations of β-mercaptoethanol ranging from 20 mM up to 0,75 mM 
EDTA.  
To avoid aggregation of the protein, we checked the effect of urea by adding 8 M urea in the 
sample and in the separating gel.  
All samples were analysed by immunoblotting. 
13.5.1.1.2. Other metal-NTA chromatographies 
Metal-affinity chromatography also was performed with other metal-ions: Copper (Cu2+-NTA), 
Cobalt (Co2+-NTA) or Zinc (Zn+-NTA). We used the same purification conditions for these matrices 
as for the Ni2+-NTA purification.  
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13.5.1.1.3. FLAG-affinity chromatography 
FLAG agarose was prepared in batch: 1 ml of resin (Sigma Aldrich) was washed 3 times in 0,1 M 
glycine-HCl pH 3,5 by centrifugation (4 minutes at 1000xg). The resin was then resuspended in 
7 ml of 50 mM Tris-HCl pH 7,5, 400 mM NaCl, 20% glycerol and 20 mM imidazole. Beads were 
afterwards pelleted and resuspended in 12 ml of the same buffer and pooled with the eluate from 
the affinity purification. The incubation was carried out overnight at 4°C with rotation.  
After the resin was packed, the flow through was collected, and the resin washed with the same 
buffer but supplemented with 125 mM imidazole, and the protein eluted with this buffer 
supplemented with 100 µg/ml of FLAG peptide (Sigma Aldrich). The column was stripped with 3 ml 
of 0,1 M glycine-HCl pH 3,5. 
13.5.1.2. Anion-exchange chromatography 
As Ste2mp has a pI of 8,93, we chose an anion-exchange chromatography. The eluates from the 
first purification were loaded onto a sepharose cation-exchange resin (CM SepharoseTM fast flow, 
Amersham Biosciences). The same protocol as for the affinity-chromatography was applied.  
In a batch procedure, 100 mg of total membranes were solubilised with 2% DDM. Then, a Ni2+-
NTA purification was performed and the eluate was concentrated to 3,5 ml. The concentrate was 
divided in 5 samples of 700 µl each (theoretically containing solubilised Ste2mp from 20 mg of total 
membranes) which were again concentrated in order to resuspend the samples in a final volume of 
500 µl of the desired buffers: 20 mM phosphate buffer pH6,5, 20 mM phosphate buffer pH7, 
20 mM HEPES buffer pH7,5, 20 mM HEPES buffer pH8, or 20 mM bicine buffer pH8,5. All buffers 
contained 20 mM NaCl. Each sample was incubated with 20 µl of resin for 10 minutes. The 
suspensions were then gently centrifuged to pellet the resin. The supernatants were collected and 
analysed on a Western-blot. The comparison of the amount of Ste2mp in the supernatants  to the 
one in the Ni2+-NTA eluate allowed an evaluation of the binding quality. The same procedure was 
performed by testing 100 µl resin. 
To test the effect of the NaCl concentration, a Ni2+-NTA purification was performed after a 
solubilisation of 200 mg of total membranes with 2% DDM,. We exchanged the buffer of the final 
eluate to 20 mM HEPES buffer pH 7,5 (containing 20 mM NaCl), before concentrating it to 4,5 ml. 
These 4,5 ml were then divided in 9 samples of 500 µl each (containing theoritically solubilised 
Ste2mp from ~20 mg of total membranes). Each sample was concentrated and resuspended in 
500 µl of the same buffer, but containing in addition different NaCl concentrations (50, 100, 150, 
200, 250, 300, 350, 400, or 450 mM). All samples were then incubated 10 minutes in the 100 µl of 
resin volume. After the incubation, the suspensions were then gently centrifuged to pellet the resin, 
the supernatants were collected and analysed on a Western-blot. The comparison of the amount of 
Ste2mp in the supernatants to the one in the Ni2+-NTA eluate allowed an evaluation of the NaCl 
concentration suitable for the protein elution.  
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13.5.1.3. Size-exclusion chromatography (gel-filtration) 
Eluates from the metal-affinity chromatography, concentrated and filtered, were analysed on a 
sephadex S200 column (pharmacia biotech), in Tris-HCl buffer pH 7,5. The flow was 40 µl/min. 
The loaded samples had a volume of 50 µl. Fractions of 80 µl were collected, and analysed on 
Coomassie-blue stained SDS gel and immunoblot. Fractions corresponding to a peak observed on 
the chromatogram were pooled and concentrated. 
13.5.1.4. Final buffers used for the different chromatographies 
 
Chemicals Chromatography Resin Steps Column 
Volumes 
(CV) 
Tris 
(mM) 
HEPES
(mM) 
NaCl 
(mM) 
Glycerol 
(%) 
Imidazole 
(mM) 
pH
wash 20 50 -- 400 20 50 7,5Ni2+-affinity  Ni2+-NTA 
elution 15 20 -- 150 20 500 7,5
wash 30 50 -- 400 20 0 7,5Other metal ions-
affinity  
Cu2+, Co2+, 
Zn+- NTA elution 15 20 -- 150 5 500 7,5
wash 20 50 -- 400 20 125 7,5Flag-affinity  Flag-
agarose elution 8 50 -- 400 20 125 7,5
wash 15 -- 20 150 5 100 7,5ion-exchange  Cation 
elution 10 -- 20 300 5 100 7,5
Size-exclusion  Sephadex wash 2 50 -- 300 10 100 7,5
Table 14: Summary of the different finaly chosen buffers used for the different chromatographies for 
Ste2mp 
All buffers contained 1 mM β-mercaptethanol and 500 mM α-factor. 
 
Optimised parameters Chromatography Resin 
Resin 
volume 
pH β-mercapto-
ethanol 
EDTA NaCl Urea 
Metal-affinity Ni2+-NTA X -- X X X X 
ion-exchange Cation X X -- -- X -- 
Table 15: Optimised parameters for each chromatography 
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13.5.2. Aatp purification 
13.5.2.1. Heat treatment 
Solubilisation was performed with each detergent, and the soluble fractions containing solubilised 
Aatp were submitted to heat treatment at different temperatures (65, 80 or 95°C) for 5 minutes or 
at 90°C for different times (5, 10 and 15 minutes), then cooled on ice for 10 minutes and 
centrifuged afterwards at 200 000xg for 1h at 4°C. Pellets were discarded, supernatants analysed 
on silver-stained SDS gel and immunoblot.   
In the case of the solubilisation within DM and DDM, a time-course of the stability of Aatp after heat 
treatment for different times was performed. Aatp was solubilised in the presence of DM or DDM 
and the solubilised samples were incubated at 90°C for different times: 1, 3, 5, 7 or 10 minutes.  
 
13.5.2.2. Metal-affinity chromatography with Ni2+- NTA beads, and heat treatment. 
Ni2+-NTA beads were prepared by three wash steps in sterile H20, then pre-equilibrated with three 
wash steps with solubilisation buffer containing a concentration of DDM slightly above the CMC 
(0,2%).  
This step was performed after a solubilisation of 100 mg of proteins in the presence of DDM. The 
supernatant containing the solubilised protein was incubated overnight at 4°C with 1 ml of Ni2+-
NTA beads. The beads were then packed in a column, the flow-through was collected.  
Beads were then washed with the wash buffer which was collected for analysis. After the washing-
step, proteins were eluted with the elution buffer. 
13.5.2.3. Size-exclusion chromatography. 
Eluates from the metal-affinity chromatography, concentrated and filtered, were analysed on a 
sephadex S200 column (Sephadex, Amersham Biosciences). The Na2HPO4 buffer was exchanged 
during this step into Tris-HCl buffer. The flow was 40 µl/min. The samples had a volume of 50 µl. 
Fractions of 80 µl were collected. The analysis of all samples on a Coomassie-stained SDS gel 
and immunoblot permitted to correlate the peak observed on the chromatogram with the presence 
of a band which migrated on the supposed size and corresponding to Aatp. The purest fractions 
were pooled and concentrated, and analysed by Mass-Spectrometry. The final buffers used for the 
different chromatographies are presented Table 16. 
Chemicals Chromatography Steps Column 
Volumes 
(CV) Tris (mM)
NaH2PO4 
(mM) 
NaCl 
(mM)
Glycerol 
(%) 
Imidazole 
(mM) 
pH 
wash 4 -- 50 400 20 10 8 Ni2+-affinity  
elution 16 -- 50 400 20 500 8 
Size-exclusion 
chromatography  
elution  50 -- 400 20 500  7,5 
Table 16: Composition of the final buffers for the chromatographies for Aatp 
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13.6. Radioactive assays 
13.6.1. Media and solutions for radioactive assays 
 
YM1 medium  
Per 1 litre 
Yeast Extract       5    g 
Bacto-peptone    10    g   
Yeast Nitrogen Base w/o amino acids   6,7 g   
Succinic acid     10    g   
Sodium hydroxide      6    g   
Glucose     10    g   
 
 
Sodium Azide: NaN3 (10 mM final concentration) 
Solubility in H2O is 41.7% at 17oC (Merck index) i.e. > 1 M 
 
Potassium Fluoride dihydrate: KF (10 mM final concentration) 
Solubility in H2O is 349.3 g/100 ml at 18oC (Merck index) i.e. > 1 M 
 
p-tosyl-L-arginine methyl ester: TAME (10 mM final concentration)  
Solubility in H2O is > 100 mM 
 
YM1+i medium  
The required amounts of NaN3, KF and are weighted and dissolved directly in the appropriate 
volume of YM1 buffer. NaN3 and KF are poisons of both oxidative and glycolytic energy 
metabolism that prevent cell growth and inhibit energy-dependent processes such as endocytosis 
that may affect binding, TAME inhibits proteolysis of α-factor  
 
Polyethyleneimine (PEI) 
PEI coats filters with a negative charge, which encourages the binding of proteins. It is used to help 
trap solubilised receptors and receptor containing membranes on the filter when separating the 
bound from unbound radioligand. We used GF/F filters (25 mm, Whatman, VWR international 
GmbH) instead of usual GF/B filters as some solubilised receptors have been reported to pass 
through GF/B filters.  
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α-factors 
[3H] α-factor (m.w. 1670) 
  Trp-His-Trp-Leu-Gln-Leu-Lys-Pro-Gly-Gln-Pro-Met-Tyr.  
 
1 mCi/ml; 56Ci/mmol ⇒ 1 µCi = 17.86 pmol = 17.86 µM 
           ⇒ 2.2 x 106 dpm = 17.86 pmol 
           ⇒ 123180 dpm = 1 pmol 
[L-Ala9]α-factor and [D-Ala9]α-factor 
Trp-His-Trp-Leu-Gln-Leu-Lys-Pro-Ala-Gln-Pro-Met-Tyr. 
The mutated codon Ala9 is underlined (peptide synthetised by the peptide synthese service of the 
Max-Planck-Institute of Biochemistry) 
 
13.6.2. Quantitation of α-factor receptor expression levels in yeast total membranes  
Both media YM1+i (wash buffer) and 0,3% PEI were cooled to 4°C. At least half an hour before 
use, GF/F filters were soaked in ice-cold 0,3% (v/v) PEI (in YM1+i) at 4oC.  
The following labeling buffers were prepared in minisorp tubes (that have low protein binding): 
YM1+i with 300 nM final of [3H]α-factor, and YM1+i with the same concentration of [3H]α-factor and 
300 µM final of non-radioactive α-factor (100xKD or 100xhighest concentration, which ever is 
greatest) to determine non-specific binding. 
[3H]α-factor binding was assessed by using 2 μg of stripped membranes. Membranes were thawed 
on ice, and diluted in ice-cold YM1+i so to reach a concentration of 0,13 mg/ml (2 µg of 
membranes in 15 µl). Specific binding was calculated at one concentration of [3H]α-factor (300 nM 
final) and by subtracting unspecific binding in the presence of non-radioactive α-factor from total 
binding.  
From the aliquots of diluted membranes, 15 µl were pipetted into 5 ml Minisorp tubes (Nalge Nunc 
international GmbH, Wiesbaden, Germany) at RT, and 15 µl of labeling buffer was added and 
mixed. After 5 min of incubation, 3x5 µl aliquots were collected to determine total [3H]α-factor 
concentration. The incubation was carried out for further 30 min at RT, and was then terminated by 
the addition of 500 µl of ice-cold YM1+i, and immediate filtered on presoaked GF/F filters. Filters 
were then placed in scintillation vials (20 ml Polyvials®, Zinsser analytic GmbH, Frankfurt, 
Germany) containing 10 ml of scintillation fluid (Rotiszint® eco plus, Roth GmbH). Samples were 
left overnight at RT before counting in a scintillation counter (liquid Scintillation Analyser, Tri-carb 
2100 TR, Packard). The dpm quantity was then divided by the specific activity to give the amount 
of pmol of receptor in the membranes. 
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13.6.3. Functionality binding-assay 
Both media YM1+i (wash buffer) and 0,3% PEI were cooled to 4°C. At least half an hour before 
use, GF/F filters were soaked in ice-cold 0,3% (v/v) PEI (in YM1+i) at 4oC.  
The following labeling buffers were prepared in Minisorp tubes (that have low protein binding 
reference: YM1+i with 300 nM final of [3H]α-factor, and YM1+i with the same concentration of 
[3H]α-factor and 300 µM final of non-radioactive α-factor (100xKd or 100xhighest concentration, 
which ever is greatest) to determine non-specific binding. 
[3H]α-factor binding was assessed by using 2 μg of stripped membranes. The membranes were 
thawed on ice, and diluted in ice-cold YM1+i so to reach a concentration of 0,13 mg/ml (2 µg of 
membranes for 15 µl). Specific binding was calculated by testing different concentrations of [3H]α-
factor, 25, 50,100, 300, 600 nM final, and by substracting the unspecific binding from total binding 
in the presence of non-radioactive α-factor.  
From the aliquots of diluted membranes, 25 µl were pipetted into Minisorp tubes at RT, and 25 µl 
of labeling buffer were added and mixed.  
After 5 min of incubation, 3x5 µl aliquots were collected to determine total [3H]α-factor 
concentration. The incubation was carried out for further 30 min at RT, and was then terminated by 
the addition of 500 µl of ice-cold YM1+i and immediate filtered on presoaked GF/F filters. Filters 
were then placed in scintillation tubes containing 10 ml of scintillation fluid. Samples were left 
overnight at RT before counting in a scintillation counter. The dpm quantity was then divided by the 
specific activity to give the amount of pmol of receptor in the membranes.  
 
13.6.4. Inhibition-assay 
Two atomically identical (but stereochemical distinct) α-factor stereoisomers, [L-Ala9]α-factor and 
[D-Ala9]α-factor were chosen because of their identical atomic compositions (and thus identical 
hydrophobicities). 
The media YM1+i (wash buffer) and 0,3% PEI were prepared first and cooled to 4°C before use. At 
least half an hour before use, GF/F filters were soaked in ice-cold 0,3% (v/v) PEI (in YM1+i) at 4oC. 
The following labeling buffers were prepared in Minisorp tubes (that have low protein binding): 
YM1+i with different concentrations of these competitors: 0, 3, 10, 30, 100, 300, 1000 and 3000 nM 
for the [D-Ala9]α-factor, and 0, 0,03, 0,1, 0,3, 1, 3, 10 and 30 nM for the [L-Ala9]α-factor. The non-
specific binding was determined with non-radioactive α-factor at a 30 µM final concentration. The 
[3H]α-factor solution had a fixed concentration of 600 nM.  
Membranes were then thawed on ice, and diluted in ice-cold YM1+i to reach a 0,13 mg/ml 
concentration (10 µg of membranes for 15 µl).  
From each individual test solution (also for the cold peptide solution), 150 µl were added to 20 µl of 
the diluted [3H]α-factor solution.  
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For each prepared solutions, 50 µl were pipetted in triplicate into fresh minisorp tubes. To start the 
binding reaction, 50 ml of the diluted membranes were added to each tube and incubated for 1h at 
RT. The reaction was then terminated by the addition of 500 µl of ice-cold YM1+i and immediately 
filtered on presoaked GF/F filters. Filters were then placed in scintillation tubes containing 10 ml of 
scintillation fluid. Samples were left overnight at RT before counting in a scintillation counter.  
To determine the total [3H]α-factor concentration, 3x5 µl aliquots were collected.  
 
13.7. Crystallisation  
13.7.1. Additional preparation for the crystallisation  
After the two-step purification performed as described above, the final eluate from the size-
exclusion chromatography was incubated with Biobeads (Biorad), at a ratio of 200 mg of beads for 
1 ml of solution, at 4°C under agitation. Aliquots of 30 µl were collected at different times (15, 30, 
45 minutes, 1h, 1h30, 2h, 2h30) and analysed on 8% SDS-polyacrylamide gel. 
The final pure protein sample was concentrated (2,5 mg/ml) and filtered and used for the 3D- and 
the 2D-crystallisation trials. 
13.7.2. 2D-crystallisation method 
Pure protein were sent to Dr. Patrick Bron (UMR-CNRS 6026 “Interactions cellulaires et 
moléculaires, Rennes, France) for 2D-crystallisation trials. The observations were done with the 
electronic microscope Technai Sphera 200 kV LAB6, after colouration of the samples by 2% uranyl 
acetate. 
13.7.2.1. Monolayer Nickel-Lipid 
The trials were performed according to the protocol of Levy and coworkers (Levy et al., 1999). The 
Ni2+-lipid monolayer was coated on the buffer surface in a Teflon well. Two different monolayers 
were used: one composed of 100% Ni2+-lipid (DOGS-NTA) and one composed of 50% / 50% lipids 
nickel/DOPC (DOGS-NTA/DOPC or DOGS-NTA/DOPG). This mixture was concentrated to 
0,5 mg/ml, in a chloroform/methanol solution. A volume of 0,5 ml was spread on the buffer surface, 
and left for at least 4h.  
The detergent-solubilised protein, at a final concentration of 1 mg/ml in the last purification buffer, 
was mixed with classical lipid mixture, composed of EPC/EPA of E.coli, or PEG. The final ratio 
lipid/protein, that has to be comprised between 0,2 and 1, was in this case of 0,5. After the 
monolayer was homogeneously spread on the air-buffer interface, between 5 to 8 µg (5 to 8 µl) of 
the protein/lipid solution were pipetted under the monolayer for incubation, through the injection 
hole. Detergent was added before inorder to remain above the CMC (concentration above 10 times 
the CMC).  
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After a 2h incubation, one can verify under the optical microscope the state of the monolayer. 
Different buffers with different ions were used, at a 20mM concentration: CaCl2, MgCl2 et MgSO4. 
DOTM was also tried, 5 µl at 0.5%. 
The rigidity of the monolayer was estimated with the photonic microscope. The rigidity is directly 
correlated with the amount of proteins that are bound to the monolayer. Biobeads were then added 
(~ 5mg) under slight agitation, to remove the excess of detergents. After a varying period (1 to 3 
days for example), the monolayer was transferred on an carbon grid, coloured with 2% uranyl 
acetate and observed on an electronic microscope. Sixteen crystallisation conditions were 
screened in total, with or without ions. 
13.7.2.2. Reconstitution in proteoliposomes 
Some reconstitution trials were also performed (classical method) with a mixture of lipids from 
E.coli. The two lipid/protein ratios tried were 0,2 and 0,8 (w/w), with or without 20 mM Mg2+, in a 
final volume of 50 µl, in the presence of DDM.  
The incubation was carried out overnight, before a sequential addition of 2 times 5 mg of Biobeads 
under slight agitation.  
After one day, the mixture was transferred to another tube to stop the absorption on Biobeads, and 
the incubation went on for a second day. As the observation revealed no successful reconstitution, 
to favour the proteoliposomes, three cycles of freezing/thawing (liquid nitrogen/ice) were 
performed, and samples were then left on the bench at RT one day before an additionnal 
observation. 
The detergent-solubilised protein was mixed with classical lipid mixture, composed of EPC/EPA of 
E.coli, or PEG (polyethylen glycol).  
The two lipid/protein ratios tried were 0,2 and 0,8 (w/w), with or without 20 mM Mg2+, in a final 
volume of 50 µl, with DDM. 
 
13.7.3. 3D-crystallisation method 
13.7.3.1. Manual trials (hanging-drop method) 
We used the silicon plates (Q-plates, 24 reservoirs) and the crystallisation screens from Hampton 
Research (Aliso Viejo, CA, USA): MembFac, Index, Crystal Screen 1 and Crystal Screen 2. For 
each condition, we used 0,5 ml for the reservoir, and we pipetted on a 22 mm silicon glassplate 
0,8 µl of protein sample, to which we added 0,5 µl from the reservoir. The glassplate was hung 
over the reservoir and the covered silicon plates were stored at 18°C. All drops were observed 
under the optical microscope Olympius SZX12. 
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13.7.3.2. Automated trials  
Automated assays were performed by Crelux GmbH, Martinsried, Germany. A total of 600 different 
conditions were screened, with the sitting-drop method. A volume of 0,1 µl of protein sample was 
used for each conditions. Covered plates were stored at 18°C. All drops were observed under the 
optical microscope Olympius SZX12.  
13.8. Characterisation 
13.8.1. N-terminal sequencing 
To confirm the sequence of the purified protein, 30 µl of the purified eluate were analysed by the 
N-terminal sequencing service of the Max-Planck-Institute of Biochemistry (department of Prof. 
Lottspeich). This analysis was performed by N-terminal Edman-sequencing. The sequence of the 
amino acids could be determined by the gradual digestion of the N-terminal part at each amino 
acid (selectively cleaves the N-terminal peptide bond).  
13.8.2. MALDI-TOF analysis 
Purified samples on SDS-PAGE were analysed by peptide mass fingerprint in the mass-
spectrometry analysis service of the Max-Planck-Institute of Biochemistry (group of Frank Siedler, 
department of Prof. Oesterhelt). 
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Abbreviations 
°C  degree Celsius        RNA  Ribonucleic acid 
A  Ampere                 RT  Room Temperature       
Å  Angström        sec         Seconds                         
ATP  Adenosine-5´-Triphosphate       SEC         Size-Exclusion Chromatography         
AmpR   Ampicilline resistance gene        TCA        Tricholoroacetic acid                     
APS  Ammonium Persulfate      TEMED   N,N,N´,N´-Tetramethyl-ethylendiamine                       
Bmax  Maximum Binding capacity      Tris         Tris-(Hydroxymethyl)-amminomethane                   
bp  Base paire                    u         unit                 
BSA   Bovine Serum Albumine             v/v         Volume per Volume           
CanR or kanR  Canamycin resistance gene        w/v         Weight per Volume 
Ci   Curie          w/w         Weight per Weight 
cm   centimetre        Ø         without 
CMC Critical micelle concentatrion           
Da   Dalton 
DMSO   Dimethylsulfoxid 
DNA   Deoxyribonucleic Acid 
dNTP Deoxyribonucleotid-triphosphate 
dpm   Disintegration per minute 
DTT   Dithiothreitol 
EDTA Ethylenediaminetetraacetic acid 
e.g.   exampli gratia 
Fig.   Figure     
g   Gram 
GDP   Guanidin-Diphosphate 
GPCR   g-Protein Coupled Receptor 
GTP   Guanidin-Triphosphate 
h   Hour 
i.e.   id est 
Kd   Dissociation constant 
kV   kilovolt 
l   litre 
µCi   microcurie 
µF   microfarad 
µl   microlitre 
µM   micromolar 
m   meter 
M   Molar 
mg   milligram 
min   minute(s) 
ml   millilitre 
MW   Molecular weight 
NeoR   Neomycin resistance gene 
nm   nanometre 
nM   nanomolar 
NTA   Nitrilotriacetic acid 
N-Glycosylation Asparagine-glycosylation 
Ω   Ohm 
ODx    Optical density at x nm 
PAGE Polyacrylamide Gel  
Electrophoresis 
PBS   Phosphate Buffered Saline 
PCR  Polymerase Chain Reaction 
PEG   Polyethylen Glycol 
pH reverse logarythmic  
representation of relative H+ 
concentration 
pmol  picomole 
PVDF  Polyvinyliden Fluoride 
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